LOCUS_COUNT	TraitNamesSuppl	CYTOBAND	CHR	BP	ID	A1	A2	A1_FREQ	BETA	SE	Z	P	ETA2	N	REGION	NEAREST_GENE	NEAREST_GENE_DESCRIPTION	NEAREST_GENE_BIOTYPE	DISTANCE	sbayes_cssizes	susieR_cssizes	finemap_cssize	NA	sbayes_genes	nonsyn_customPthresh	SMR_eqtl	SMR_sqtl	GTEx_singleTissue	GTEx_multiTissue	PoPS	prioritized	NA.1	GWAS_CATALOG	LITERATURE_LONG
1	white matter	1p34.3	1	39471759	1:39471759_CT_C	CT	C	0.8878	0.19904522	0.03377476	5.89331263937923	3.785e-09	0.000654196830982109	53057	downstream	AKIRIN1	akirin 1	protein_coding	0	3	22	21		AKIRIN1 (0.892) | NDUFS5 (0.072)	-	AKIRIN1 (rs35796260;1e-06) | RHBDL2 (rs2147594;4e-05)	NDUFS5 (rs4427397;7e-07)	AKIRIN1 (11;2e-20) | NDUFS5 (3;4e-08)	NDUFS5 (27/49;2e-39)	NDUFS5 (0.73) | AKIRIN1 (0.18) | RHBDL2 (0.15)	NDUFS5		-	Novel
2	white matter	1q21.3	1	153888217	rs552429854	T	TA	0.3675	0.14181831	0.02251521	6.29877802605439	3e-10	0.000722306285621774	54890	intronic	GATAD2B	GATA zinc finger domain containing 2B	protein_coding	0	6	6	5		GATAD2B (0.721) | DENND4B (0.149) | LOC343052 (0.135)	-	-	-	CREB3L4 (21;3e-33) | DENND4B (7;4e-07) | ENSG00000272030 (5;2e-07) | NUP210L (4;3e-06) | CRTC2 (4;5e-06) | SLC39A1 (3;5e-09) | RAB13 (2;8e-07) | SLC27A3 (2;5e-06) | S100A16 (2;1e-05) | S100A14 (1;5e-06) | S100A1 (1;8e-06) | CHTOP (1;2e-05) | S100A13 (1;2e-05) | SNAPIN (1;2e-05) | C1orf43 (1;1e-04)	NUP210L (25/29;3e-41) | CREB3L4 (38/49;1e-274) | ENSG00000272030 (38/49;1e-46) | CRTC2 (28/49;4e-27) | DENND4B (26/49;3e-52)	S100A4 (0.67) | RAB13 (0.47) | NPR1 (0.27)	DENND4B		Height	Smith_2020 (rs12133923)
2	grey and white matter	1q21.3	1	153888217	rs552429854	T	TA	0.3675	0.13140573	0.02156296	6.0940487762348	1.101e-09	0.000676146337077987	54890	intronic	GATAD2B	GATA zinc finger domain containing 2B	protein_coding	0	9	4	4		GATAD2B (0.615) | LOC343052 (0.161) | DENND4B (0.122) | SLC39A1 (0.075)	-	-	-	-	-	RAB13 (0.54) | S100A4 (0.54) | TPM3 (0.19)	RAB13		-	Smith_2020 (rs12133923)
3	white matter	1q25.3	1	180956936	rs35306826	A	T	0.5941	-0.22362235	0.02131966	-10.4890204628029	9.703e-26	0.00200042749118517	54890	intronic	STX6	syntaxin 6	protein_coding	0	6	30	30 | 258		STX6 (1.013)	-	STX6 (rs11586493;5e-20)	STX6 (rs57113693;1e-07)	STX6 (10;2e-13) | KIAA1614 (5;1e-12) | ENSG00000243155 (4;6e-08) | KIAA1614-AS1 (1;2e-07) | MR1 (1;1e-04)	-	IER5 (0.89) | STX6 (0.86) | MR1 (0.56)	STX6		Age at menopause | aseg lh intensity Accumbens-area | aseg lh number HolesBeforeFixing | aseg lh volume CerebralWhiteMatter | aseg rh intensity Accumbens-area | aseg rh intensity Cerebellum-Cortex | aseg rh number HolesBeforeFixing | aseg rh volume CerebralWhiteMatter | Brain morphology (MOSTest) | Brain region volumes | Central nucleus volume | Cortical thickness | Creutzfeldt-Jakob disease (sporadic) | Educational attainment | Height | IDP T1 FAST ROIs L ventral striatum | Intralaminar thalamic nuclei volume | KLK6/MOG protein level ratio | Lower thalamus volume | Medial temporal thickness (unadjusted for global measures) | Menopause (age at onset) | Paralaminar nucleus volume | Progressive supranuclear palsy | QC T2 FLAIR-to-T1 linear alignment discrepancy | Regional cortical thickness (rostralmiddlefrontal) | Regional cortical thickness (superiorfrontal) | Subcortical volume (MOSTest) | Vertex-wise cortical thickness | wg lh intensity-contrast caudalmiddlefrontal | wg lh intensity-contrast entorhinal | wg lh intensity-contrast frontalpole | wg lh intensity-contrast fusiform | wg lh intensity-contrast inferiorparietal | wg lh intensity-contrast inferiortemporal | wg lh intensity-contrast insula | wg lh intensity-contrast isthmuscingulate | wg lh intensity-contrast lateraloccipital | wg lh intensity-contrast lateralorbitofrontal | wg lh intensity-contrast lingual | wg lh intensity-contrast medialorbitofrontal | wg lh intensity-contrast middletemporal | wg lh intensity-contrast parahippocampal | wg lh intensity-contrast parsopercularis | wg lh intensity-contrast parsorbitalis | wg lh intensity-contrast parstriangularis | wg lh intensity-contrast posteriorcingulate | wg lh intensity-contrast precuneus | wg lh intensity-contrast rostralanteriorcingulate | wg lh intensity-contrast rostralmiddlefrontal | wg lh intensity-contrast superiorfrontal | wg lh intensity-contrast superiorparietal | wg lh intensity-contrast superiortemporal | wg lh intensity-contrast supramarginal | wg lh intensity-contrast temporalpole | wg rh intensity-contrast bankssts | wg rh intensity-contrast caudalmiddlefrontal | wg rh intensity-contrast frontalpole | wg rh intensity-contrast fusiform | wg rh intensity-contrast inferiorparietal | wg rh intensity-contrast inferiortemporal | wg rh intensity-contrast insula | wg rh intensity-contrast isthmuscingulate | wg rh intensity-contrast lateraloccipital | wg rh intensity-contrast lateralorbitofrontal | wg rh intensity-contrast lingual | wg rh intensity-contrast medialorbitofrontal | wg rh intensity-contrast middletemporal | wg rh intensity-contrast parahippocampal | wg rh intensity-contrast parsopercularis | wg rh intensity-contrast parsorbitalis | wg rh intensity-contrast parstriangularis | wg rh intensity-contrast posteriorcingulate | wg rh intensity-contrast precuneus | wg rh intensity-contrast rostralanteriorcingulate | wg rh intensity-contrast rostralmiddlefrontal | wg rh intensity-contrast superiorfrontal | wg rh intensity-contrast superiorparietal | wg rh intensity-contrast superiortemporal | wg rh intensity-contrast supramarginal | wg rh intensity-contrast temporalpole | White matter microstructure (mode of anisotropy) | Whole brain restricted directional diffusion (multivariate analysis) | Whole brain restricted isotropic diffusion (multivariate analysis)	Smith_2020 (rs6665134), Kim_2023 (rs534102361)
3	grey and white matter	1q25.3	1	180956936	rs35306826	A	T	0.5942	-0.16650624	0.02042709	-8.15124621274983	3.602e-16	0.00120905265193498	54890	intronic	STX6	syntaxin 6	protein_coding	0	2	35	35		STX6 (0.988)	-	STX6 (rs11586493;2e-13)	STX6 (rs57113693;1e-06)	STX6 (10;2e-13) | KIAA1614 (5;1e-12) | ENSG00000243155 (4;6e-08) | KIAA1614-AS1 (1;1e-07) | MR1 (1;1e-04)	-	IER5 (0.72) | STX6 (0.68) | MR1 (0.67)	STX6		Age at menopause | aseg lh intensity Accumbens-area | aseg lh number HolesBeforeFixing | aseg lh volume CerebralWhiteMatter | aseg rh intensity Accumbens-area | aseg rh intensity Cerebellum-Cortex | aseg rh number HolesBeforeFixing | aseg rh volume CerebralWhiteMatter | Brain morphology (MOSTest) | Brain region volumes | Central nucleus volume | Cortical thickness | Creutzfeldt-Jakob disease (sporadic) | Educational attainment | Height | IDP T1 FAST ROIs L ventral striatum | Intralaminar thalamic nuclei volume | KLK6/MOG protein level ratio | Lower thalamus volume | Medial temporal thickness (unadjusted for global measures) | Menopause (age at onset) | Paralaminar nucleus volume | Progressive supranuclear palsy | QC T2 FLAIR-to-T1 linear alignment discrepancy | Regional cortical thickness (rostralmiddlefrontal) | Regional cortical thickness (superiorfrontal) | Subcortical volume (MOSTest) | Vertex-wise cortical thickness | wg lh intensity-contrast caudalmiddlefrontal | wg lh intensity-contrast entorhinal | wg lh intensity-contrast frontalpole | wg lh intensity-contrast fusiform | wg lh intensity-contrast inferiorparietal | wg lh intensity-contrast inferiortemporal | wg lh intensity-contrast insula | wg lh intensity-contrast isthmuscingulate | wg lh intensity-contrast lateraloccipital | wg lh intensity-contrast lateralorbitofrontal | wg lh intensity-contrast lingual | wg lh intensity-contrast medialorbitofrontal | wg lh intensity-contrast middletemporal | wg lh intensity-contrast parahippocampal | wg lh intensity-contrast parsopercularis | wg lh intensity-contrast parsorbitalis | wg lh intensity-contrast parstriangularis | wg lh intensity-contrast posteriorcingulate | wg lh intensity-contrast precuneus | wg lh intensity-contrast rostralanteriorcingulate | wg lh intensity-contrast rostralmiddlefrontal | wg lh intensity-contrast superiorfrontal | wg lh intensity-contrast superiorparietal | wg lh intensity-contrast superiortemporal | wg lh intensity-contrast supramarginal | wg lh intensity-contrast temporalpole | wg rh intensity-contrast bankssts | wg rh intensity-contrast caudalmiddlefrontal | wg rh intensity-contrast frontalpole | wg rh intensity-contrast fusiform | wg rh intensity-contrast inferiorparietal | wg rh intensity-contrast inferiortemporal | wg rh intensity-contrast insula | wg rh intensity-contrast isthmuscingulate | wg rh intensity-contrast lateraloccipital | wg rh intensity-contrast lateralorbitofrontal | wg rh intensity-contrast lingual | wg rh intensity-contrast medialorbitofrontal | wg rh intensity-contrast middletemporal | wg rh intensity-contrast parahippocampal | wg rh intensity-contrast parsopercularis | wg rh intensity-contrast parsorbitalis | wg rh intensity-contrast parstriangularis | wg rh intensity-contrast posteriorcingulate | wg rh intensity-contrast precuneus | wg rh intensity-contrast rostralanteriorcingulate | wg rh intensity-contrast rostralmiddlefrontal | wg rh intensity-contrast superiorfrontal | wg rh intensity-contrast superiorparietal | wg rh intensity-contrast superiortemporal | wg rh intensity-contrast supramarginal | wg rh intensity-contrast temporalpole | White matter microstructure (mode of anisotropy) | Whole brain restricted directional diffusion (multivariate analysis) | Whole brain restricted isotropic diffusion (multivariate analysis)	Smith_2020 (rs6665134), Kim_2023 (rs534102361)
4	white matter	1q32.3	1	212557599	rs3767867	T	C	0.6179	-0.13722613	0.02147043	-6.3914011037506	1.644e-10	0.000743689483086275	54890	intronic	PACC1	proton activated chloride channel 1	protein_coding	0	-	-	24		-	-	PACC1 (rs6540738;2e-08)	TMEM206 (rs765364;8e-06)	LINC02608 (15;2e-18) | PACC1 (14;1e-18) | PPP2R5A (5;1e-19) | ENSG00000229832 (3;2e-09) | NENF (2;1e-04) | LINC02771 (1;1e-04)	LINC02608 (17/25;2e-115) | ENSG00000229832 (21/39;1e-27)	PPP2R5A (0.44) | NENF (0.38) | TMEM206 (0.36)	PACC1		Height	Novel
4	grey and white matter	1q32.3	1	212557599	rs3767867	T	C	0.6179	-0.12561551	0.0205648	-6.10827773671516	1.007e-09	0.000679305336481238	54890	intronic	PACC1	proton activated chloride channel 1	protein_coding	0	-	-	93 | 119		-	-	PACC1 (rs6540738;4e-08)	TMEM206 (rs765364;1e-05)	LINC02608 (15;2e-18) | PACC1 (14;1e-18) | PPP2R5A (5;1e-19) | ENSG00000229832 (3;2e-09) | NENF (2;1e-04) | LINC02771 (1;1e-04)	LINC02608 (17/25;2e-115) | ENSG00000229832 (21/39;1e-27)	ATF3 (0.50) | TMEM206 (0.38) | NENF (0.27)	TMEM206		Height	Novel
5	grey matter	1q41	1	215139887	rs1452628	A	T	0.6216	0.1945586	0.02164881	8.98703439126677	2.54e-19	0.00146932143234279	54890	intergenic	KCNK2	potassium two pore domain channel subfamily K member 2	protein_coding	38998	7	4	2 | 13		KCNK2 (0.956)	-	-	-	KCNK2 (1;2e-05)	-	KCNK2 (0.95) | CENPF (0.45)	KCNK2		aparc-a2009s lh thickness S-cingul-Marginalis | aparc-a2009s lh thickness S-intrapariet+P-trans | Brain morphology (min-P) | Brain morphology (MOSTest) | Brain region volumes | Brain shape (segment 1) | Cortical surface area | Cortical thickness | Cortical thickness (min-P) | Cortical thickness (MOSTest) | Edge-level brain connectivity (multivariate analysis) | Extensive hippocampal perivascular space burden | Extensive white matter perivascular space burden | Left-hemisphere dorsal attention network to left-hemisphere default mode network white-matter structural connectivity | Left-hemisphere somatomotor network to left-hemisphere default mode network white-matter structural connectivity | Node-level brain connectivity (multivariate analysis) | Regional cortical thickness (precuneus) | Regional cortical thickness (superiorparietal) | Superior parietal thickness (unadjusted for global measures) | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 91) | Vertex-wise cortical surface area | Vertex-wise cortical thickness | Vertex-wise sulcal depth | Whole brain free water diffusion (multivariate analysis) | Whole brain restricted directional diffusion (multivariate analysis) | Whole brain restricted isotropic diffusion (multivariate analysis)	Wen_2024 (rs1452628), Jonsson_2019 (rs1452628)
5	white matter	1q41	1	215147374	rs78300504	A	G	0.0684	-0.2584537	0.04146299	-6.23335895457612	4.565e-10	0.000707391020724562	54890	intergenic	KCNK2	potassium two pore domain channel subfamily K member 2	protein_coding	31511	6	10	9		KCNK2 (0.962)	-	-	-	KCTD3 (1;6e-05)	-	KCNK2 (0.22) | CENPF (0.05)	KCNK2		Brain morphology (MOSTest) | Brain region volumes | IDP dMRI ProbtrackX ISOVF slf l | IDP dMRI ProbtrackX ISOVF slf r | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 81)	Wen_2024 (rs1452628), Jonsson_2019 (rs1452628)
6	white matter	2p16.1	2	56116193	2:56116193_TTGATTCTTGGCCTCCCTCCC_T	T	TTGATTCTTGGCCTCCCTCCC	0.0955	0.20201504	0.03609678	5.59648367527519	2.187e-08	0.000570302566903605	54890	intronic	EFEMP1	EGF containing fibulin extracellular matrix protein 1	protein_coding	0	-	-	35 | 390		-	-	-	-	EFEMP1 (1;6e-05)	-	CCDC104 (0.21) | PNPT1 (0.16) | SMEK2 (0.13)	EFEMP1		Extensive white matter perivascular space burden | Inguinal hernia | Periventricular white matter hyperintensities | White matter hyperintensities | White matter hyperintensity volume | Whole brain free water diffusion (multivariate analysis) | Whole brain restricted isotropic diffusion (multivariate analysis)	Novel
7	grey matter	2q32.1	2	188028317	rs62172472	A	G	0.2021	-0.1513803	0.02616551	-5.78549013567861	7.23e-09	0.000609450092185261	54890	intergenic	CALCRL	calcitonin receptor like receptor	protein_coding	178375	5	176	171		CALCRL (0.909) | TFPI (0.104)	TFPI (1;rs7586970;20.200)	-	-	CALCRL-AS1 (9;4e-11) | CALCRL (7;1e-70) | TFPI (7;4e-07) | FAM171B (2;2e-06)	CALCRL-AS1 (23/45;6e-62)	CALCRL (0.90) | TFPI (0.88)	TFPI		A body shape index | Aspartate aminotransferase levels | Cancer (pleiotropy) | Eczema | Heel bone mineral density | Height | High density lipoprotein cholesterol levels | Lymphocyte count | Resting heart rate | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 98) | Waist circumference adjusted for body mass index | Waist-hip index | Waist-to-hip ratio adjusted for BMI | White blood cell count | White matter hyperintensities | White matter hyperintensity volume | White matter hyperintensity volume (adjusted for hypertension) | White matter hyperintensity volume x hypertension interaction (2df) | Whole brain free water diffusion (multivariate analysis)	Novel
8	white matter	2q32.2	2	190694175	rs1233297	T	C	0.2649	0.16370119	0.02356731	6.94611264501549	3.755e-12	0.000878263117912736	54890	intronic	PMS1	PMS1 homolog 1%2C mismatch repair system component	protein_coding	0	32	67	66		PMS1 (0.423) | ORMDL1 (0.200) | ANKAR (0.166) | ASNSD1 (0.062) | ASDURF (0.046) | OSGEPL1 (0.044) | OSGEPL1-AS1 (0.021)	-	ORMDL1 (rs6741074;2e-10) | AC013468.1 (rs10197331;3e-10) | OSGEPL1-AS1 (rs757537817;4e-07)	ORMDL1 (rs1233272;4e-08) | PMS1 (rs10210345;6e-08) | OSGEPL1-AS1 (rs10210345;6e-06)	ORMDL1 (47;7e-99) | ASNSD1 (46;6e-80) | OSGEPL1-AS1 (33;2e-22) | ENSG00000273240 (32;6e-20) | PMS1 (17;7e-42) | ANKAR (3;1e-05) | OSGEPL1 (3;6e-05) | HIBCH (1;5e-05)	ORMDL1 (48/49;0e+00) | OSGEPL1-AS1 (47/49;7e-227) | HIBCH (46/49;7e-20) | ASNSD1 (42/49;0e+00) | ENSG00000273240 (42/49;2e-302) | PMS1 (29/49;8e-151) | ANKAR (29/49;2e-26) | OSGEPL1 (28/49;2e-20)	C2orf88 (0.25) | ANKAR (0.16) | OSGEPL1 (0.15)	ORMDL1		p53 and DNA damage-regulated protein 1 levels	Smith_2020 (rs151052089)
8	grey and white matter	2q32.2	2	190700494	rs1233245	A	G	0.2528	0.14012091	0.02300453	6.09101381336632	1.122e-09	0.000675473489736865	54890	intronic	PMS1	PMS1 homolog 1%2C mismatch repair system component	protein_coding	0	11	-	115		ORMDL1 (0.464) | PMS1 (0.288) | ASDURF (0.125) | OSGEPL1-AS1 (0.049) | ANKAR (0.045)	-	ORMDL1 (rs6741074;4e-08) | AC013468.1 (rs10197331;5e-08) | ASNSD1 (rs2289226;6e-08) | OSGEPL1-AS1 (rs757537817;4e-06)	PMS1 (rs10210345;2e-07) | ORMDL1 (rs1233272;8e-07) | OSGEPL1-AS1 (rs10210345;3e-05)	ORMDL1 (47;2e-73) | ASNSD1 (46;6e-56) | OSGEPL1-AS1 (33;7e-20) | ENSG00000273240 (32;1e-13) | PMS1 (16;5e-33) | ANKAR (3;2e-05) | OSGEPL1 (3;6e-05) | HIBCH (1;4e-05)	ORMDL1 (48/49;0e+00) | HIBCH (47/49;4e-27) | OSGEPL1-AS1 (46/49;7e-184) | ASNSD1 (41/49;0e+00) | ENSG00000273240 (40/49;4e-198) | ANKAR (29/49;2e-26) | OSGEPL1 (28/49;2e-20) | PMS1 (26/49;7e-112)	ASNSD1 (0.14) | ANKAR (0.14) | HIBCH (0.13)	ORMDL1		p53 and DNA damage-regulated protein 1 levels	Smith_2020 (rs151052089)
9	grey matter	2q33.1	2	198567638	rs12619333	C	G	0.6678	0.137745	0.02259225	6.09700229060851	1.081e-09	0.00070016792542584	53057	intergenic	MARS2	methionyl-tRNA synthetase 2%2C mitochondrial	protein_coding	2455	17	-	436		SF3B1 (0.293) | PLCL1 (0.198) | RFTN2 (0.156) | HSPD1 (0.120) | ANKRD44-IT1 (0.097) | ANKRD44 (0.049) | HSPE1-MOB4 (0.047)	-	-	-	SF3B1 (20;5e-19) | ANKRD44 (6;1e-20) | PLCL1 (5;5e-13) | RFTN2 (4;4e-08) | ANKRD44-AS1 (3;6e-14) | MARS2 (2;6e-05) | ENSG00000222017 (1;6e-05) | HSPD1 (1;2e-04)	SF3B1 (44/49;3e-154)	PLCL1 (1.38) | RFTN2 (0.49) | HSPD1 (0.30)	SF3B1		Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy) | Bipolar disorder or glomerular filtration rate estimated from cystatin (MTAG) | Bipolar disorder or major depressive disorder | Brain morphology (MOSTest) | Cortical surface area | Depression | Dorsolateral prefrontal area (unadjusted for global measures) | Dorsomedial frontal area (unadjusted for global measures) | Inferior parietal area (unadjusted for global measures) | Intracranial aneurysm | Motor premotor area (unadjusted for global measures) | Orbitofrontal area (unadjusted for global measures) | Parsopercularis area (unadjusted for global measures) | Platelet count | Precuneus area (unadjusted for global measures) | Right molecular layer hippocampal volume (head) | Schizophrenia | Superior temporal area (unadjusted for global measures) | Whole brain restricted directional diffusion (multivariate analysis) | Whole brain restricted isotropic diffusion (multivariate analysis)	Novel
9	grey and white matter	2q33.1	2	198245965	rs55775495	T	C	0.6477	0.12655777	0.02091293	6.05165177715413	1.434e-09	0.000666777258944524	54890	intergenic	SF3B1	splicing factor 3b subunit 1	protein_coding	10733	16	279	279		PLCL1 (0.389) | SF3B1 (0.388) | RFTN2 (0.086) | HSPE1-MOB4 (0.056) | HSPD1 (0.032)	-	SF3B1 (rs2914983;6e-07)	SF3B1 (rs2565163;7e-05)	SF3B1 (21;1e-16) | ANKRD44 (7;1e-23) | PLCL1 (4;2e-08) | RFTN2 (4;4e-05) | ANKRD44-AS1 (3;1e-17) | ENSG00000222017 (1;7e-05) | HSPD1 (1;1e-04)	SF3B1 (42/49;3e-143)	PLCL1 (1.31) | HSPD1 (0.72) | HSPE1 (0.37)	SF3B1		Autism spectrum disorder or schizophrenia | Bipolar disorder (MTAG) | Bipolar disorder or glomerular filtration rate estimated from cystatin (MTAG) | Brain morphology (MOSTest) | Cognitive ability, years of educational attainment or schizophrenia (pleiotropy) | Cortical surface area | Cortical thickness | Depression | Dorsolateral prefrontal area (unadjusted for global measures) | Dorsomedial frontal area (unadjusted for global measures) | Edge-level brain connectivity (multivariate analysis) | Hay fever and/or eczema | Insomnia | Major depressive disorder (broad) | Motor premotor area (unadjusted for global measures) | Orbitofrontal area (unadjusted for global measures) | Parsopercularis area (unadjusted for global measures) | Precuneus area (unadjusted for global measures) | Schizophrenia | Schizophrenia (MTAG) | Superior temporal area (unadjusted for global measures) | Vertex-wise cortical surface area | Vertex-wise cortical thickness | Vertex-wise sulcal depth | Whole brain restricted isotropic diffusion (multivariate analysis)	Novel
10	grey matter	2q33.1	2	201160771	rs1367858	T	C	0.3362	0.14620146	0.02213611	6.60465908418417	3.984e-11	0.000794105843045781	54890	intergenic	SPATS2L	spermatogenesis associated serine rich 2 like	protein_coding	9831	8	-	309 | 523		SPATS2L (0.961)	-	-	-	FTCDNL1 (21;9e-09) | C2orf69 (6;2e-08) | SPATS2L (5;1e-18) | TYW5 (2;3e-05) | MAIP1 (1;2e-07) | ENSG00000232732 (1;9e-05)	FTCDNL1 (46/49;5e-118) | C2orf69 (31/49;4e-39) | TYW5 (31/49;5e-26)	SPATS2L (0.46) | C2orf69 (0.27) | TYW5 (0.22)	SPATS2L		Bipolar disorder (MTAG) | Cognitive performance (MTAG) | Highest math class taken (MTAG) | Reaction time | Schizophrenia	Novel
10	grey and white matter	2q33.1	2	201160771	rs1367858	T	C	0.3364	0.13277712	0.02112852	6.28426032679998	3.294e-10	0.00071898290762781	54890	intergenic	SPATS2L	spermatogenesis associated serine rich 2 like	protein_coding	9831	6	-	123		SPATS2L (0.954)	-	-	-	FTCDNL1 (21;9e-09) | C2orf69 (6;2e-08) | SPATS2L (5;1e-18) | TYW5 (2;3e-05) | MAIP1 (1;2e-07) | ENSG00000232732 (1;9e-05)	FTCDNL1 (46/49;5e-118) | C2orf69 (31/49;4e-39) | TYW5 (31/49;5e-26)	SPATS2L (0.59) | C2orf69 (0.30) | TYW5 (0.17)	SPATS2L		Bipolar disorder (MTAG) | Cognitive performance (MTAG) | Highest math class taken (MTAG) | Reaction time | Schizophrenia	Novel
11	grey and white matter	2q33.2	2	203877365	rs530464314	CA	C	0.1432	-0.22801074	0.02917442	-7.81543352018652	5.477e-15	0.00111159276908058	54890	intergenic	NBEAL1	neurobeachin like 1	protein_coding	2237	6	262	264		CARF (0.505) | NBEAL1 (0.392) | WDR12 (0.058)	WDR12 (1;rs35212307;15.630) | CARF (1;rs72932557;1.747)	ICA1L (rs72932772;6e-12) | CARF (rs143805266;7e-10) | NBEAL1 (rs72932588;1e-09)	ICA1L (rs72932780;4e-11) | CARF (rs72934745;5e-10) | NBEAL1 (rs115400054;4e-07)	CARF (22;1e-35) | ICA1L (18;8e-33) | NBEAL1 (13;4e-69) | FAM117B (6;2e-09) | WDR12 (2;3e-05) | BMPR2 (1;8e-06) | ENSG00000273456 (1;1e-04) | CYP20A1 (1;3e-04)	CARF (38/49;4e-217) | ICA1L (25/49;3e-195)	CYP20A1 (0.33) | ICA1L (0.26) | WDR12 (0.19)	CARF		Alzheimer's disease | Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile) | Angina pectoris | Body fat percentage or coronary artery disease (MTAG) | Brain morphology (MOSTest) | Cholesterol, total | Coronary artery disease | Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease) | Coronary artery disease or fibrinogen levels (pleiotropy) | Coronary artery disease or ischemic stroke | Coronary artery disease or large artery stroke | Coronary artery disease or plasminogen activator inhibitor 1 levels (pleiotropy) | Coronary artery disease or tissue plasminogen activator levels (pleiotropy) | Coronary heart disease | Cortical surface area | Cortical thickness | Extensive basal ganglia perivascular space burden | Headache or migraine | Hemoglobin concentration | IDP dMRI TBSS ISOVF External capsule L | IDP dMRI TBSS L2 Anterior limb of internal capsule R | Insomnia | Migraine | Migraine (MTAG) | Myocardial infarction | Myocardial infarction (early onset) | Non-lobar intracerebral hemorrhage (MTAG) | Periventricular white matter hyperintensities | Personality traits or cognitive traits (multivariate analysis) | Pulse pressure | Renin levels | Small vessel stroke (MTAG) | Smoking initiation | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 6) | Vertex-wise cortical thickness | White matter fractional anisotropy x age interaction (2df) | White matter hyperintensities | White matter hyperintensity volume | White matter hyperintensity volume (adjusted for hypertension) | White matter hyperintensity volume x hypertension interaction (2df) | White matter integrity (fractional anisotropy) | White matter microstructure (fractional anisotropy) | White matter microstructure (mean diusivities) | White matter microstructure (mode of anisotropy) | White matter microstructure (radial diusivities)	Wen_2024 (rs186399184)
11	grey matter	2q33.2	2	203877365	rs530464314	CA	C	0.1432	-0.22575127	0.03056844	-7.38510928264576	1.523e-13	0.000992670511343756	54890	intergenic	NBEAL1	neurobeachin like 1	protein_coding	2237	9	265	267		CARF (0.342) | ICA1L (0.311) | NBEAL1 (0.224) | WDR12 (0.102)	WDR12 (1;rs35212307;15.630) | CARF (1;rs72932557;1.747)	ICA1L (rs72932772;6e-11) | CARF (rs143805266;4e-09) | NBEAL1 (rs72932588;7e-09)	ICA1L (rs72932780;4e-10) | CARF (rs72934745;3e-09) | NBEAL1 (rs115400054;7e-07)	CARF (22;1e-35) | ICA1L (18;8e-33) | NBEAL1 (13;4e-69) | FAM117B (6;2e-09) | WDR12 (2;3e-05) | BMPR2 (1;8e-06) | ENSG00000273456 (1;1e-04) | CYP20A1 (1;3e-04)	CARF (38/49;4e-217) | ICA1L (25/49;3e-195)	NBEAL1 (0.28) | CYP20A1 (0.27) | WDR12 (0.27)	CARF		Alzheimer's disease | Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile) | Angina pectoris | Body fat percentage or coronary artery disease (MTAG) | Brain morphology (MOSTest) | Cholesterol, total | Coronary artery disease | Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease) | Coronary artery disease or fibrinogen levels (pleiotropy) | Coronary artery disease or ischemic stroke | Coronary artery disease or large artery stroke | Coronary artery disease or plasminogen activator inhibitor 1 levels (pleiotropy) | Coronary artery disease or tissue plasminogen activator levels (pleiotropy) | Coronary heart disease | Cortical surface area | Cortical thickness | Extensive basal ganglia perivascular space burden | Headache or migraine | Hemoglobin concentration | IDP dMRI TBSS ISOVF External capsule L | IDP dMRI TBSS L2 Anterior limb of internal capsule R | Insomnia | Migraine | Migraine (MTAG) | Myocardial infarction | Myocardial infarction (early onset) | Non-lobar intracerebral hemorrhage (MTAG) | Periventricular white matter hyperintensities | Personality traits or cognitive traits (multivariate analysis) | Pulse pressure | Renin levels | Small vessel stroke (MTAG) | Smoking initiation | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 6) | Vertex-wise cortical thickness | White matter fractional anisotropy x age interaction (2df) | White matter hyperintensities | White matter hyperintensity volume | White matter hyperintensity volume (adjusted for hypertension) | White matter hyperintensity volume x hypertension interaction (2df) | White matter integrity (fractional anisotropy) | White matter microstructure (fractional anisotropy) | White matter microstructure (mean diusivities) | White matter microstructure (mode of anisotropy) | White matter microstructure (radial diusivities)	Wen_2024 (rs186399184)
11	white matter	2q33.2	2	204127320	2:204127320_AAC_A	A	AAC	0.1238	-0.22856316	0.03188675	-7.16796663190824	7.612e-13	0.000935207966927057	54890	intronic	CYP20A1	cytochrome P450 family 20 subfamily A member 1	protein_coding	0	5	253	253		CARF (0.481) | NBEAL1 (0.371) | WDR12 (0.222)	WDR12 (1;rs35212307;15.630) | CARF (1;rs72932557;1.747)	ICA1L (rs72932772;4e-10) | CARF (rs143805266;1e-08) | NBEAL1 (rs72932588;2e-08)	CARF (rs72934745;8e-09) | ICA1L (rs72932767;9e-09) | NBEAL1 (rs115400054;2e-06)	CARF (22;4e-28) | ICA1L (18;4e-26) | NBEAL1 (13;1e-58) | FAM117B (6;5e-09) | WDR12 (2;3e-05) | ENSG00000273456 (2;1e-04) | BMPR2 (1;3e-05) | CYP20A1 (1;3e-04)	CARF (45/49;3e-205) | ICA1L (25/49;3e-195)	WDR12 (0.29) | CYP20A1 (0.28) | CARF (0.27)	CARF		Alzheimer's disease | Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile) | Angina pectoris | Apolipoprotein B levels | Appendicular lean mass | Attention deficit hyperactivity disorder or risk-taking behavior (pleiotropy) | Body fat percentage or coronary artery disease (MTAG) | Brain morphology (MOSTest) | Cholesterol, total | Coronary artery disease | Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease) | Coronary artery disease or factor VII levels (pleiotropy) | Coronary artery disease or factor VIII levels (pleiotropy) | Coronary artery disease or factor XI levels (pleiotropy) | Coronary artery disease or fibrinogen levels (pleiotropy) | Coronary artery disease or ischemic stroke | Coronary artery disease or large artery stroke | Coronary artery disease or plasminogen activator inhibitor 1 levels (pleiotropy) | Coronary artery disease or tissue plasminogen activator levels (pleiotropy) | Coronary artery disease or von Willebrand factor levels (pleiotropy) | Coronary heart disease | Cortical surface area | Cortical thickness | Educational attainment | Extensive basal ganglia perivascular space burden | Headache or migraine | Hemoglobin concentration | IDP dMRI TBSS ISOVF External capsule L | IDP dMRI TBSS L2 Anterior limb of internal capsule R | Insomnia | Ischemic heart disease (PheCode 411) | Lacunar stroke | Low density lipoprotein cholesterol levels | Migraine | Migraine (MTAG) | Myocardial infarction | Myocardial infarction (early onset) | Non-lobar intracerebral hemorrhage (MTAG) | Periventricular white matter hyperintensities | Personality traits or cognitive traits (multivariate analysis) | Pulse pressure | Renin levels | Respiratory diseases | Serum alkaline phosphatase levels | Small vessel stroke (MTAG) | Smoking initiation | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 6) | Total cholesterol levels | Vertex-wise cortical thickness | White matter fractional anisotropy x age interaction (2df) | White matter hyperintensities | White matter hyperintensity volume | White matter hyperintensity volume (adjusted for hypertension) | White matter hyperintensity volume x hypertension interaction (2df) | White matter integrity (fractional anisotropy) | White matter microstructure (fractional anisotropy) | White matter microstructure (mean diusivities) | White matter microstructure (mode of anisotropy) | White matter microstructure (radial diusivities)	Wen_2024 (rs186399184)
12	white matter	3p13	3	69893971	rs62252239	T	G	0.2116	-0.15314242	0.02566184	-5.96771003170466	2.406e-09	0.000648419881944647	54890	intronic	MITF	melanocyte inducing transcription factor	protein_coding	0	11	95	94		MITF (0.972)	-	-	-	MITF (1;9e-05)	-	MITF (1.91)	MITF		Brain morphology (MOSTest) | Brain region volumes | Cortical thickness | Estimated glomerular filtration rate (creatinine) | High density lipoprotein cholesterol levels | Interventricular septum cross-sectional area | JT interval | Left ventricular end systole anterolateral wall thickness | Left ventricular end systole inferolateral wall thickness | Neutrophil count | QRS duration | QT interval | Subcortical volume (MOSTest) | Supranormal left ventricular ejection fraction | Vertex-wise cortical thickness	Novel
13	white matter	3q13.33	3	121628658	3:121628658_AT_A	A	AT	0.4777	-0.14347238	0.02094897	-6.84866033986397	7.455e-12	0.000853813239103436	54890	intronic	SLC15A2	solute carrier family 15 member 2	protein_coding	0	14	139	139		SLC15A2 (0.917) | ILDR1 (0.046)	SLC15A2 (1;rs2257212;15.490)	SLC15A2 (rs1920318;8e-10)	SLC15A2 (rs874741;2e-06)	IQCB1 (27;4e-11) | SLC15A2 (18;2e-44) | GOLGB1 (3;2e-10) | EAF2 (3;1e-06) | WDR5B-DT (3;2e-05) | HCLS1 (2;5e-07) | RN7SL172P (1;5e-07) | CD86 (1;3e-05) | MIX23 (1;2e-04)	IQCB1 (47/49;4e-170) | WDR5B-DT (32/49;6e-30) | HCLS1 (32/49;4e-21) | GOLGB1 (25/49;2e-33) | EAF2 (25/49;5e-33)	SLC15A2 (0.74) | CCDC58 (0.34) | CASR (0.26)	SLC15A2		Allergic disease (asthma, hay fever or eczema) | Atopic asthma | Blood urea nitrogen levels | Creatinine levels | Eczema | Estimated glomerular filtration rate | Estimated glomerular filtration rate (creatinine) | Estimated glomerular filtration rate (cystatin c) | Glomerular filtration rate | Hay fever and/or eczema | Height | Hematocrit | Hemoglobin | Hemoglobin concentration | Hemoglobin levels | Platelet count | Plateletcrit | Serum creatinine levels | Serum urate levels | Serum uric acid levels | Systolic blood pressure	Novel
14	white matter	3q26.31	3	171040852	rs776970253	CTCATTCCTTTGTG	C	0.7396	-0.14284632	0.0239277	-5.96991436703068	2.374e-09	0.000648898682409563	54890	intronic	TNIK	TRAF2 and NCK interacting kinase	protein_coding	0	7	7	7 | 192		TNIK (0.959)	-	-	-	TNIK (3;3e-07)	-	PLD1 (1.01) | TNIK (0.49) | EIF5A2 (0.22)	TNIK		Ventral frontal thickness (unadjusted for global measures) | Vertex-wise cortical thickness	Novel
14	grey and white matter	3q26.31	3	171040899	rs73171590	C	G	0.2651	0.13064008	0.02268998	5.75761106885066	8.531e-09	0.000603594155779935	54890	intronic	TNIK	TRAF2 and NCK interacting kinase	protein_coding	0	5	6	7 | 666		TNIK (1.006)	-	-	-	TNIK (3;3e-07)	-	PLD1 (0.97) | TNIK (0.36) | EIF5A2 (0.24)	TNIK		Ventral frontal thickness (unadjusted for global measures) | Vertex-wise cortical thickness	Novel
15	grey and white matter	3q26.31	3	171500441	rs72622537	A	C	0.3494	-0.11798658	0.02106249	-5.60173939548458	2.122e-08	0.000571373612550016	54890	intronic	PLD1	phospholipase D1	protein_coding	0	15	35	26		PLD1 (0.958)	-	-	-	PLD1 (9;1e-22)	-	PLD1 (0.97) | FNDC3B (0.20) | PP13439 (0.01)	PLD1		-	Novel
16	white matter	3q29	3	193549408	rs1146045	T	C	0.5917	-0.11826768	0.0211914	-5.58092811234746	2.392e-08	0.000567138428644934	54890	intergenic	LINC02038	long intergenic non-protein coding RNA 2038	lncRNA	9209	12	42	37		LINC02038 (0.954)	-	-	-	-	-	OPA1 (0.39) | ATP13A4 (0.03)	LINC02038		Age of onset of childhood onset asthma	Novel
17	grey and white matter	4p16.3	4	2944571	rs66571798	CGT	C	0.41	-0.11760443	0.02073403	-5.67204880093257	1.411e-08	0.000606024700595683	53057	ncRNA_intronic	NOP14-AS1	NOP14 antisense RNA 1	lncRNA	0	12	101	121 | 719		NOP14 (0.433) | GRK4 (0.373) | NOP14-AS1 (0.137) | ADD1 (0.040)	GRK4 (2;rs2960306;22.700) | NOP14 (2;rs2515960;9.464)	-	-	GRK4 (38;1e-67) | NOP14 (9;2e-21) | ADD1 (3;1e-07) | NOP14-AS1 (2;4e-30) | MFSD10 (2;2e-20) | HTT (2;3e-06) | SH3BP2 (1;1e-04)	GRK4 (33/49;0e+00)	SH3BP2 (0.45) | ADD1 (0.38) | MFSD10 (0.36)	GRK4		Cigarettes smoked per day (MTAG) | Educational attainment | Height (standard GWA) | Household income (MTAG)	Novel
18	grey and white matter	4p14	4	38680015	rs13132853	A	G	0.634	-0.26036678	0.02085811	-12.4827599432547	9.272e-36	0.00283082274802851	54890	intronic	KLF3	Kruppel like factor 3	protein_coding	0	1	12	12		KLF3 (1.000)	-	-	-	KLF3-AS1 (11;9e-06) | TLR1 (1;4e-05)	KLF3-AS1 (42/49;5e-45)	KLF3 (0.74) | TLR10 (0.46) | TLR6 (0.24)	KLF3-AS1		Body fat percentage | Body fat percentage (adjusted for testosterone and SHBG) | Body mass index | Body size at age 10 | Brain age gap | Brain morphology (MOSTest) | Brain region volumes | Central nucleus volume | Corpus callosum fractional anisotropy (genu) | Corpus callosum fractional anisotropy (MOSTest) | Cortical surface area | Cortical thickness | Edge-level brain connectivity (multivariate analysis) | Hand grip strength | IDP dMRI TBSS MD Genu of corpus callosum | IDP SWI T2star left putamen | IDP SWI T2star right putamen | Lower thalamus volume | Metabolic biomarkers (multivariate analysis) | Platelet-to-lymphocyte ratio | Red cell distribution width | Relative brain age | Reticulocyte count | Reticulocyte fraction of red cells | Serum alkaline phosphatase levels | Subcortical volume (MOSTest) | Type 1 diabetes | Vertex-wise cortical surface area | Vertex-wise cortical thickness | Vertex-wise sulcal depth | wg lh intensity-contrast medialorbitofrontal | wg lh intensity-contrast postcentral | wg rh intensity-contrast fusiform | wg rh intensity-contrast inferiortemporal | wg rh intensity-contrast lateralorbitofrontal | wg rh intensity-contrast lingual | wg rh intensity-contrast parsorbitalis | wg rh intensity-contrast rostralanteriorcingulate | wg rh intensity-contrast supramarginal | White blood cell count | Whole brain free water diffusion (multivariate analysis) | Whole brain restricted directional diffusion (multivariate analysis) | Whole brain restricted isotropic diffusion (multivariate analysis)	Leonardsen_2023 (rs13132853), Kim_2023 (rs201791735), Smith_2020 (rs140659812), Ning_2021 (rs337638)
18	white matter	4p14	4	38680015	rs13132853	A	G	0.6342	-0.25250026	0.02178342	-11.5913965759279	4.556e-31	0.00244192494508676	54890	intronic	KLF3	Kruppel like factor 3	protein_coding	0	1	12	12		KLF3-AS1 (1.000)	-	-	-	KLF3-AS1 (11;9e-06) | TLR1 (1;4e-05)	KLF3-AS1 (42/49;5e-45)	KLF3 (0.74) | TLR10 (0.60) | TLR1 (0.32)	KLF3-AS1		Body fat percentage | Body fat percentage (adjusted for testosterone and SHBG) | Body mass index | Body size at age 10 | Brain age gap | Brain morphology (MOSTest) | Brain region volumes | Central nucleus volume | Corpus callosum fractional anisotropy (genu) | Corpus callosum fractional anisotropy (MOSTest) | Cortical surface area | Cortical thickness | Edge-level brain connectivity (multivariate analysis) | Hand grip strength | IDP dMRI TBSS MD Genu of corpus callosum | IDP SWI T2star left putamen | IDP SWI T2star right putamen | Lower thalamus volume | Metabolic biomarkers (multivariate analysis) | Platelet-to-lymphocyte ratio | Red cell distribution width | Relative brain age | Reticulocyte count | Reticulocyte fraction of red cells | Serum alkaline phosphatase levels | Subcortical volume (MOSTest) | Type 1 diabetes | Vertex-wise cortical surface area | Vertex-wise cortical thickness | Vertex-wise sulcal depth | wg lh intensity-contrast medialorbitofrontal | wg lh intensity-contrast postcentral | wg rh intensity-contrast fusiform | wg rh intensity-contrast inferiortemporal | wg rh intensity-contrast lateralorbitofrontal | wg rh intensity-contrast lingual | wg rh intensity-contrast parsorbitalis | wg rh intensity-contrast rostralanteriorcingulate | wg rh intensity-contrast supramarginal | White blood cell count | Whole brain free water diffusion (multivariate analysis) | Whole brain restricted directional diffusion (multivariate analysis) | Whole brain restricted isotropic diffusion (multivariate analysis)	Leonardsen_2023 (rs13132853), Kim_2023 (rs201791735), Smith_2020 (rs140659812), Ning_2021 (rs337638)
18	grey matter	4p14	4	38626522	rs13102095	T	C	0.3584	0.23276483	0.0218722	10.642040123993	1.899e-26	0.00205909887114048	54890	ncRNA_exonic	KLF3-AS1	KLF3 antisense RNA 1	lncRNA	0	2	13	13		KLF3-AS1 (0.669) | KLF3 (0.322)	-	-	-	KLF3-AS1 (11;8e-07) | TLR1 (1;2e-05)	KLF3-AS1 (39/49;2e-51)	KLF3 (0.70) | FAM114A1 (0.11) | TLR1 (0.06)	KLF3-AS1		Body fat percentage | Body fat percentage (adjusted for testosterone and SHBG) | Body mass index | Body size at age 10 | Brain age gap | Brain morphology (MOSTest) | Brain region volumes | Central nucleus volume | Corpus callosum fractional anisotropy (genu) | Corpus callosum fractional anisotropy (MOSTest) | Cortical surface area | Cortical thickness | Edge-level brain connectivity (multivariate analysis) | Hand grip strength | IDP dMRI TBSS MD Genu of corpus callosum | IDP SWI T2star left putamen | IDP SWI T2star right putamen | Lower thalamus volume | Metabolic biomarkers (multivariate analysis) | Platelet-to-lymphocyte ratio | Red cell distribution width | Relative brain age | Reticulocyte count | Reticulocyte fraction of red cells | Serum alkaline phosphatase levels | Subcortical volume (MOSTest) | Type 1 diabetes | Vertex-wise cortical surface area | Vertex-wise cortical thickness | Vertex-wise sulcal depth | wg lh intensity-contrast medialorbitofrontal | wg lh intensity-contrast postcentral | wg rh intensity-contrast fusiform | wg rh intensity-contrast inferiortemporal | wg rh intensity-contrast lateralorbitofrontal | wg rh intensity-contrast lingual | wg rh intensity-contrast parsorbitalis | wg rh intensity-contrast rostralanteriorcingulate | wg rh intensity-contrast supramarginal | White blood cell count | Whole brain free water diffusion (multivariate analysis) | Whole brain restricted directional diffusion (multivariate analysis) | Whole brain restricted isotropic diffusion (multivariate analysis)	Leonardsen_2023 (rs13132853), Kim_2023 (rs201791735), Smith_2020 (rs140659812), Ning_2021 (rs337638)
19	white matter	4q26	4	115534729	rs75563007	T	C	0.9747	-0.40007188	0.06678	-5.99089368074274	2.087e-09	0.00065346439530332	54890	intronic	UGT8	UDP glycosyltransferase 8	protein_coding	0	8	26	25		UGT8 (0.953)	-	-	-	-	-	UGT8 (1.07) | NDST4 (0.04)	UGT8		T1 FreeSurfer BA rh V2 exvivo thickness	Novel
19	grey and white matter	4q26	4	115534729	rs75563007	T	C	0.9748	-0.36303192	0.06400067	-5.67231436795896	1.409e-08	0.00058585301669025	54890	intronic	UGT8	UDP glycosyltransferase 8	protein_coding	0	11	28	28		UGT8 (0.958)	UGT8 (1;rs4148254;29.000)	-	-	-	-	UGT8 (0.85) | NDST4 (0.26)	UGT8		-	Novel
20	grey and white matter	5q13.2	5	72257180	rs2548331	T	G	0.4836	0.11536314	0.0199658	5.77803744402929	7.558e-09	0.000607881907365096	54890	intronic	FCHO2	FCH and mu domain containing endocytic adaptor 2	protein_coding	0	18	-	89		FCHO2 (0.784) | TNPO1 (0.186)	-	-	-	FCHO2 (26;8e-30) | FCHO2-DT (10;7e-08) | TMEM171 (4;1e-07) | ENSG00000271926 (4;2e-05) | TNPO1 (2;1e-04)	FCHO2-DT (25/41;3e-52) | FCHO2 (29/49;2e-219)	FOXD1 (0.26) | FCHO2 (0.21) | TNPO1 (0.20)	FCHO2		-	Novel
21	grey matter	5q14.3	5	90567689	5:90567689_TTAAATAAATAAATAAATAAA_T	T	TTAAATAAATAAATAAATAAA	0.9339	-0.23875542	0.04220794	-5.65664706687889	1.544e-08	0.000582623040875365	54890	intergenic	LUCAT1	lung cancer associated transcript 1	lncRNA	31114	12	18	18		LUCAT1 (0.941) | ADGRV1 (0.017)	-	-	-	-	-	-	LUCAT1		-	Novel
22	grey matter	5q23.2	5	122879901	rs36048468	T	C	0.2098	0.1559121	0.02572461	6.0608149161445	1.354e-09	0.000668796644463328	54890	intronic	CSNK1G3	casein kinase 1 gamma 3	protein_coding	0	15	32	37		CSNK1G3 (0.925) | CEP120 (0.032)	-	-	CSNK1G3 (rs10062103;2e-05)	KRT8P33 (4;7e-07) | CSNK1G3 (3;1e-05) | CEP120 (3;2e-05) | PRDM6 (1;6e-05)	-	PRDM6 (0.33) | CSNK1G3 (0.18)	CSNK1G3		-	Novel
22	grey and white matter	5q23.2	5	122912461	rs4546375	T	C	0.2245	0.13322809	0.02395491	5.56161930894334	2.673e-08	0.000563223071374394	54890	intronic	CSNK1G3	casein kinase 1 gamma 3	protein_coding	0	15	53	51		CSNK1G3 (0.891) | CEP120 (0.073)	-	-	CSNK1G3 (rs10062103;6e-05)	KRT8P33 (4;6e-07) | CEP120 (3;2e-05) | CSNK1G3 (2;1e-06) | PRDM6 (1;5e-05)	-	PRDM6 (0.26) | CSNK1G3 (0.09)	CSNK1G3		-	Novel
23	grey and white matter	5q33.3	5	159528663	rs55790564	A	AT	0.4035	-0.12281813	0.02042274	-6.01379295824165	1.812e-09	0.000658466182961322	54890	intronic	PWWP2A	PWWP domain containing 2A	protein_coding	0	12	36	35		PWWP2A (0.725) | TTC1 (0.232)	-	-	-	PWWP2A (5;6e-09) | TTC1 (1;3e-05)	PWWP2A (29/49;8e-43)	PTTG1 (0.24) | ATP10B (0.20) | PWWP2A (0.19)	PWWP2A		Facial morphology (segment 5) | Lung function (FEV1/FVC) | Prostate cancer | Smoking initiation	Novel
23	white matter	5q33.3	5	159528663	rs55790564	A	AT	0.4035	-0.12383574	0.02132384	-5.8073845986464	6.346e-09	0.000614068757618191	54890	intronic	PWWP2A	PWWP domain containing 2A	protein_coding	0	12	36	35		PWWP2A (0.612) | TTC1 (0.352)	-	-	-	PWWP2A (5;2e-09) | TTC1 (1;4e-05)	PWWP2A (28/49;2e-42)	PWWP2A (0.27) | ADRA1B (0.21) | TTC1 (0.19)	PWWP2A		Facial morphology (segment 5) | Lung function (FEV1/FVC) | Prostate cancer | Smoking initiation	Novel
24	grey and white matter	6p21.33	6	31249217	rs2253491	A	G	0.2062	-0.15813565	0.02463731	-6.41854366406073	1.376e-10	0.000750014645951737	54890	intergenic	HLA-C	major histocompatibility complex%2C class I%2C C	protein_coding	9304	-	20	19		-	-	-	-	HLA-C (46;6e-24) | C4A (40;3e-15) | CYP21A1P (32;3e-10) | CCHCR1 (28;9e-16) | MICB (27;1e-16) | PSORS1C1 (24;1e-13) | FLOT1 (20;2e-09) | NOTCH4 (15;8e-09) | HLA-S (14;2e-10) | MIR6891 (13;3e-08) | STK19B (12;5e-06) | VARS2 (12;9e-06) | ENSG00000271581 (10;3e-07) | C4B (9;7e-15) | CYP21A2 (8;6e-10) | HCG22 (8;9e-10) | HCP5 (6;3e-07) | RNF5 (6;5e-06) | PSORS1C2 (6;4e-05) | LY6G5B (5;9e-05) | POU5F1 (4;1e-06) | TNXA (4;2e-06) | LINC00243 (4;3e-06) | PPP1R18 (4;4e-06) | ENSG00000280128 (3;1e-05) | MSH5 (3;2e-05) | SKIC2 (3;3e-05) | SFTA2 (2;9e-08) | APOM (2;2e-06) | GPANK1 (2;1e-05) | TCF19 (2;1e-05) | WASF5P (1;9e-10) | LY6G6C (1;5e-09) | DDR1-DT (1;1e-08) | LINC01149 (1;1e-06) | MUC22 (1;4e-06) | SNHG32 (1;7e-06) | HCG20 (1;8e-06) | HLA-B (1;1e-05) | MPIG6B (1;1e-05) | IER3 (1;3e-05) | ENSG00000272501 (1;4e-05) | HLA-E (1;9e-05) | ATP6V1G2 (1;9e-05) | ENSG00000272221 (1;1e-04) | CLIC1 (1;1e-04) | LST1 (1;2e-04) | LINC02570 (1;2e-04) | BAG6 (1;3e-04) | MICA (1;4e-04)	C4A (49/49;2e-292) | CYP21A1P (49/49;3e-157) | TNXA (43/43;4e-39) | HLA-C (48/49;3e-273) | STK19B (46/47;6e-68) | VARS2 (47/49;2e-51) | MSH5 (47/49;8e-36) | MIR6891 (31/33;5e-76) | MICA (46/49;9e-30) | ENSG00000280128 (46/49;1e-24) | LY6G5B (45/49;6e-32) | PSORS1C1 (42/48;1e-150) | RNF5 (41/49;2e-36) | MICB (40/49;9e-195) | NOTCH4 (38/49;2e-87) | ATP6V1G2 (38/49;7e-13) | ENSG00000272221 (37/49;2e-24) | CCHCR1 (35/49;1e-215) | HLA-E (35/49;4e-08) | PSORS1C2 (33/47;6e-34) | HCG20 (33/47;7e-14) | FLOT1 (34/49;4e-60) | HCP5 (31/49;3e-47) | HLA-S (15/24;3e-30) | ENSG00000271581 (13/22;1e-24) | GPANK1 (28/49;1e-22) | SKIC2 (28/49;4e-21) | HCG22 (23/41;2e-59) | APOM (27/49;1e-29) | CLIC1 (26/49;6e-13) | LINC00243 (16/32;3e-24)	CLIC1 (0.54) | HLA-B (0.36) | BAG6 (0.26)	CLIC1		CLEC4D/OSM protein level ratio | Sarcoidosis (Lofgren's syndrome vs non-Lofgren's syndrome) | Seropositivity for streptococcus pneumoniae peptide (agilent_220184)	Smith_2020 (rs3129787)
24	grey matter	6p21.33	6	31249217	rs2253491	A	G	0.2062	-0.16280478	0.02580844	-6.30819917825332	2.823e-10	0.000724467058042621	54890	intergenic	HLA-C	major histocompatibility complex%2C class I%2C C	protein_coding	9304	-	26	30		-	-	-	-	HLA-C (46;6e-24) | C4A (40;3e-15) | CYP21A1P (32;3e-10) | CCHCR1 (28;9e-16) | MICB (27;1e-16) | PSORS1C1 (24;1e-13) | FLOT1 (20;2e-09) | NOTCH4 (15;8e-09) | HLA-S (14;2e-10) | MIR6891 (13;3e-08) | STK19B (12;5e-06) | VARS2 (12;9e-06) | ENSG00000271581 (10;3e-07) | C4B (9;7e-15) | CYP21A2 (8;6e-10) | HCG22 (8;9e-10) | HCP5 (6;3e-07) | RNF5 (6;5e-06) | PSORS1C2 (6;4e-05) | LY6G5B (5;9e-05) | POU5F1 (4;1e-06) | TNXA (4;2e-06) | LINC00243 (4;3e-06) | PPP1R18 (4;4e-06) | ENSG00000280128 (3;1e-05) | MSH5 (3;2e-05) | SKIC2 (3;3e-05) | SFTA2 (2;9e-08) | APOM (2;2e-06) | GPANK1 (2;1e-05) | TCF19 (2;1e-05) | WASF5P (1;9e-10) | LY6G6C (1;5e-09) | DDR1-DT (1;1e-08) | LINC01149 (1;1e-06) | MUC22 (1;4e-06) | SNHG32 (1;7e-06) | HCG20 (1;8e-06) | HLA-B (1;1e-05) | MPIG6B (1;1e-05) | IER3 (1;3e-05) | ENSG00000272501 (1;4e-05) | HLA-E (1;9e-05) | ATP6V1G2 (1;9e-05) | ENSG00000272221 (1;1e-04) | CLIC1 (1;1e-04) | LST1 (1;2e-04) | LINC02570 (1;2e-04) | BAG6 (1;3e-04) | MICA (1;4e-04)	C4A (49/49;2e-292) | CYP21A1P (49/49;3e-157) | HLA-C (48/49;3e-273) | STK19B (46/47;6e-68) | VARS2 (47/49;2e-51) | TNXA (41/43;4e-39) | MIR6891 (31/33;5e-76) | MICA (46/49;9e-30) | ENSG00000280128 (46/49;1e-24) | MSH5 (45/49;8e-36) | LY6G5B (45/49;6e-32) | PSORS1C1 (42/48;1e-150) | RNF5 (41/49;2e-36) | MICB (40/49;9e-195) | NOTCH4 (38/49;2e-87) | ENSG00000272221 (37/49;2e-24) | CCHCR1 (35/49;1e-215) | SKIC2 (35/49;4e-21) | HLA-E (35/49;4e-08) | PSORS1C2 (33/47;6e-34) | HCG20 (33/47;7e-14) | FLOT1 (34/49;4e-60) | ATP6V1G2 (32/49;7e-13) | HCP5 (31/49;3e-47) | HLA-S (15/24;3e-30) | ENSG00000271581 (13/22;1e-24) | GPANK1 (28/49;1e-22) | HCG22 (23/41;2e-59) | APOM (27/49;1e-29) | CLIC1 (26/49;6e-13) | LINC00243 (16/32;3e-24)	LST1 (0.54) | HLA-B (0.36) | PRRC2A (0.31)	LST1		CLEC4D/OSM protein level ratio | Sarcoidosis (Lofgren's syndrome vs non-Lofgren's syndrome) | Seropositivity for streptococcus pneumoniae peptide (agilent_220184)	Smith_2020 (rs3129787)
24	white matter	6p21.33	6	31249217	rs2253491	A	G	0.2062	-0.14182302	0.02572622	-5.51278112369404	3.532e-08	0.000553380303019771	54890	intergenic	HLA-C	major histocompatibility complex%2C class I%2C C	protein_coding	9304	-	-	913		-	-	-	-	C4A (32;3e-15) | HLA-C (30;6e-24) | MICB (25;1e-16) | CYP21A1P (22;3e-10) | MIR6891 (10;3e-08) | NOTCH4 (9;8e-09) | HCG22 (8;9e-10) | FLOT1 (7;2e-09) | C4B (6;7e-15) | HLA-S (6;8e-06) | CYP21A2 (5;6e-10) | CCHCR1 (5;8e-06) | HCP5 (4;3e-07) | ENSG00000271581 (4;1e-06) | STK19B (4;5e-06) | VARS2 (4;8e-05) | LINC00243 (3;3e-06) | PPP1R18 (3;4e-06) | RNF5 (2;2e-05) | LY6G5B (2;9e-05) | WASF5P (1;9e-10) | LY6G6C (1;5e-09) | DDR1-DT (1;1e-08) | APOM (1;2e-06) | MUC22 (1;4e-06) | HCG20 (1;8e-06) | ENSG00000280128 (1;1e-05) | PSORS1C1 (1;1e-05) | ENSG00000272501 (1;4e-05) | GPANK1 (1;5e-05) | SFTA2 (1;6e-05) | ENSG00000272221 (1;1e-04) | CLIC1 (1;1e-04) | LINC02570 (1;2e-04)	C4A (49/49;2e-292) | CYP21A1P (49/49;3e-157) | HLA-C (48/49;3e-273) | STK19B (46/47;6e-68) | VARS2 (47/49;2e-51) | MIR6891 (31/33;5e-76) | ENSG00000280128 (46/49;1e-24) | LY6G5B (45/49;6e-32) | RNF5 (41/49;2e-36) | MICB (40/49;9e-195) | NOTCH4 (38/49;2e-87) | ENSG00000272221 (37/49;2e-24) | FLOT1 (34/49;4e-60) | HCP5 (31/49;3e-47) | HLA-S (15/24;3e-30) | ENSG00000271581 (13/22;1e-24) | GPANK1 (28/49;1e-22) | HCG22 (23/41;2e-59) | CLIC1 (26/49;6e-13)	TNF (0.35) | DDX39B (0.28) | CLIC1 (0.28)	TNF		-	Smith_2020 (rs3129787)
25	grey and white matter	6p21.1	6	45410312	rs910586	T	C	0.3615	-0.21086173	0.02108166	-10.0021407232637	1.491e-23	0.00181935588028086	54890	intronic	RUNX2	RUNX family transcription factor 2	protein_coding	0	2	34	35		RUNX2 (1.059)	-	RUNX2 (rs2790100;3e-14)	-	RUNX2 (4;3e-11)	-	RUNX2 (3.86)	RUNX2		aseg lh intensity Putamen | aseg lh intensity Thalamus-Proper | aseg lh volume CerebralWhiteMatter | aseg rh intensity Putamen | aseg rh intensity Thalamus-Proper | Brain age gap | Brain morphology (min-P) | Brain morphology (MOSTest) | Brain region volumes | Cortical thickness | Cortical thickness (min-P) | Cortical thickness (MOSTest) | Hip shape (DXA scan) | Regional cortical thickness (medialorbitofrontal) | Regional cortical thickness (rostralanteriorcingulate) | Relative brain age | Subcortical volume (MOSTest) | Ventral frontal thickness (unadjusted for global measures) | Vertex-wise cortical thickness | Youthful appearance (self-reported)	Smith_2020 (rs2790103), Leonardsen_2023 (rs2790102), Jonsson_2019 (rs2790099), Ning_2021 (rs2677110)
25	white matter	6p21.1	6	45439307	rs2790095	C	G	0.6461	0.20724205	0.02208568	9.38354852556045	6.379e-21	0.0016016243683797	54890	intronic	RUNX2	RUNX family transcription factor 2	protein_coding	0	5	35	36		RUNX2 (1.004)	-	RUNX2 (rs2790100;2e-13)	-	RUNX2 (4;6e-12)	-	RUNX2 (3.65) | CLIC5 (0.14)	RUNX2		aseg lh intensity Putamen | aseg lh intensity Thalamus-Proper | aseg lh volume CerebralWhiteMatter | aseg rh intensity Putamen | aseg rh intensity Thalamus-Proper | Brain age gap | Brain morphology (min-P) | Brain morphology (MOSTest) | Brain region volumes | Cortical thickness | Cortical thickness (min-P) | Cortical thickness (MOSTest) | Hip shape (DXA scan) | Regional cortical thickness (medialorbitofrontal) | Regional cortical thickness (rostralanteriorcingulate) | Relative brain age | Subcortical volume (MOSTest) | Ventral frontal thickness (unadjusted for global measures) | Vertex-wise cortical thickness | Youthful appearance (self-reported)	Smith_2020 (rs2790103), Leonardsen_2023 (rs2790102), Jonsson_2019 (rs2790099), Ning_2021 (rs2677110)
25	grey matter	6p21.1	6	45410312	rs910586	T	C	0.3614	-0.19053984	0.02209205	-8.62481480894711	6.42e-18	0.00135342429552777	54890	intronic	RUNX2	RUNX family transcription factor 2	protein_coding	0	39	39	39		RUNX2 (0.956)	-	RUNX2 (rs2790100;4e-12)	-	RUNX2 (4;3e-11)	-	RUNX2 (3.63)	RUNX2		aseg lh intensity Putamen | aseg lh intensity Thalamus-Proper | aseg lh volume CerebralWhiteMatter | aseg rh intensity Putamen | aseg rh intensity Thalamus-Proper | Brain age gap | Brain morphology (min-P) | Brain morphology (MOSTest) | Brain region volumes | Cortical thickness | Cortical thickness (min-P) | Cortical thickness (MOSTest) | Hip shape (DXA scan) | Regional cortical thickness (medialorbitofrontal) | Regional cortical thickness (rostralanteriorcingulate) | Relative brain age | Subcortical volume (MOSTest) | Ventral frontal thickness (unadjusted for global measures) | Vertex-wise cortical thickness | Youthful appearance (self-reported)	Smith_2020 (rs2790103), Leonardsen_2023 (rs2790102), Jonsson_2019 (rs2790099), Ning_2021 (rs2677110)
26	grey matter	6q22.32	6	126690257	6:126690257_AT_A	A	AT	0.4417	0.11864517	0.02121429	5.59270048632313	2.236e-08	0.000569532224359956	54890	intergenic	CENPW	centromere protein W	protein_coding	20235	10	93	92		MIR588 (0.860) | CENPW (0.136)	-	CENPW (rs2326451;1e-05)	-	CENPW (7;2e-11)	-	CENPW (0.82)	CENPW		aparc-a2009s lh area S-orbital-med-olfact | aparc-pial rh area lateralorbitofrontal | Brain region volumes | Cortical surface area | Free androgen index | Height | Hip circumference adjusted for BMI | Optic disc size | Soy sauce liking | Type 1 diabetes | Type 2 diabetes | Vertical cup-disc ratio | Whole body fat free mass (UKB data field 23101) | Whole brain restricted directional diffusion (multivariate analysis)	Jonsson_2019 (rs2184968)
26	grey and white matter	6q22.32	6	126726295	rs9398805	T	C	0.4537	0.11040618	0.02001217	5.51695193474771	3.449e-08	0.000554217498653079	54890	intergenic	CENPW	centromere protein W	protein_coding	56274	9	93	91		MIR588 (0.873) | CENPW (0.082)	-	CENPW (rs2326451;1e-05)	-	CENPW (7;3e-11)	-	CENPW (0.95) | TRMT11 (0.01)	CENPW		Cortical surface area | Free androgen index | Height | Soy sauce liking	Jonsson_2019 (rs2184968)
27	grey and white matter	7p22.3	7	1213127	rs1543985	A	G	0.3624	0.11603812	0.02088168	5.55693411641209	2.746e-08	0.000562275069080987	54890	intergenic	LOC101927021	-	-	7533	17	107	106 | 659		LOC101927021 (0.533) | ZFAND2A (0.220) | C7orf50 (0.118) | GPER1 (0.100)	-	ZFAND2A-DT (rs2960837;9e-08)	AC091729.9 (rs6969322;7e-08)	ZFAND2A-DT (49;1e-165) | ZFAND2A (36;2e-107) | GPER1 (7;4e-17) | ENSG00000224079 (6;1e-16) | C7orf50 (5;3e-09) | GPR146 (4;4e-10) | CYP2W1 (3;4e-21) | COX19 (1;8e-14) | ENSG00000226291 (1;3e-11) | ADAP1 (1;2e-06)	ZFAND2A-DT (49/49;0e+00) | ZFAND2A (35/49;0e+00) | ENSG00000224079 (13/26;4e-45)	ZFAND2A (0.83) | PSMG3 (0.37) | MAFK (0.31)	ZFAND2A-DT		-	Novel
27	grey matter	7p22.3	7	1213127	rs1543985	A	G	0.3624	0.11951566	0.02187699	5.46307604473924	4.68e-08	0.000543451764394319	54890	intergenic	LOC101927021	-	-	7533	26	113	106		C7orf50 (0.465) | ZFAND2A (0.259) | LOC101927021 (0.216) | GPER1 (0.035)	-	ZFAND2A-DT (rs2960837;2e-07)	AC091729.9 (rs2949185;2e-07)	ZFAND2A-DT (49;1e-165) | ZFAND2A (35;2e-107) | GPER1 (7;4e-17) | ENSG00000224079 (5;1e-16) | GPR146 (4;4e-10) | C7orf50 (4;3e-09) | CYP2W1 (3;4e-21) | COX19 (1;8e-14) | ENSG00000226291 (1;3e-11) | ADAP1 (1;2e-06)	ZFAND2A-DT (49/49;0e+00) | ZFAND2A (35/49;0e+00) | ENSG00000224079 (13/26;4e-45)	ZFAND2A (0.64) | MICALL2 (0.20) | PSMG3 (0.19)	ZFAND2A-DT		-	Novel
28	grey matter	7q31.31	7	120803286	rs35789132	A	G	0.6464	-0.13419985	0.02194366	-6.11565481783805	9.616e-10	0.000680946028809254	54890	intronic	CPED1	cadherin like and PC-esterase domain containing 1	protein_coding	0	11	20 | 95	95 | 19		CPED1 (0.967)	-	-	-	CPED1 (3;3e-22) | WNT16 (3;2e-05)	-	CPED1 (0.79) | FAM3C (0.25) | WNT16 (0.25)	CPED1		Body surface area | Bone mineral density (paediatric, upper limb) | Bone mineral density mean | Height (standard GWA) | Pediatric areal bone mineral density (radius vs spine & hip discordant skeletal phenotype) | Pediatric areal bone mineral density (radius) | Pierre Robin Sequence endophenotypic score | Total body bone mineral density | Vertex-wise sulcal depth | Waist circumference adjusted for body mass index | Waist-hip index | White matter microstructure (radial diusivities)	Novel
28	grey and white matter	7q31.31	7	120908822	rs2536149	A	G	0.1135	0.17671234	0.03177303	5.5617087825744	2.671e-08	0.00056324118323422	54890	intronic	CPED1	cadherin like and PC-esterase domain containing 1	protein_coding	0	-	19	114 | 19		-	-	-	-	WNT16 (2;1e-09) | CPED1 (2;2e-04)	-	CPED1 (0.42) | TSPAN12 (0.24) | WNT16 (0.18)	WNT16		White matter microstructure (radial diusivities)	Novel
29	white matter	8p23.1	8	10813904	rs10096381	T	G	0.5205	0.12688279	0.02088898	6.07414962338994	1.246e-09	0.000671740809883628	54890	intronic	XKR6	XK related 6	protein_coding	0	-	-	372		-	-	-	-	ENSG00000255310 (38;3e-29) | ENSG00000269918 (33;3e-27) | FAM167A (11;1e-10) | ENSG00000272505 (11;7e-07) | TDH (9;7e-12) | CTSB (9;3e-07) | TDH-AS1 (7;2e-13) | MTMR9 (7;6e-09) | SLC35G5 (7;7e-07) | BLK (6;3e-18) | FDFT1 (6;3e-15) | NEIL2 (6;1e-06) | MSRA (5;2e-06) | ENSG00000255046 (5;4e-05) | ENSG00000280273 (4;2e-07) | ENSG00000280294 (4;3e-06) | RP1L1 (4;1e-05) | LINC03022 (4;6e-05) | FAM167A-AS1 (3;2e-06) | ENSG00000261451 (3;4e-05) | ENSG00000269954 (2;2e-22) | ENSG00000254774 (2;7e-21) | ENSG00000255518 (2;1e-20) | PRSS55 (2;4e-05) | SUB1P1 (2;9e-05) | ENSG00000255354 (1;3e-18) | LINC00208 (1;2e-07) | ENSG00000248896 (1;4e-05) | OR7E161P (1;5e-05) | ENSG00000254556 (1;2e-04)	ENSG00000255310 (46/49;0e+00) | ENSG00000269918 (45/49;0e+00) | SLC35G5 (41/49;2e-55) | RP1L1 (13/16;1e-23) | ENSG00000272505 (38/49;3e-50) | ENSG00000261451 (33/43;2e-23) | MTMR9 (34/49;1e-50) | CTSB (32/49;3e-49) | TDH-AS1 (14/24;9e-65) | TDH (26/46;9e-62) | ENSG00000280294 (25/47;1e-23) | NEIL2 (26/49;2e-42) | ENSG00000255046 (24/48;4e-24) | LINC03022 (24/48;2e-23) | BLK (16/32;3e-39)	XKR6 (0.32) | SOX7 (0.15) | PINX1 (0.10)	XKR6		A body shape index | Carotid intima media thickness (maximum) | Carotid intima media thickness (mean) | Carotid intima media thickness (minimum) | CDKN1A/TXLNA protein level ratio | Cholesteryl esters to total lipids ratio in medium LDL | Cryptic phenotype that captures autosomal dominant polycystic kidney disease severity | Estimated glomerular filtration rate | F-fatty food liking (derived food-liking factor) | Hip circumference adjusted for BMI | Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test) | Neuroticism | Peak expiratory flow | Personality traits or cognitive traits (multivariate analysis) | PPP1R2/STK4 protein level ratio | PPP1R2/USP8 protein level ratio | REG1A/REG4 protein level ratio | Restless legs syndrome | Risk-taking behavior (multivariate analysis) | Supranormal left ventricular ejection fraction | Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test) | Systolic blood pressure x alcohol consumption interaction (2df test) | Waist circumference adjusted for body mass index | White matter microstructure (radial diusivities)	Smith_2020 (rs907183)
30	white matter	8q23.3	8	116635942	rs2721939	T	C	0.5983	0.16464833	0.02130776	7.72715339388092	1.1e-14	0.00108664948490746	54890	UTR5	TRPS1	transcriptional repressor GATA binding 1	protein_coding	0	4	15	15		TRPS1 (1.096)	-	-	TRPS1 (rs2142331;5e-12)	TRPS1-AS1 (1;9e-05)	-	TRPS1 (1.28)	TRPS1		Appendicular lean mass | Basal cell carcinoma (MTAG) | Body surface area | Cholesterol in large HDL (UKB data field 23561) | Cholesteryl esters in HDL (UKB data field 23418) | Cholesteryl esters in large HDL (UKB data field 23562) | Concentration of large HDL particles (UKB data field 23558) | Free cholesterol in HDL (UKB data field 23422) | Free cholesterol in large HDL (UKB data field 23563) | Free cholesterol to total lipids in medium HDL percentage (UKB data field 23642) | Free cholesterol to total lipids in very large HDL percentage (UKB data field 23632) | HDL cholesterol levels (UKB data field 23406) | Height | Multi-trait sex score | Neuroticism | Phospholipids in large HDL (UKB data field 23560) | Ratio of triglycerides to phosphoglycerides | Subcortical volume (MOSTest) | Total lipids in large HDL (UKB data field 23559) | Triglyceride to HDL cholesterol ratio | Type 2 diabetes | Weight | Whole body fat free mass (UKB data field 23101) | Whole brain restricted isotropic diffusion (multivariate analysis)	Novel
30	grey and white matter	8q23.3	8	116635942	rs2721939	T	C	0.5983	0.13995092	0.02040894	6.85733408986454	7.016e-12	0.000855975445639427	54890	UTR5	TRPS1	transcriptional repressor GATA binding 1	protein_coding	0	3	15	15		TRPS1 (0.972)	-	-	TRPS1 (rs2142331;4e-10)	TRPS1-AS1 (1;6e-05)	-	TRPS1 (1.27)	TRPS1		Appendicular lean mass | Basal cell carcinoma (MTAG) | Body surface area | Cholesterol in large HDL (UKB data field 23561) | Cholesteryl esters in HDL (UKB data field 23418) | Cholesteryl esters in large HDL (UKB data field 23562) | Concentration of large HDL particles (UKB data field 23558) | Free cholesterol in HDL (UKB data field 23422) | Free cholesterol in large HDL (UKB data field 23563) | Free cholesterol to total lipids in medium HDL percentage (UKB data field 23642) | Free cholesterol to total lipids in very large HDL percentage (UKB data field 23632) | HDL cholesterol levels (UKB data field 23406) | Height | Multi-trait sex score | Neuroticism | Phospholipids in large HDL (UKB data field 23560) | Ratio of triglycerides to phosphoglycerides | Subcortical volume (MOSTest) | Total lipids in large HDL (UKB data field 23559) | Triglyceride to HDL cholesterol ratio | Type 2 diabetes | Weight | Whole body fat free mass (UKB data field 23101) | Whole brain restricted isotropic diffusion (multivariate analysis)	Novel
31	grey matter	8q24.21	8	130903153	rs12548781	A	T	0.7929	0.1495835	0.02585641	5.78516120374019	7.244e-09	0.000609380836257382	54890	intronic	FAM49B	CYFIP related Rac1 interactor B	protein_coding	0	12	60	60		FAM49B (0.950)	-	-	-	-	-	FAM49B (0.30) | ASAP1 (0.26)	FAM49B		-	Novel
32	grey and white matter	9q33.2	9	123543953	rs5021405	T	C	0.4701	0.12021654	0.02181108	5.51171881447411	3.553e-08	0.000553167169506737	54890	intronic	FBXW2	F-box and WD repeat domain containing 2	protein_coding	0	-	-	98		-	-	-	-	-	-	PHF19 (0.31) | CDK5RAP2 (0.24) | MEGF9 (0.16)	PHF19		-	Novel
33	white matter	9q33.3	9	128010901	rs755594165	CA	C	0.6104	-0.1237548	0.02233313	-5.54131015222676	3.002e-08	0.000559119476287035	54890	intergenic	HSPA5	heat shock protein family A (Hsp70) member 5	protein_coding	7278	-	-	244		-	-	-	-	-	-	HSPA5 (0.89) | PBX3 (0.80) | OLFML2A (0.30)	HSPA5		-	Novel
34	grey matter	10q23.33	10	94839642	rs2068888	A	G	0.4492	-0.13245681	0.02099787	-6.30810696513504	2.825e-10	0.000724445893054064	54890	intergenic	CYP26A1	cytochrome P450 family 26 subfamily A member 1	protein_coding	2000	-	2	2 | 237		-	-	-	-	CYP26C1 (1;1e-06) | FRA10AC1 (1;3e-05) | MARK2P9 (1;2e-04)	FRA10AC1 (25/49;1e-14) | CYP26C1 (11/22;1e-16)	MYOF (0.22) | EXOC6 (0.04) | HHEX (0.03)	FRA10AC1		Apolipoprotein B levels | Average diameter for HDL particles | Average diameter for HDL particles (UKB data field 23433) | Blood urea nitrogen levels | Body fat percentage (adjusted for testosterone and SHBG) | C-reactive protein | C-reactive protein levels | Caffeine consumption from coffee or tea | Cholesterol in large HDL (UKB data field 23561) | Cholesterol levels in large HDL | Cholesterol levels in very large HDL | Cholesterol to total lipids ratio in large HDL | Cholesterol to total lipids ratio in medium HDL | Cholesteryl ester levels in large HDL | Cholesteryl ester levels in very large HDL | Cholesteryl esters in large HDL (UKB data field 23562) | Cholesteryl esters to total lipids ratio in large HDL | Cholesteryl esters to total lipids ratio in medium HDL | Citrate levels | Concentration of large HDL particles | Concentration of very large HDL particles | Diastolic blood pressure | Estimated glomerular filtration rate | Estimated glomerular filtration rate (creatinine) | Estimated glomerular filtration rate (cystatin c) | Familial combined hyperlipidemia defined by Consensus criteria | Familial combined hyperlipidemia defined by Dutch criteria | Free cholesterol levels in large HDL | Free cholesterol levels in very large HDL | Free cholesterol to total lipids ratio in large HDL | Free cholesterol to total lipids ratio in large LDL | Free cholesterol to total lipids ratio in medium LDL | Gamma glutamyl transferase levels | Gamma glutamyl transpeptidase | HDL cholesterol levels | HDL cholesterol levels in current drinkers | HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) | HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) | High density lipoprotein cholesterol levels | LDL cholesterol | LDL cholesterol levels | LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) | LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) | Liver enzyme levels (gamma-glutamyl transferase) | Low density lipoprotein cholesterol levels | Low-density lipoprotein levels (MTAG) | Mean diameter of HDL particles | Medication use (agents acting on the renin-angiotensin system) | Medication use (HMG CoA reductase inhibitors) | Metabolic signature | Monocyte percentage of white cells | Node-level brain connectivity (multivariate analysis) | Non-HDL cholesterol levels | Omega-3 fatty acid levels | Omega-3 fatty acids levels | Omega-3 fatty acids levels (UKB data field 23444) | Phospholipid levels in large HDL | Phospholipid levels in large VLDL | Phospholipid levels in very large HDL | Phospholipids in very large HDL | Phospholipids to total lipids ratio in large HDL | Phospholipids to total lipids ratio in large VLDL | Phospholipids to total lipids ratio in very large HDL | Platelet count | Plateletcrit | Ratio of omega-6 fatty acids to omega-3 fatty acids | Ratio of omega-6 fatty acids to total fatty acids | Saturated fatty acids | Serum 25-Hydroxyvitamin D levels | Serum creatinine levels | Serum total protein levels | Sex hormone-binding globulin levels | Sex hormone-binding globulin levels adjusted for BMI | Sex hormone-binding globulin levels in postmenopausal women | Sex hormone-binding globulin levels in premenopausal women | Tea intake (UKB data field 1488) | Total bilirubin levels | Total cholesterol levels | Total cholesterol to total lipids ratio in large HDL | Total fatty acids | Total lipid levels in large HDL | Total lipid levels in very large HDL | Total triglycerides levels | Triglyceride levels | Triglyceride levels (MTAG) | Triglyceride levels in current drinkers | Triglyceride levels in IDL | Triglyceride levels in large LDL | Triglyceride levels in LDL | Triglyceride levels in medium LDL | Triglyceride levels in medium VLDL | Triglyceride levels in non-type 2 diabetes | Triglyceride levels in small HDL | Triglyceride levels in small LDL | Triglyceride levels in small VLDL | Triglyceride levels in very large VLDL | Triglyceride levels in very small VLDL | Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) | Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) | Triglyceride to HDL cholesterol ratio | Triglycerides | Triglycerides in medium HDL | Triglycerides to total lipids ratio in small HDL | Triglycerides to total lipids ratio in very large HDL | Triglycerides x physical activity interaction (2df test) | Urinary albumin-to-creatinine ratio	Novel
35	white matter	10q24.1	10	98115019	rs41306852	A	G	0.0184	0.42270341	0.07730685	5.46786487872679	4.555e-08	0.000544404423107978	54890	exonic	OPALIN	oligodendrocytic myelin paranodal and inner loop protein	protein_coding	0	-	1	1 | 116		-	-	-	OPALIN (rs41306852;9e-08)	-	-	BLNK (0.66) | OPALIN (0.21) | TLL2 (0.10)	OPALIN		-	Novel
36	grey and white matter	10q24.33	10	105454043	rs2863994	T	G	0.5135	0.11800244	0.02007527	5.87800014644884	4.153e-09	0.000629083776417145	54890	intronic	SH3PXD2A	SH3 and PX domains 2A	protein_coding	0	16	7	3 | 985		SH3PXD2A (0.966)	-	-	-	BORCS7 (2;1e-04) | NEURL1 (1;3e-05) | AS3MT (1;3e-04)	BORCS7 (43/49;1e-40) | AS3MT (26/49;3e-17)	COL17A1 (0.49) | OBFC1 (0.39) | SH3PXD2A (0.29)	SH3PXD2A		IDP dMRI TBSS FA Anterior limb of internal capsule R | Periventricular white matter hyperintensities | White matter mean diffusivity x age interaction (2df)	Novel
36	grey matter	10q24.33	10	105454043	rs2863994	T	G	0.5136	0.11981643	0.02103355	5.69644353901267	1.223e-08	0.000590844927652667	54890	intronic	SH3PXD2A	SH3 and PX domains 2A	protein_coding	0	17	4	8		SH3PXD2A (0.961)	-	-	-	BORCS7 (2;1e-04) | NEURL1 (1;3e-05) | AS3MT (1;3e-04)	BORCS7 (43/49;1e-40) | AS3MT (26/49;3e-17)	COL17A1 (0.42) | SH3PXD2A (0.39) | NEURL1 (0.39)	SH3PXD2A		IDP dMRI TBSS FA Anterior limb of internal capsule R | Periventricular white matter hyperintensities | White matter mean diffusivity x age interaction (2df)	Novel
37	white matter	10q26.3	10	134573767	rs12258248	A	G	0.7506	-0.22325941	0.02428762	-9.19231320318747	3.845e-20	0.00153710717437972	54890	intronic	INPP5A	inositol polyphosphate-5-phosphatase A	protein_coding	0	3	16	16		INPP5A (0.984)	-	NKX6-2 (rs12766928;4e-07)	-	NKX6-2 (1;4e-08) | INPP5A (1;4e-05)	-	INPP5A (0.67) | PWWP2B (0.18) | TTC40 (0.16)	INPP5A		Cortical surface area | Regional cortical thickness (paracentral)	Ning_2021 (rs12775208), Leonardsen_2023 (rs4880424), Kim_2023 (10:134559486_CGCCTACCCT_C)
37	grey and white matter	10q26.3	10	134575836	rs12775990	T	C	0.2492	0.18855451	0.02326433	8.10487600545556	5.28e-16	0.00119535223642225	54890	intronic	INPP5A	inositol polyphosphate-5-phosphatase A	protein_coding	0	10	34	33		INPP5A (0.909) | NKX6-2 (0.043)	-	NKX6-2 (rs12766928;1e-06)	-	NKX6-2 (1;3e-08) | INPP5A (1;4e-05)	-	INPP5A (0.52) | PWWP2B (0.06) | NKX6-2 (0.06)	NKX6-2		Cortical surface area | Regional cortical thickness (paracentral)	Ning_2021 (rs12775208), Leonardsen_2023 (rs4880424), Kim_2023 (10:134559486_CGCCTACCCT_C)
38	grey and white matter	11p13	11	32758240	rs10767960	A	G	0.5381	-0.11653005	0.02034221	-5.72848525307722	1.013e-08	0.000597506482198072	54890	intronic	CCDC73	coiled-coil domain containing 73	protein_coding	0	17	166	162 | 545		EIF3M (0.667) | CCDC73 (0.293)	-	-	EIF3M (rs201874;7e-07)	HNRNPA3P9 (13;2e-15) | EIF3M (3;4e-05) | CCDC73 (1;2e-12)	-	WT1 (0.62)	EIF3M		-	Novel
39	white matter	12p11.21	12	32526829	rs6488048	T	C	0.65	0.12652449	0.02187137	5.78493665463114	7.254e-09	0.000609333560170747	54890	intronic	BICD1	BICD cargo adaptor 1	protein_coding	0	18	-	50 | 166		BICD1 (0.963)	-	-	-	ENSG00000274964 (6;4e-08) | FGD4 (2;4e-05)	ENSG00000274964 (33/49;1e-51)	BICD1 (1.39) | FGD4 (0.63) | DNM1L (0.03)	ENSG00000274964		Brain morphology (MOSTest) | Height	Novel
40	white matter	12q23.3	12	106476805	rs12146713	T	C	0.9051	-0.24643662	0.03564338	-6.91395204382974	4.713e-12	0.000870156263972825	54890	intronic	NUAK1	NUAK family kinase 1	protein_coding	0	1	1	1		NUAK1 (0.999)	-	-	-	ENSG00000257890 (7;8e-10)	ENSG00000257890 (13/15;8e-47)	RFX4 (0.82) | NUAK1 (0.57) | CKAP4 (0.19)	ENSG00000257890		aseg global volume 3rd-Ventricle | aseg global volume VentricleChoroid | aseg lh intensity Inf-Lat-Vent | aseg lh intensity Lateral-Ventricle | aseg lh volume Inf-Lat-Vent | aseg lh volume Lateral-Ventricle | aseg rh intensity Lateral-Ventricle | aseg rh volume Lateral-Ventricle | Brain morphology (min-P) | Brain morphology (MOSTest) | Brain region volumes | Brain shape (segment 7) | Corpus callosum central volume | Corpus callosum fractional anisotropy (MOSTest) | Corpus callosum fractional anisotropy (splenium) | Corpus callosum volume (MOSTest) | Cortical surface area | Cortical surface area (MOSTest) | Cortical thickness | Corticoamygdaloid transition area volume | Edge-level brain connectivity (multivariate analysis) | Fornix white matter microstructure (diffusion tensor mode) | Fornix white matter microstructure (intra-cellular volume fraction) | Fornix white matter microstructure (isotropic or free water volume fraction) | Fornix white matter microstructure (orientation dispersion index) | IDP dMRI ProbtrackX FA str l | IDP dMRI ProbtrackX FA str r | IDP dMRI ProbtrackX OD str l | IDP dMRI ProbtrackX OD str r | IDP dMRI TBSS FA Fornix | IDP dMRI TBSS FA Posterior limb of internal capsule L | IDP dMRI TBSS FA Posterior limb of internal capsule R | IDP dMRI TBSS ISOVF Fornix | IDP dMRI TBSS L2 Anterior limb of internal capsule R | IDP dMRI TBSS L2 Fornix | IDP dMRI TBSS L2 Posterior limb of internal capsule R | IDP dMRI TBSS L3 Fornix | IDP dMRI TBSS MD Fornix | IDP dMRI TBSS MO Anterior corona radiata R | IDP dMRI TBSS MO Body of corpus callosum | IDP dMRI TBSS MO Fornix | IDP dMRI TBSS MO Retrolenticular part of internal capsule R | IDP dMRI TBSS OD Fornix | IDP dMRI TBSS OD Posterior limb of internal capsule R | IDP T1 SIENAX CSF normalised volume | IDP T1 SIENAX CSF unnormalised volume | Lateral ventricular volume in normal aging | Left-hemisphere control network to putamen white-matter structural connectivity | Left-hemisphere control network to thalamus white-matter structural connectivity | Left-hemisphere default mode network to right-hemisphere control network white-matter structural connectivity | Left-hemisphere default mode network to right-hemisphere default mode network white-matter structural connectivity | Left-hemisphere default mode network to thalamus white-matter structural connectivity | Left-hemisphere dorsal attention network to right-hemisphere default mode network white-matter structural connectivity | Left-hemisphere dorsal attention network to thalamus white-matter structural connectivity | Left-hemisphere limbic network to thalamus white-matter structural connectivity | Left-hemisphere salience/ventral attention network to right-hemisphere default mode network white-matter structural connectivity | Left-hemisphere salience/ventral attention network to thalamus white-matter structural connectivity | Left-hemisphere somatomotor network to right-hemisphere somatomotor network white-matter structural connectivity | Left-hemisphere visual network to thalamus white-matter structural connectivity | Medial thalamic nuclei volume | MRI-derived phenotypes (MOSTest) (pleiotropy) | Node-level brain connectivity (multivariate analysis) | QC T1-to-standard linear alignment discrepancy | Right-hemisphere control network to thalamus white-matter structural connectivity | Right-hemisphere default mode network to thalamus white-matter structural connectivity | Right-hemisphere dorsal attention network to thalamus white-matter structural connectivity | Right-hemisphere limbic network to putamen white-matter structural connectivity | Right-hemisphere limbic network to thalamus white-matter structural connectivity | Right-hemisphere somatomotor network to pallidum white-matter structural connectivity | Right-hemisphere somatomotor network to thalamus white-matter structural connectivity | sMRI-derived phenotypes (MOSTest) (pleiotropy) | Subcortical volume (min-P) | Subcortical volume (MOSTest) | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 84) | Vertex-wise cortical surface area | Vertex-wise cortical thickness | Vertex-wise sulcal depth | White matter microstructure (axial diusivities) | White matter microstructure (fractional anisotropy) | White matter microstructure (mean diusivities) | White matter microstructure (mode of anisotropy) | White matter microstructure (radial diusivities) | Whole brain free water diffusion (multivariate analysis) | Whole brain restricted directional diffusion (multivariate analysis) | Whole brain restricted isotropic diffusion (multivariate analysis)	Wen_2024 (rs12146713), Smith_2020 (rs12146713)
40	grey and white matter	12q23.3	12	106476805	rs12146713	T	C	0.9051	-0.21943044	0.03413306	-6.42867765152026	1.287e-10	0.000752383069844631	54890	intronic	NUAK1	NUAK family kinase 1	protein_coding	0	1	1	1		NUAK1 (0.991)	-	-	-	ENSG00000257890 (7;8e-10)	ENSG00000257890 (13/15;8e-47)	NUAK1 (0.67) | RFX4 (0.60)	ENSG00000257890		aseg global volume 3rd-Ventricle | aseg global volume VentricleChoroid | aseg lh intensity Inf-Lat-Vent | aseg lh intensity Lateral-Ventricle | aseg lh volume Inf-Lat-Vent | aseg lh volume Lateral-Ventricle | aseg rh intensity Lateral-Ventricle | aseg rh volume Lateral-Ventricle | Brain morphology (min-P) | Brain morphology (MOSTest) | Brain region volumes | Brain shape (segment 7) | Corpus callosum central volume | Corpus callosum fractional anisotropy (MOSTest) | Corpus callosum fractional anisotropy (splenium) | Corpus callosum volume (MOSTest) | Cortical surface area | Cortical surface area (MOSTest) | Cortical thickness | Corticoamygdaloid transition area volume | Edge-level brain connectivity (multivariate analysis) | Fornix white matter microstructure (diffusion tensor mode) | Fornix white matter microstructure (intra-cellular volume fraction) | Fornix white matter microstructure (isotropic or free water volume fraction) | Fornix white matter microstructure (orientation dispersion index) | IDP dMRI ProbtrackX FA str l | IDP dMRI ProbtrackX FA str r | IDP dMRI ProbtrackX OD str l | IDP dMRI ProbtrackX OD str r | IDP dMRI TBSS FA Fornix | IDP dMRI TBSS FA Posterior limb of internal capsule L | IDP dMRI TBSS FA Posterior limb of internal capsule R | IDP dMRI TBSS ISOVF Fornix | IDP dMRI TBSS L2 Anterior limb of internal capsule R | IDP dMRI TBSS L2 Fornix | IDP dMRI TBSS L2 Posterior limb of internal capsule R | IDP dMRI TBSS L3 Fornix | IDP dMRI TBSS MD Fornix | IDP dMRI TBSS MO Anterior corona radiata R | IDP dMRI TBSS MO Body of corpus callosum | IDP dMRI TBSS MO Fornix | IDP dMRI TBSS MO Retrolenticular part of internal capsule R | IDP dMRI TBSS OD Fornix | IDP dMRI TBSS OD Posterior limb of internal capsule R | IDP T1 SIENAX CSF normalised volume | IDP T1 SIENAX CSF unnormalised volume | Lateral ventricular volume in normal aging | Left-hemisphere control network to putamen white-matter structural connectivity | Left-hemisphere control network to thalamus white-matter structural connectivity | Left-hemisphere default mode network to right-hemisphere control network white-matter structural connectivity | Left-hemisphere default mode network to right-hemisphere default mode network white-matter structural connectivity | Left-hemisphere default mode network to thalamus white-matter structural connectivity | Left-hemisphere dorsal attention network to right-hemisphere default mode network white-matter structural connectivity | Left-hemisphere dorsal attention network to thalamus white-matter structural connectivity | Left-hemisphere limbic network to thalamus white-matter structural connectivity | Left-hemisphere salience/ventral attention network to right-hemisphere default mode network white-matter structural connectivity | Left-hemisphere salience/ventral attention network to thalamus white-matter structural connectivity | Left-hemisphere somatomotor network to right-hemisphere somatomotor network white-matter structural connectivity | Left-hemisphere visual network to thalamus white-matter structural connectivity | Medial thalamic nuclei volume | MRI-derived phenotypes (MOSTest) (pleiotropy) | Node-level brain connectivity (multivariate analysis) | QC T1-to-standard linear alignment discrepancy | Right-hemisphere control network to thalamus white-matter structural connectivity | Right-hemisphere default mode network to thalamus white-matter structural connectivity | Right-hemisphere dorsal attention network to thalamus white-matter structural connectivity | Right-hemisphere limbic network to putamen white-matter structural connectivity | Right-hemisphere limbic network to thalamus white-matter structural connectivity | Right-hemisphere somatomotor network to pallidum white-matter structural connectivity | Right-hemisphere somatomotor network to thalamus white-matter structural connectivity | sMRI-derived phenotypes (MOSTest) (pleiotropy) | Subcortical volume (min-P) | Subcortical volume (MOSTest) | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 84) | Vertex-wise cortical surface area | Vertex-wise cortical thickness | Vertex-wise sulcal depth | White matter microstructure (axial diusivities) | White matter microstructure (fractional anisotropy) | White matter microstructure (mean diusivities) | White matter microstructure (mode of anisotropy) | White matter microstructure (radial diusivities) | Whole brain free water diffusion (multivariate analysis) | Whole brain restricted directional diffusion (multivariate analysis) | Whole brain restricted isotropic diffusion (multivariate analysis)	Wen_2024 (rs12146713), Smith_2020 (rs12146713)
41	white matter	12q23.3	12	107349294	rs2287163	T	C	0.3735	0.13416078	0.02159947	6.21129962911127	5.255e-10	0.000702396597637381	54890	upstream	TMEM263	transmembrane protein 263	protein_coding	0	15	110	114 | 454		TMEM263 (0.872) | MTERF2 (0.049) | RIC8B (0.045)	-	TMEM263 (rs10735418;4e-06)	-	TMEM263-DT (21;2e-30) | TMEM263 (13;6e-18) | ENSG00000257918 (2;2e-05) | MTERF2 (1;2e-07)	TMEM263-DT (41/49;2e-221) | TMEM263 (26/49;8e-96)	RFX4 (0.82) | CRY1 (0.48) | RIC8B (0.26)	TMEM263		Intrinsic epigenetic age acceleration | Waist-hip index | Waist-to-hip ratio adjusted for BMI	Novel
42	white matter	14q24.2	14	73297741	rs2215590	T	C	0.2529	0.14296069	0.02408342	5.93606265223129	2.919e-09	0.000641565243395736	54890	intronic	DPF3	double PHD fingers 3	protein_coding	0	8	5	5		DPF3 (0.951)	-	-	-	DCAF4 (17;2e-07) | MIDEAS-AS1 (3;3e-05) | DPF3 (2;3e-17) | ENSG00000259015 (1;1e-05)	MIDEAS-AS1 (49/49;4e-58) | DCAF4 (35/49;4e-39)	DPF3 (0.51) | PSEN1 (0.41) | NUMB (0.38)	DPF3		Pulse pressure | Serum urate levels	Novel
42	grey and white matter	14q24.2	14	73297741	rs2215590	T	C	0.253	0.1314441	0.02306496	5.69886529176725	1.206e-08	0.000591347114026504	54890	intronic	DPF3	double PHD fingers 3	protein_coding	0	27	8	7		DPF3 (0.958)	-	-	-	DCAF4 (3;2e-07) | MIDEAS-AS1 (3;3e-05) | DPF3 (2;3e-17)	MIDEAS-AS1 (49/49;4e-58) | DCAF4 (35/49;4e-39)	NUMB (0.53) | PSEN1 (0.37) | DPF3 (0.34)	DPF3		Pulse pressure | Serum urate levels	Novel
43	white matter	14q31.3	14	88433660	rs413420	T	C	0.5182	-0.15644714	0.02087427	-7.49473586381703	6.643e-14	0.00102232984098078	54890	intronic	GALC	galactosylceramidase	protein_coding	0	23	82	85		GALC (0.941) | GPR65 (0.013)	GALC (1;rs398607;22.900)	-	GALC (rs4904408;5e-07)	GALC (12;2e-19) | GPR65 (2;6e-11) | ENSG00000258407 (1;1e-04)	-	GALC (0.90) | GPR65 (0.45) | SPATA7 (0.06)	GALC		Intralaminar thalamic nuclei volume	Leonardsen_2023 (rs17203398)
43	grey and white matter	14q31.3	14	88454691	rs2245387	T	C	0.3477	-0.13072899	0.0210401	-6.21332550700805	5.187e-10	0.000702854537708205	54890	intronic	GALC	galactosylceramidase	protein_coding	0	8	122	122		GALC (0.784) | GPR65 (0.192)	-	-	-	GALC (17;5e-28)	-	GALC (0.80) | GPR65 (0.23) | SPATA7 (0.11)	GALC		Brain age gap	Leonardsen_2023 (rs17203398)
44	white matter	15q23	15	71169352	rs2031017	A	T	0.3994	-0.14386754	0.02128452	-6.75925696233695	1.387e-11	0.000831685559747314	54890	intronic	LRRC49	leucine rich repeat containing 49	protein_coding	0	9	51	51		LRRC49 (0.974)	-	LARP6 (rs1534615;3e-10) | AC009269.4 (rs2249595;5e-06)	LARP6 (rs11853599;2e-07) | LRRC49 (rs4777326;2e-05)	LARP6 (18;2e-27) | ENSG00000259744 (4;4e-11) | ENSG00000274297 (1;2e-05)	-	LARP6 (0.32) | UACA (0.25) | THSD4 (0.17)	LARP6		Brain region volumes | Corpus callosum Mid-posterior volume | Corpus callosum volume (MOSTest) | Vertex-wise cortical thickness	Smith_2020 (rs4777315)
44	grey and white matter	15q23	15	71159216	rs11072229	A	G	0.3994	-0.12346863	0.02037636	-6.0594056053191	1.366e-09	0.000668485860261134	54890	intronic	LRRC49	leucine rich repeat containing 49	protein_coding	0	11	53	53		LRRC49 (0.938) | THAP10 (0.028)	-	LARP6 (rs1534615;1e-08) | AC009269.4 (rs2249595;2e-05)	LARP6 (rs11853599;1e-06) | LRRC49 (rs4777326;6e-05)	LARP6 (17;6e-26) | ENSG00000259744 (4;2e-10) | ENSG00000274297 (1;6e-06)	-	UACA (0.48) | THSD4 (0.42) | LARP6 (0.14)	LARP6		Brain region volumes | Corpus callosum Mid-posterior volume | Corpus callosum volume (MOSTest) | Vertex-wise cortical thickness	Smith_2020 (rs4777315)
45	grey matter	16p11.2	16	30122181	rs536906899	CAAAAAAAAAAAAA	C	0.4006	-0.12168831	0.02221572	-5.47757668893918	4.312e-08	0.000546338983243761	54890	intronic	GDPD3	glycerophosphodiester phosphodiesterase domain containing 3	protein_coding	0	39	72	67		KCTD13 (0.338) | MAPK3 (0.289) | TMEM219 (0.120) | TBX6 (0.110) | TAOK2 (0.062) | DOC2A (0.021) | INO80E (0.013)	-	MAPK3 (rs55732507;2e-07)	-	-	-	MAPK3 (1.22) | CORO1A (0.84) | MYLPF (0.42)	MAPK3		-	Novel
46	grey matter	16q24.3	16	90051269	rs76839250	A	G	0.9066	0.24620312	0.0361571	6.80926069845203	9.81e-12	0.000844025964240666	54890	ncRNA_intronic	AFG3L1P	AFG3 like matrix AAA peptidase subunit 1%2C pseudogene	transcribed_pseudogene	0	6	15	14		MC1R (0.701) | DEF8 (0.129) | FANCA (0.073) | SPIRE2 (0.037) | TUBB3 (0.028)	MC1R (1;rs1805008;24.500) | FANCA (1;rs1800282;17.100)	-	DEF8 (rs6500462;4e-10)	CDK10 (47;2e-60) | VPS9D1 (24;5e-13) | CPNE7 (13;3e-09) | FANCA (10;5e-15) | DEF8 (9;3e-09) | CENPBD1P (9;1e-05) | SPIRE2 (8;5e-08) | LINC02166 (7;3e-14) | TCF25 (5;3e-05) | VPS9D1-AS1 (4;2e-05) | CHMP1A (3;6e-08) | GAS8 (3;7e-08) | CICP25 (2;2e-07) | TUBB3 (2;5e-05) | URAHP (2;1e-04) | ENSG00000261172 (1;2e-08) | DBNDD1 (1;2e-07) | SPATA33 (1;7e-06) | FAM157C (1;2e-05) | SPATA2L (1;2e-05) | LINC00304 (1;2e-05) | ENSG00000275734 (1;6e-05) | SPG7 (1;1e-04) | ZNF276 (1;1e-04) | MC1R (1;2e-04)	CDK10 (47/49;0e+00) | CENPBD1P (46/49;4e-64) | CHMP1A (41/49;2e-45) | DEF8 (39/49;5e-53) | VPS9D1 (35/49;3e-131) | TCF25 (35/49;7e-36) | LINC02166 (27/47;5e-55) | MC1R (27/49;2e-15) | LINC00304 (25/46;2e-27) | URAHP (26/49;9e-29) | CPNE7 (24/46;1e-64) | SPIRE2 (25/49;2e-43)	FANCA (0.17) | TUBB3 (0.17) | GAS8 (0.14)	DEF8		Basal cell carcinoma | Educational attainment (years of education) | Highest math class taken | Highest math class taken (MTAG) | Melanocyte protein PMEL levels | Monobrow | Self-reported math ability (MTAG)	Smith_2020 (rs4625719)
46	grey and white matter	16q24.3	16	90051269	rs76839250	A	G	0.9066	0.20426079	0.03451462	5.91809470885092	3.257e-09	0.000637689670579355	54890	ncRNA_intronic	AFG3L1P	AFG3 like matrix AAA peptidase subunit 1%2C pseudogene	transcribed_pseudogene	0	13	-	29		MC1R (0.604) | FANCA (0.136) | TCF25 (0.047) | SPIRE2 (0.045) | TUBB3 (0.030) | CDK10 (0.024) | CPNE7 (0.023) | DPEP1 (0.022) | DEF8 (0.017) | CHMP1A (0.015)	MC1R (1;rs1805008;24.500) | FANCA (1;rs1800282;17.100)	-	DEF8 (rs6500462;7e-08)	CDK10 (47;2e-60) | VPS9D1 (24;5e-13) | CPNE7 (12;3e-09) | FANCA (10;5e-15) | DEF8 (8;3e-09) | SPIRE2 (8;5e-08) | LINC02166 (7;3e-14) | CENPBD1P (7;1e-05) | TCF25 (5;3e-05) | VPS9D1-AS1 (4;2e-05) | CHMP1A (3;6e-08) | GAS8 (3;7e-08) | CICP25 (2;2e-07) | TUBB3 (2;5e-05) | ENSG00000261172 (1;2e-08) | DBNDD1 (1;2e-07) | SPATA33 (1;7e-06) | FAM157C (1;2e-05) | SPATA2L (1;2e-05) | LINC00304 (1;2e-05) | ENSG00000275734 (1;6e-05) | SPG7 (1;1e-04) | URAHP (1;1e-04) | ZNF276 (1;1e-04) | MC1R (1;2e-04)	CDK10 (47/49;0e+00) | CENPBD1P (46/49;4e-64) | CHMP1A (41/49;2e-45) | DEF8 (39/49;5e-53) | VPS9D1 (35/49;3e-131) | TCF25 (35/49;7e-36) | LINC02166 (27/47;5e-55) | MC1R (27/49;2e-15) | LINC00304 (25/46;2e-27) | CPNE7 (24/46;1e-64) | SPIRE2 (25/49;2e-43)	TUBB3 (0.41) | ZNF276 (0.26) | SPATA33 (0.24)	DEF8		Basal cell carcinoma | Educational attainment (years of education) | Highest math class taken | Highest math class taken (MTAG) | Melanocyte protein PMEL levels | Monobrow | Self-reported math ability (MTAG)	Smith_2020 (rs4625719)
47	white matter	17p11.2	17	19889274	rs111513543	A	T	0.6428	-0.13072402	0.02269179	-5.76085095093864	8.369e-09	0.000604273236756487	54890	intergenic	AKAP10	A-kinase anchoring protein 10	protein_coding	8105	30	47	47		AKAP10 (0.840) | SPECC1 (0.118)	AKAP10 (1;rs2108978;8.872)	-	-	-	-	SLC47A1 (0.76) | SPECC1 (0.52) | AKAP10 (0.34)	AKAP10		-	Novel
47	grey and white matter	17p11.2	17	19824272	17:19824272_CT_C	CT	C	0.605	-0.11704411	0.02055721	-5.69357952757208	1.244e-08	0.00059025130720698	54890	intronic	AKAP10	A-kinase anchoring protein 10	protein_coding	0	4	48	48		AKAP10 (0.925) | SPECC1 (0.054)	AKAP10 (2;rs203462;8.255)	-	AKAP10 (rs203465;3e-06)	ENSG00000270091 (24;1e-15) | AKAP10 (20;1e-28) | CCDC144CP (8;6e-09) | LGALS9B (6;2e-15) | USP32P3 (6;3e-06) | SPECC1-DT (3;5e-17) | SPECC1 (2;1e-05) | KRT16P3 (1;2e-21) | ENSG00000266126 (1;1e-06) | NOS2P3 (1;5e-06) | ENSG00000260907 (1;1e-04) | SRP68P3 (1;1e-04)	ENSG00000270091 (46/49;7e-229) | CCDC144CP (34/42;4e-68) | AKAP10 (37/49;4e-176) | LGALS9B (11/16;2e-59) | USP32P3 (31/49;3e-42) | NOS2P3 (9/18;2e-15)	SPECC1 (0.40) | SLC47A1 (0.38) | SLC47A2 (0.22)	AKAP10		Neutrophil count | Whole brain restricted directional diffusion (multivariate analysis)	Novel
48	grey matter	17q11.2	17	27962571	17:27962571_GCCC_G	G	GCCC	0.471	0.13800755	0.02247594	6.14023484668494	8.24e-10	0.000710125539076216	53057	intronic	SSH2	slingshot protein phosphatase 2	protein_coding	0	10	79	43 | 785		SSH2 (0.749) | ANKRD13B (0.157) | CORO6 (0.058)	SSH2 (1;rs2289629;23.700)	-	-	EFCAB5 (23;1e-34) | SSH2 (10;3e-35) | CORO6 (9;4e-124) | ANKRD13B (8;4e-33) | NSRP1 (7;2e-05) | GOSR1 (6;2e-06) | TP53I13 (5;5e-20) | GIT1 (4;1e-23) | SLC6A4 (4;2e-05) | ENSG00000266876 (3;1e-05) | ENSG00000264290 (2;3e-04) | ENSG00000264007 (1;6e-58) | ENSG00000265625 (1;3e-05) | BLMH (1;5e-05) | DHRS13 (1;1e-04)	EFCAB5 (31/38;5e-200) | GOSR1 (35/49;2e-26) | CORO6 (32/49;4e-252) | ENSG00000266876 (7/12;3e-13) | SSH2 (25/49;4e-91)	GIT1 (0.43) | TAOK1 (0.33) | CORO6 (0.20)	SSH2		Body mass index | Brain morphology (MOSTest) | Coronary artery disease | Cortical thickness (MOSTest) | Lymphocyte count | Subcortical volume (MOSTest) | Whole brain restricted directional diffusion (multivariate analysis)	Novel
48	grey and white matter	17q11.2	17	27959903	rs2289629	A	G	0.3488	0.12582505	0.02099577	5.99287618410756	2.062e-09	0.00065389667219673	54890	exonic	SSH2	slingshot protein phosphatase 2	protein_coding	0	3	33 | 16	13 | 32		SSH2 (0.812) | CORO6 (0.205)	SSH2 (1;rs2289629;23.700)	-	-	EFCAB5 (19;3e-19) | ANKRD13B (10;1e-17) | TP53I13 (9;4e-19) | SSH2 (7;8e-25) | CORO6 (6;1e-54) | GIT1 (4;2e-14) | SLC6A4 (3;2e-04) | ENSG00000264007 (2;3e-36) | ENSG00000266876 (2;1e-04) | BLMH (2;1e-04) | GOSR1 (1;2e-07) | PROCA1 (1;2e-05) | ENSG00000264290 (1;2e-05) | NSRP1 (1;1e-04) | ABHD15 (1;1e-04) | CPD (1;2e-04)	EFCAB5 (33/38;7e-126) | GOSR1 (36/49;2e-22) | ENSG00000266876 (6/12;1e-11)	GIT1 (0.55) | ABHD15 (0.38) | SSH2 (0.36)	SSH2		Brain region volumes | Chronic obstructive pulmonary disease	Novel
49	white matter	17q21.31	17	44305199	rs2260227	T	C	0.7774	-0.48347721	0.02508808	-19.2711921358669	9.375e-83	0.00672064822462465	54890	intergenic	KANSL1	KAT8 regulatory NSL complex subunit 1	protein_coding	2459	5	1760	1750		KANSL1 (0.923) | MAPT (0.148)	MAPT (1;rs17651549;34.000) | KANSL1 (2;rs17585974;24.700)	MAPT (rs2222746;7e-17)	KANSL1 (rs2696532;6e-55) | KANSL1-AS1 (rs199456;3e-46) | MAPT (rs2732599;1e-26) | LRRC37A4P (rs62061817;4e-23) | PLEKHM1 (rs1052594;8e-21) | ARL17A (rs199528;1e-20) | CRHR1-IT1 (rs2668690;2e-17) | MAPT-AS1 (rs62063670;3e-08) | AC005829.1 (rs199441;7e-08)	LINC02210 (49;4e-222) | LRRC37A4P (49;2e-193) | KANSL1-AS1 (49;6e-158) | ENSG00000262539 (49;4e-155) | MAPK8IP1P2 (49;2e-153) | DND1P1 (49;1e-136) | LRRC37A2 (49;2e-118) | ARL17A (47;2e-47) | LRRC37A (46;7e-44) | ENSG00000261575 (44;7e-63) | ENSG00000280022 (39;9e-104) | MAPK8IP1P1 (37;3e-128) | WNT3 (32;2e-41) | ENSG00000266918 (31;9e-23) | PLEKHM1 (27;5e-40) | KANSL1 (24;4e-22) | MAPT (21;4e-117) | NSF (17;1e-09) | FAM215B (16;3e-29) | ARHGAP27 (15;2e-34) | CRHR1 (15;5e-23) | MAPT-AS1 (11;3e-20) | ARL17B (10;5e-34) | DCAKD (7;2e-05) | MAPT-IT1 (6;1e-13) | ENSG00000236234 (6;3e-12) | LRRC37A17P (5;2e-10) | ENSG00000267344 (5;3e-08) | NMT1 (5;3e-06) | SPPL2C (4;5e-24) | ENSG00000267198 (4;1e-09) | RPS26P8 (3;1e-44) | ENSG00000262372 (3;5e-08) | ENSG00000262881 (2;2e-30) | FMNL1 (2;2e-22) | FMNL1-DT (2;5e-10) | NSFP1 (2;3e-06) | FMNL1-AS1 (2;7e-05) | ENSG00000131484 (2;2e-04) | ACBD4 (2;2e-04) | ENSG00000274883 (1;2e-17) | ENSG00000265964 (1;2e-05) | MAP3K14 (1;2e-04) | GOSR2 (1;3e-04)	ENSG00000262539 (49/49;0e+00) | KANSL1-AS1 (49/49;0e+00) | LRRC37A4P (49/49;0e+00) | MAPK8IP1P2 (49/49;0e+00) | MAPK8IP1P1 (37/37;0e+00) | ARL17A (48/49;0e+00) | LRRC37A2 (48/49;0e+00) | DND1P1 (47/49;0e+00) | LINC02210 (46/49;0e+00) | LRRC37A (45/49;0e+00) | ENSG00000266918 (44/48;1e-194) | ENSG00000261575 (43/48;0e+00) | FAM215B (19/22;6e-150) | WNT3 (38/49;3e-269) | KANSL1 (38/49;1e-180) | DCAKD (38/49;2e-35) | ENSG00000280022 (35/49;0e+00) | NMT1 (35/49;1e-36) | ACBD4 (31/49;8e-18) | NSFP1 (27/49;4e-11) | MAPT-IT1 (11/20;2e-44) | PLEKHM1 (25/49;3e-276) | ENSG00000262372 (25/49;5e-28) | ENSG00000267198 (23/46;9e-32)	MAPT (0.38) | STH (0.12) | KANSL1 (0.10)	MAPT		Accelerometer-based physical activity measurement (average acceleration) | Age at first birth | Albumin levels | Alcohol consumption | Alcohol consumption (drinks per month) (UKB data field 1578, 4424) | Alcohol consumption (drinks per week) | Alcohol consumption (drinks per week) (MTAG) | Alcohol consumption (heavy vs. light/non-drinkers) | Alcohol frequency weekly (standard GWA) | Alcohol liking | Alcohol use disorder (consumption score) | Alcohol use disorder (total score) | Alzheimer's disease | Alzheimer's disease in APOE e4- carriers | Alzheimer's disease or educational attainment (pleiotropy) | Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile) | Anteromedial temporal area (unadjusted for global measures) | aparc-a2009s lh area S-collat-transv-ant | aparc-a2009s lh area S-orbital-H-Shaped | aparc-a2009s lh thickness S-orbital-H-Shaped | aparc-a2009s rh area G-oc-temp-lat-fusifor | aparc-a2009s rh area G+S-occipital-inf | aparc-Desikan lh area fusiform | aparc-Desikan lh area TotalSurface | aparc-Desikan lh thickness inferiortemporal | aparc-Desikan rh area lateraloccipital | aparc-Desikan rh area TotalSurface | aparc-Desikan rh volume fusiform | aparc-DKTatlas lh area fusiform | aparc-DKTatlas rh area lateraloccipital | aparc-DKTatlas rh area lingual | aparc-DKTatlas rh volume fusiform | aparc-pial lh area TotalSurface | aparc-pial rh area TotalSurface | aseg global volume BrainSeg | aseg global volume BrainSegNotVent | aseg global volume BrainSegNotVentSurf | aseg global volume SupraTentorial | aseg global volume SupraTentorialNotVent | aseg lh volume CerebralWhiteMatter | aseg rh volume CerebralWhiteMatter | Attention deficit hyperactivity disorder or autism spectrum disorder or intelligence (pleiotropy) | Automobile speeding propensity | Average diameter for HDL particles | Avocado liking | BA-exvivo rh area V2 | Baked/steamed fish liking | Beans liking | Bioavailable testosterone levels | Bitter alcoholic beverage consumption | Brain age (difference between predicted and chronological age) | Brain age gap | Brain morphology (MOSTest) | Brain region volumes | Brain shape (segment 1) | Breast cancer | Breast cancer or critical COVID-19 (pleiotropy) | Breast cancer or hospitalized COVID-19 (pleiotropy) | Breast cancer or ovarian cancer (pleiotropy) | Broad bean liking | Brussel sprout liking | CALCOCO1/IKBKG protein level ratio | CALCOCO1/TJAP1 protein level ratio | Cancer (pleiotropy) | Capers liking | Cardiorespiratory fitness (vo2 max) | CASP2/NUB1 protein level ratio | CDKN2D/CNPY4 protein level ratio | Chronic obstructive pulmonary disease | Circulating docosahexaenoic acid levels | Cognitive ability | Cognitive ability (MTAG) | Cognitive aspects of educational attainment | Common executive function | Corpus callosum fractional anisotropy (body) | Corpus callosum fractional anisotropy (genu) | Corpus callosum fractional anisotropy (MOSTest) | Corpus callosum fractional anisotropy (splenium) | Cortical surface area | Cortical surface area (global PC1) | Cortical surface area (MOSTest) | Cortical thickness | Cortical volume | Corticobasal degeneration | COVID-19 (critical illness vs population or mild symptoms) | COVID-19 (critical illness vs population) | COVID-19 (hospitalized covid vs population) | COVID-19 (hospitalized vs population) | COVID-19 hospitalization or systemic lupus erythematosus (MTAG) | COVID-19 severity | CTF1/ITGB1BP2 protein level ratio | Daytime nap | Depressed affect | Dietary macronutrient intake (multi-trait analysis) | Disruptive behavior (multivariate analysis) | Docosahexaenoic acid levels | Docosahexaenoic acid levels (UKB data field 23450) | Docosahexaenoic acid to total fatty acids percentage (UKB data field 23457) | Dorsolateral prefrontal area (unadjusted for global measures) | Dorsolateral prefrontal thickness (unadjusted for global measures) | Dorsomedial frontal area (unadjusted for global measures) | Drinks per week | Ease of getting up in the morning | ECG cardiac MRI latent space | ECG latent space | Edge-level brain connectivity (multivariate analysis) | Educational attainment | Educational attainment (MTAG) | Educational attainment (years of education) | Eosinophil counts | Eosinophil percentage of white cells | Experiencing mood swings | Externalizing behaviour (multivariate analysis) | Eye color | F-acquired taste liking (derived food-liking factor) | F-bitter food liking (derived food-liking factor) | F-cheese liking (derived food-liking factor) | F-cooking vegetables liking (derived food-liking factor) | F-fatty/salty food liking (derived food-liking factor) | F-fish liking (derived food-liking factor) | F-oily fish liking (derived food-liking factor) | F-savoury food liking (derived food-liking factor) | F-seafood liking (derived food-liking factor) | F-sharp flavour liking (derived food-liking factor) | F-small fish liking (derived food-liking factor) | F-strong flavour liking (derived food-liking factor) | F-strong vegetable liking (derived food-liking factor) | Feeling fed-up | Feeling guilty | Feeling hurt | Feeling miserable | Feeling nervous | Feeling worry | FEV1 | Fornix volume | FOXO1/NUB1 protein level ratio | Free testosterone levels | Frontal QRS-T angle | FVC | General cognitive ability | General factor of neuroticism | Generalized anxiety disorder (mental health questionnaire or predicted) | Generalized anxiety disorder (phenotype risk score) | Globe artichoke liking | Goat cheese liking | Granulocyte count | Hand grip strength | Handedness (left-handed vs. right-handed) | Headache | Headache or migraine | Heel bone mineral density | Height | Height (standard GWA) | Hematocrit | Hemoglobin | Hemoglobin concentration | Hemoglobin levels | Herring liking | High light scatter reticulocyte count | High light scatter reticulocyte percentage of red cells | Highest math class taken | Highest math class taken (MTAG) | Hip circumference adjusted for BMI | Horseradish liking | Household income | Household income (MTAG) | Hypertrophic cardiomyopathy | Hypertrophic cardiomyopathy (MTAG) | Hypertrophic cardiomyopathy (sarcomere negative) | Idiopathic pulmonary fibrosis | IDP dMRI ProbtrackX ICVF atr l | IDP dMRI ProbtrackX ICVF atr r | IDP dMRI ProbtrackX ICVF slf l | IDP dMRI ProbtrackX ICVF slf r | IDP dMRI ProbtrackX ICVF str l | IDP dMRI ProbtrackX ICVF str r | IDP dMRI ProbtrackX L1 atr l | IDP dMRI ProbtrackX L1 ptr l | IDP dMRI ProbtrackX L1 slf l | IDP dMRI ProbtrackX L1 slf r | IDP dMRI ProbtrackX L1 str r | IDP dMRI ProbtrackX L2 atr l | IDP dMRI ProbtrackX MD atr l | IDP dMRI ProbtrackX MD str l | IDP dMRI ProbtrackX MD str r | IDP dMRI TBSS ICVF Anterior corona radiata L | IDP dMRI TBSS ICVF Anterior corona radiata R | IDP dMRI TBSS ICVF Anterior limb of internal capsule L | IDP dMRI TBSS ICVF Anterior limb of internal capsule R | IDP dMRI TBSS ICVF Cingulum cingulate gyrus L | IDP dMRI TBSS ICVF Cingulum cingulate gyrus R | IDP dMRI TBSS ICVF External capsule L | IDP dMRI TBSS ICVF External capsule R | IDP dMRI TBSS ICVF Genu of corpus callosum | IDP dMRI TBSS ICVF Posterior limb of internal capsule R | IDP dMRI TBSS ICVF Retrolenticular part of internal capsule L | IDP dMRI TBSS ICVF Superior corona radiata R | IDP dMRI TBSS ICVF Superior fronto-occipital fasciculus L | IDP dMRI TBSS ICVF Superior fronto-occipital fasciculus R | IDP dMRI TBSS L1 Anterior corona radiata L | IDP dMRI TBSS L1 External capsule L | IDP dMRI TBSS L1 External capsule R | IDP dMRI TBSS L1 Superior fronto-occipital fasciculus R | IDP dMRI TBSS L1 Superior longitudinal fasciculus L | IDP dMRI TBSS L1 Superior longitudinal fasciculus R | IDP dMRI TBSS L1 Uncinate fasciculus L | IDP dMRI TBSS L2 Genu of corpus callosum | IDP dMRI TBSS L2 Superior fronto-occipital fasciculus L | IDP dMRI TBSS L3 Anterior limb of internal capsule L | IDP dMRI TBSS L3 Anterior limb of internal capsule R | IDP dMRI TBSS L3 Genu of corpus callosum | IDP dMRI TBSS L3 Superior fronto-occipital fasciculus L | IDP dMRI TBSS MD Anterior corona radiata L | IDP dMRI TBSS MD Anterior corona radiata R | IDP dMRI TBSS MD Anterior limb of internal capsule L | IDP dMRI TBSS MD Anterior limb of internal capsule R | IDP dMRI TBSS MD Cingulum cingulate gyrus L | IDP dMRI TBSS MD Cingulum cingulate gyrus R | IDP dMRI TBSS MD Genu of corpus callosum | IDP dMRI TBSS MD Posterior limb of internal capsule R | IDP dMRI TBSS MD Superior corona radiata L | IDP dMRI TBSS MD Superior corona radiata R | IDP dMRI TBSS MD Superior fronto-occipital fasciculus L | IDP dMRI TBSS MD Superior fronto-occipital fasciculus R | IDP SWI T2star left putamen | IDP T1 SIENAX brain-normalised volume | IDP T1 SIENAX brain-unnormalised volume | IDP T1 SIENAX white normalised volume | IDP T1 SIENAX white unnormalised volume | Immature fraction of reticulocytes | Inferior parietal area (unadjusted for global measures) | Inferior parietal thickness (unadjusted for global measures) | Intelligence (MTAG) | Interstitial lung disease | Interventricular septum cross-sectional area | Intracranial volume | Irritable mood | ITGB1BP2/MITD1 protein level ratio | Joint mobility (Beighton score) | Lager liking | Left hippocampal volume (body) | Left molecular layer hippocampal volume (head) | Left ventricle wall thickness | Left ventricular end diastole anterior wall thickness | Left ventricular end diastole anterospetal wall thickness | Left ventricular end diastole inferolateral wall thickness | Left ventricular end diastole inferoseptal wall thickness | Left ventricular end diastolic mass | Left-handedness | Left-hemisphere limbic network to caudate white-matter structural connectivity | Left–right brain asymmetry | Lifetime smoking (without educational attainment) | Liver enzyme levels (alkaline phosphatase) | Liver liking | Loneliness | Low testosterone levels | Lower thalamus volume | Lumbar spine bone mineral density | Lung function (FEV1) | Lung function (FVC) | Lung function in never smokers (low FEV1 vs high FEV1) | Lymphocyte percentage of white cells | Lymphocyte-to-monocyte ratio | Mackerel liking | Macular thickness | Major depressive disorder or hospitalized COVID-19 (pleiotropy) | Major depressive disorder or severe COVID-19 (pleiotropy) | Male puberty timing (age at voice breaking MTAG) | Male puberty timing (late vs. average onset facial hair) | Male puberty timing (late vs. average onset voice breaking) | Male-pattern baldness | Maximum habitual alcohol consumption | Maximum habitual alcohol consumption (MTAG) | Mean corpuscular volume | Mean reticulocyte volume | Mean spheric corpuscular volume | Medial temporal thickness (unadjusted for global measures) | Medication use (anilides) | Medication use (antithrombotic agents) | Menarche (age at onset) | Middle temporal thickness (unadjusted for global measures) | Moderate to vigorous physical activity duration | Mood instability | Motor premotor area (unadjusted for global measures) | Mouth ulcers | Myeloid white cell count | Neurociticism | Neuroticism | Neutrophil count | Neutrophil percentage of white cells | Neutrophil-to-lymphocyte ratio | Node-level brain connectivity (multivariate analysis) | Number of sexual partners | Number of sexual partners in opposite-sex sexual behavior | Obstructive sleep apnea | Occipital area (unadjusted for global measures) | Occipital thickness (unadjusted for global measures) | Occupational attainment | Omega-3 fatty acid levels | Omega-3 fatty acids levels (UKB data field 23444) | Omega-3 fatty acids to total fatty acids percentage (UKB data field 23451) | Omega-6 fatty acids to omega-3 fatty acids ratio (UKB data field 23459) | Orbitofrontal area (unadjusted for global measures) | Osteoarthritis (hip) | Osteoarthrosis (time to event) | Ovarian cancer or critical COVID-19 (pleiotropy) | Ovarian cancer or hospitalized COVID-19 (pleiotropy) | Pain (pleiotropy) | Parkinson's disease | Parsopercularis area (unadjusted for global measures) | Peak expiratory flow | Personality traits or cognitive traits (multivariate analysis) | Phospholipid levels in large HDL | Phospholipids to total lipids ratio in small HDL | Phospholipids to total lipids ratio in very large HDL | Photoreceptor cell layer thickness phenotypes (MTAG) | Physical activity | Physical activity (overall physical activity time) | Physical activity (Total log acceleration) | Post-traumatic stress disorder (mental health questionnaire or predicted) | Post-traumatic stress disorder (phenotype risk score) | Post-traumatic stress disorder symptom severity (avoidance) | Post-traumatic stress disorder symptom severity (hyperarousal) | Post-traumatic stress disorder symptom severity (total) | Posterolateral temporal area (unadjusted for global measures) | Precuneus area (unadjusted for global measures) | Primary biliary cirrhosis | Primary open angle glaucoma (MTAG) | Primary open angle glaucoma (multi-trait analysis) | Problematic alcohol use (MTAG) | Progressive supranuclear palsy | Ratio of docosahexaenoic acid to total fatty acid levels | Ratio of omega-3 fatty acids to total fatty acids | Ratio of omega-6 fatty acids to omega-3 fatty acids | Red blood cell count | Red cell distribution width | Refractive error | Regional cortical thickness (inferiorparietal) | Regional cortical thickness (inferiortemporal) | Regional cortical thickness (lateraloccipital) | Regional cortical thickness (middletemporal) | Reticulocyte count | Reticulocyte fraction of red cells | Right molecular layer hippocampal volume (head) | Risk-taking behavior (multivariate analysis) | Risk-taking tendency (4-domain principal component model) | Salad dressing liking | Salami liking | Sardines liking | Schizophrenia | Schizophrenia or breast cancer (pleiotropy) | Schizophrenia or ER positive breast cancer (pleiotropy) | Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS)) | Self-reported math ability | Sensitivity to environmental stress and adversity | Seropositivity for lactobacillus rhamnosus GG peptide (agilent_192425) | Severe COVID-19 or systemic lupus erythematosus (MTAG) | Sleep duration | Sleep duration (long sleep) | Smoking initiation | Snoring | Stool frequency | Subcortical brain region volumes | Sum basophil neutrophil counts | Sum neutrophil eosinophil counts | Superior parietal area (unadjusted for global measures) | Superior temporal area (unadjusted for global measures) | Systemic lupus erythematosus (MTAG) | Systolic blood pressure | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 109) | ThalamNuclei lh volume VAmc | Thalamus volume | Thyroid stimulating hormone levels | Total omega-3 fatty acid levels | Total testosterone levels | Turnip liking | Type 1 diabetes | Ventral frontal thickness (unadjusted for global measures) | Ventromedial occipital thickness (unadjusted for global measures) | Vertex-wise cortical surface area | Vertex-wise cortical thickness | Vertex-wise sulcal depth | Waist-hip index | Waist-hip ratio | Waist-to-hip ratio adjusted for BMI | White matter integrity (mean diffusivity) | White matter microstructure (axial diusivities) | White matter microstructure (fractional anisotropy) | White matter microstructure (mean diusivities) | White matter microstructure (radial diusivities) | Whole brain free water diffusion (multivariate analysis) | Whole brain restricted directional diffusion (multivariate analysis) | Whole brain restricted isotropic diffusion (multivariate analysis) | Worry | Worry too long after an embarrassing experience	Ning_2021 (rs2696671), Wen_2024 (rs62064415), Leonardsen_2023 (rs2106786), Kim_2023 (rs147431626), Smith_2020 (rs62064364), Jonsson_2019 (rs2435204)
49	grey and white matter	17q21.31	17	44021717	rs4327091	A	G	0.2208	0.44592484	0.02413043	18.4797718068016	3.005e-76	0.00618332510478727	54890	intronic	MAPT	microtubule associated protein tau	protein_coding	0	8	1698	1688		KANSL1 (0.842) | KANSL1-AS1 (0.123)	-	MAPT (rs2222746;1e-16)	KANSL1 (rs2696532;5e-52) | KANSL1-AS1 (rs199456;2e-44) | MAPT (rs2732599;9e-26) | LRRC37A4P (rs62061817;1e-22) | PLEKHM1 (rs1052594;2e-20) | ARL17A (rs199528;3e-20) | CRHR1-IT1 (rs2668690;4e-17) | MAPT-AS1 (rs62063670;3e-08) | AC005829.1 (rs199441;7e-08)	LINC02210 (49;1e-218) | LRRC37A4P (49;2e-191) | KANSL1-AS1 (49;1e-153) | ENSG00000262539 (49;6e-150) | MAPK8IP1P2 (49;1e-149) | DND1P1 (49;2e-134) | LRRC37A2 (49;5e-115) | ARL17A (47;2e-47) | LRRC37A (46;1e-43) | ENSG00000261575 (44;1e-62) | ENSG00000280022 (39;4e-103) | MAPK8IP1P1 (37;4e-128) | WNT3 (32;2e-41) | ENSG00000266918 (31;5e-22) | PLEKHM1 (27;5e-40) | KANSL1 (24;2e-21) | MAPT (21;3e-111) | NSF (17;4e-09) | FAM215B (16;3e-29) | ARHGAP27 (15;4e-35) | CRHR1 (15;3e-22) | MAPT-AS1 (11;3e-20) | ARL17B (10;2e-33) | DCAKD (7;4e-05) | MAPT-IT1 (6;3e-14) | ENSG00000236234 (6;3e-12) | LRRC37A17P (5;2e-10) | ENSG00000267344 (5;3e-08) | NMT1 (5;3e-06) | SPPL2C (4;5e-24) | ENSG00000267198 (4;6e-10) | RPS26P8 (3;2e-44) | ENSG00000262372 (3;3e-07) | ENSG00000262881 (2;2e-30) | FMNL1 (2;2e-22) | FMNL1-DT (2;5e-10) | NSFP1 (2;3e-06) | FMNL1-AS1 (2;7e-05) | ACBD4 (2;9e-05) | ENSG00000131484 (2;2e-04) | ENSG00000274883 (1;2e-17) | ENSG00000265964 (1;2e-05) | MAP3K14 (1;2e-04) | GOSR2 (1;4e-04)	ENSG00000262539 (49/49;0e+00) | KANSL1-AS1 (49/49;0e+00) | LRRC37A4P (49/49;0e+00) | MAPK8IP1P2 (49/49;0e+00) | MAPK8IP1P1 (37/37;0e+00) | ARL17A (48/49;0e+00) | LRRC37A2 (48/49;0e+00) | DND1P1 (47/49;0e+00) | LINC02210 (46/49;0e+00) | LRRC37A (45/49;0e+00) | ENSG00000266918 (44/48;9e-191) | ENSG00000261575 (43/48;0e+00) | FAM215B (19/22;3e-150) | DCAKD (40/49;6e-35) | KANSL1 (39/49;2e-176) | WNT3 (38/49;6e-267) | NMT1 (36/49;1e-37) | ENSG00000280022 (35/49;0e+00) | ACBD4 (29/49;5e-18) | ENSG00000262372 (27/49;2e-27) | MAPT-IT1 (11/20;6e-45) | PLEKHM1 (25/49;5e-276) | NSFP1 (25/49;4e-11) | ENSG00000267198 (23/46;9e-32)	STH (0.09) | KANSL1 (0.04) | LRRC37A (0.04)	KANSL1		Accelerometer-based physical activity measurement (average acceleration) | Age at first birth | Albumin levels | Alcohol consumption | Alcohol consumption (drinks per month) (UKB data field 1578, 4424) | Alcohol consumption (drinks per week) | Alcohol consumption (drinks per week) (MTAG) | Alcohol consumption (heavy vs. light/non-drinkers) | Alcohol frequency weekly (standard GWA) | Alcohol liking | Alcohol use disorder (consumption score) | Alcohol use disorder (total score) | Alzheimer's disease | Alzheimer's disease in APOE e4- carriers | Alzheimer's disease or educational attainment (pleiotropy) | Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile) | Anteromedial temporal area (unadjusted for global measures) | aparc-a2009s lh area S-collat-transv-ant | aparc-a2009s lh area S-orbital-H-Shaped | aparc-a2009s lh thickness S-orbital-H-Shaped | aparc-a2009s rh area G-oc-temp-lat-fusifor | aparc-a2009s rh area G+S-occipital-inf | aparc-Desikan lh area fusiform | aparc-Desikan lh area TotalSurface | aparc-Desikan lh thickness inferiortemporal | aparc-Desikan rh area lateraloccipital | aparc-Desikan rh area TotalSurface | aparc-Desikan rh volume fusiform | aparc-DKTatlas lh area fusiform | aparc-DKTatlas rh area lateraloccipital | aparc-DKTatlas rh area lingual | aparc-DKTatlas rh volume fusiform | aparc-pial lh area TotalSurface | aparc-pial rh area TotalSurface | aseg global volume BrainSeg | aseg global volume BrainSegNotVent | aseg global volume BrainSegNotVentSurf | aseg global volume SupraTentorial | aseg global volume SupraTentorialNotVent | aseg lh volume CerebralWhiteMatter | aseg rh volume CerebralWhiteMatter | Attention deficit hyperactivity disorder or autism spectrum disorder or intelligence (pleiotropy) | Automobile speeding propensity | Average diameter for HDL particles | Avocado liking | BA-exvivo rh area V2 | Baked/steamed fish liking | Beans liking | Bioavailable testosterone levels | Bitter alcoholic beverage consumption | Brain age (difference between predicted and chronological age) | Brain age gap | Brain morphology (MOSTest) | Brain region volumes | Brain shape (segment 1) | Breast cancer | Breast cancer or critical COVID-19 (pleiotropy) | Breast cancer or hospitalized COVID-19 (pleiotropy) | Breast cancer or ovarian cancer (pleiotropy) | Broad bean liking | Brussel sprout liking | CALCOCO1/IKBKG protein level ratio | CALCOCO1/TJAP1 protein level ratio | Cancer (pleiotropy) | Capers liking | Cardiorespiratory fitness (vo2 max) | CASP2/NUB1 protein level ratio | CDKN2D/CNPY4 protein level ratio | Chronic obstructive pulmonary disease | Circulating docosahexaenoic acid levels | Cognitive ability | Cognitive ability (MTAG) | Cognitive aspects of educational attainment | Common executive function | Corpus callosum fractional anisotropy (body) | Corpus callosum fractional anisotropy (genu) | Corpus callosum fractional anisotropy (MOSTest) | Corpus callosum fractional anisotropy (splenium) | Cortical surface area | Cortical surface area (global PC1) | Cortical surface area (MOSTest) | Cortical thickness | Cortical volume | Corticobasal degeneration | COVID-19 (critical illness vs population or mild symptoms) | COVID-19 (critical illness vs population) | COVID-19 (hospitalized covid vs population) | COVID-19 (hospitalized vs population) | COVID-19 hospitalization or systemic lupus erythematosus (MTAG) | COVID-19 severity | CTF1/ITGB1BP2 protein level ratio | Daytime nap | Depressed affect | Dietary macronutrient intake (multi-trait analysis) | Disruptive behavior (multivariate analysis) | Docosahexaenoic acid levels | Docosahexaenoic acid levels (UKB data field 23450) | Docosahexaenoic acid to total fatty acids percentage (UKB data field 23457) | Dorsolateral prefrontal area (unadjusted for global measures) | Dorsolateral prefrontal thickness (unadjusted for global measures) | Dorsomedial frontal area (unadjusted for global measures) | Drinks per week | Ease of getting up in the morning | ECG cardiac MRI latent space | ECG latent space | Edge-level brain connectivity (multivariate analysis) | Educational attainment | Educational attainment (MTAG) | Educational attainment (years of education) | Eosinophil counts | Eosinophil percentage of white cells | Experiencing mood swings | Externalizing behaviour (multivariate analysis) | Eye color | F-acquired taste liking (derived food-liking factor) | F-bitter food liking (derived food-liking factor) | F-cheese liking (derived food-liking factor) | F-cooking vegetables liking (derived food-liking factor) | F-fatty/salty food liking (derived food-liking factor) | F-fish liking (derived food-liking factor) | F-oily fish liking (derived food-liking factor) | F-savoury food liking (derived food-liking factor) | F-seafood liking (derived food-liking factor) | F-sharp flavour liking (derived food-liking factor) | F-small fish liking (derived food-liking factor) | F-strong flavour liking (derived food-liking factor) | F-strong vegetable liking (derived food-liking factor) | Feeling fed-up | Feeling guilty | Feeling hurt | Feeling miserable | Feeling nervous | Feeling worry | FEV1 | Fornix volume | FOXO1/NUB1 protein level ratio | Free testosterone levels | Frontal QRS-T angle | FVC | General cognitive ability | General factor of neuroticism | Generalized anxiety disorder (mental health questionnaire or predicted) | Generalized anxiety disorder (phenotype risk score) | Globe artichoke liking | Goat cheese liking | Granulocyte count | Hand grip strength | Handedness (left-handed vs. right-handed) | Headache | Headache or migraine | Heel bone mineral density | Height | Height (standard GWA) | Hematocrit | Hemoglobin | Hemoglobin concentration | Hemoglobin levels | Herring liking | High light scatter reticulocyte count | High light scatter reticulocyte percentage of red cells | Highest math class taken | Highest math class taken (MTAG) | Hip circumference adjusted for BMI | Horseradish liking | Household income | Household income (MTAG) | Hypertrophic cardiomyopathy | Hypertrophic cardiomyopathy (MTAG) | Hypertrophic cardiomyopathy (sarcomere negative) | Idiopathic pulmonary fibrosis | IDP dMRI ProbtrackX ICVF atr l | IDP dMRI ProbtrackX ICVF atr r | IDP dMRI ProbtrackX ICVF slf l | IDP dMRI ProbtrackX ICVF slf r | IDP dMRI ProbtrackX ICVF str l | IDP dMRI ProbtrackX ICVF str r | IDP dMRI ProbtrackX L1 atr l | IDP dMRI ProbtrackX L1 ptr l | IDP dMRI ProbtrackX L1 slf l | IDP dMRI ProbtrackX L1 slf r | IDP dMRI ProbtrackX L1 str r | IDP dMRI ProbtrackX L2 atr l | IDP dMRI ProbtrackX MD atr l | IDP dMRI ProbtrackX MD str l | IDP dMRI ProbtrackX MD str r | IDP dMRI TBSS ICVF Anterior corona radiata L | IDP dMRI TBSS ICVF Anterior corona radiata R | IDP dMRI TBSS ICVF Anterior limb of internal capsule L | IDP dMRI TBSS ICVF Anterior limb of internal capsule R | IDP dMRI TBSS ICVF Cingulum cingulate gyrus L | IDP dMRI TBSS ICVF Cingulum cingulate gyrus R | IDP dMRI TBSS ICVF External capsule L | IDP dMRI TBSS ICVF External capsule R | IDP dMRI TBSS ICVF Genu of corpus callosum | IDP dMRI TBSS ICVF Posterior limb of internal capsule R | IDP dMRI TBSS ICVF Retrolenticular part of internal capsule L | IDP dMRI TBSS ICVF Superior corona radiata R | IDP dMRI TBSS ICVF Superior fronto-occipital fasciculus L | IDP dMRI TBSS ICVF Superior fronto-occipital fasciculus R | IDP dMRI TBSS L1 Anterior corona radiata L | IDP dMRI TBSS L1 External capsule L | IDP dMRI TBSS L1 External capsule R | IDP dMRI TBSS L1 Superior fronto-occipital fasciculus R | IDP dMRI TBSS L1 Superior longitudinal fasciculus L | IDP dMRI TBSS L1 Superior longitudinal fasciculus R | IDP dMRI TBSS L1 Uncinate fasciculus L | IDP dMRI TBSS L2 Genu of corpus callosum | IDP dMRI TBSS L2 Superior fronto-occipital fasciculus L | IDP dMRI TBSS L3 Anterior limb of internal capsule L | IDP dMRI TBSS L3 Anterior limb of internal capsule R | IDP dMRI TBSS L3 Genu of corpus callosum | IDP dMRI TBSS L3 Superior fronto-occipital fasciculus L | IDP dMRI TBSS MD Anterior corona radiata L | IDP dMRI TBSS MD Anterior corona radiata R | IDP dMRI TBSS MD Anterior limb of internal capsule L | IDP dMRI TBSS MD Anterior limb of internal capsule R | IDP dMRI TBSS MD Cingulum cingulate gyrus L | IDP dMRI TBSS MD Cingulum cingulate gyrus R | IDP dMRI TBSS MD Genu of corpus callosum | IDP dMRI TBSS MD Posterior limb of internal capsule R | IDP dMRI TBSS MD Superior corona radiata L | IDP dMRI TBSS MD Superior corona radiata R | IDP dMRI TBSS MD Superior fronto-occipital fasciculus L | IDP dMRI TBSS MD Superior fronto-occipital fasciculus R | IDP SWI T2star left putamen | IDP T1 SIENAX brain-normalised volume | IDP T1 SIENAX brain-unnormalised volume | IDP T1 SIENAX white normalised volume | IDP T1 SIENAX white unnormalised volume | Immature fraction of reticulocytes | Inferior parietal area (unadjusted for global measures) | Inferior parietal thickness (unadjusted for global measures) | Intelligence (MTAG) | Interstitial lung disease | Interventricular septum cross-sectional area | Intracranial volume | Irritable mood | ITGB1BP2/MITD1 protein level ratio | Joint mobility (Beighton score) | Lager liking | Left hippocampal volume (body) | Left molecular layer hippocampal volume (head) | Left ventricle wall thickness | Left ventricular end diastole anterior wall thickness | Left ventricular end diastole anterospetal wall thickness | Left ventricular end diastole inferolateral wall thickness | Left ventricular end diastole inferoseptal wall thickness | Left ventricular end diastolic mass | Left-handedness | Left-hemisphere limbic network to caudate white-matter structural connectivity | Left–right brain asymmetry | Lifetime smoking (without educational attainment) | Liver enzyme levels (alkaline phosphatase) | Liver liking | Loneliness | Low testosterone levels | Lower thalamus volume | Lumbar spine bone mineral density | Lung function (FEV1) | Lung function (FVC) | Lung function in never smokers (low FEV1 vs high FEV1) | Lymphocyte percentage of white cells | Lymphocyte-to-monocyte ratio | Mackerel liking | Macular thickness | Major depressive disorder or hospitalized COVID-19 (pleiotropy) | Major depressive disorder or severe COVID-19 (pleiotropy) | Male puberty timing (age at voice breaking MTAG) | Male puberty timing (late vs. average onset facial hair) | Male puberty timing (late vs. average onset voice breaking) | Male-pattern baldness | Maximum habitual alcohol consumption | Maximum habitual alcohol consumption (MTAG) | Mean corpuscular volume | Mean reticulocyte volume | Mean spheric corpuscular volume | Medial temporal thickness (unadjusted for global measures) | Medication use (anilides) | Medication use (antithrombotic agents) | Menarche (age at onset) | Middle temporal thickness (unadjusted for global measures) | Moderate to vigorous physical activity duration | Mood instability | Motor premotor area (unadjusted for global measures) | Mouth ulcers | Myeloid white cell count | Neurociticism | Neuroticism | Neutrophil count | Neutrophil percentage of white cells | Neutrophil-to-lymphocyte ratio | Node-level brain connectivity (multivariate analysis) | Number of sexual partners | Number of sexual partners in opposite-sex sexual behavior | Obstructive sleep apnea | Occipital area (unadjusted for global measures) | Occipital thickness (unadjusted for global measures) | Occupational attainment | Omega-3 fatty acid levels | Omega-3 fatty acids levels (UKB data field 23444) | Omega-3 fatty acids to total fatty acids percentage (UKB data field 23451) | Omega-6 fatty acids to omega-3 fatty acids ratio (UKB data field 23459) | Orbitofrontal area (unadjusted for global measures) | Osteoarthritis (hip) | Osteoarthrosis (time to event) | Ovarian cancer or critical COVID-19 (pleiotropy) | Ovarian cancer or hospitalized COVID-19 (pleiotropy) | Pain (pleiotropy) | Parkinson's disease | Parsopercularis area (unadjusted for global measures) | Peak expiratory flow | Personality traits or cognitive traits (multivariate analysis) | Phospholipid levels in large HDL | Phospholipids to total lipids ratio in small HDL | Phospholipids to total lipids ratio in very large HDL | Photoreceptor cell layer thickness phenotypes (MTAG) | Physical activity | Physical activity (overall physical activity time) | Physical activity (Total log acceleration) | Post-traumatic stress disorder (mental health questionnaire or predicted) | Post-traumatic stress disorder (phenotype risk score) | Post-traumatic stress disorder symptom severity (avoidance) | Post-traumatic stress disorder symptom severity (hyperarousal) | Post-traumatic stress disorder symptom severity (total) | Posterolateral temporal area (unadjusted for global measures) | Precuneus area (unadjusted for global measures) | Primary biliary cirrhosis | Primary open angle glaucoma (MTAG) | Primary open angle glaucoma (multi-trait analysis) | Problematic alcohol use (MTAG) | Progressive supranuclear palsy | Ratio of docosahexaenoic acid to total fatty acid levels | Ratio of omega-3 fatty acids to total fatty acids | Ratio of omega-6 fatty acids to omega-3 fatty acids | Red blood cell count | Red cell distribution width | Refractive error | Regional cortical thickness (inferiorparietal) | Regional cortical thickness (inferiortemporal) | Regional cortical thickness (lateraloccipital) | Regional cortical thickness (middletemporal) | Reticulocyte count | Reticulocyte fraction of red cells | Right molecular layer hippocampal volume (head) | Risk-taking behavior (multivariate analysis) | Risk-taking tendency (4-domain principal component model) | Salad dressing liking | Salami liking | Sardines liking | Schizophrenia | Schizophrenia or breast cancer (pleiotropy) | Schizophrenia or ER positive breast cancer (pleiotropy) | Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS)) | Self-reported math ability | Sensitivity to environmental stress and adversity | Seropositivity for lactobacillus rhamnosus GG peptide (agilent_192425) | Severe COVID-19 or systemic lupus erythematosus (MTAG) | Sleep duration | Sleep duration (long sleep) | Smoking initiation | Snoring | Stool frequency | Subcortical brain region volumes | Sum basophil neutrophil counts | Sum neutrophil eosinophil counts | Superior parietal area (unadjusted for global measures) | Superior temporal area (unadjusted for global measures) | Systemic lupus erythematosus (MTAG) | Systolic blood pressure | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 109) | ThalamNuclei lh volume VAmc | Thalamus volume | Thyroid stimulating hormone levels | Total omega-3 fatty acid levels | Total testosterone levels | Turnip liking | Type 1 diabetes | Ventral frontal thickness (unadjusted for global measures) | Ventromedial occipital thickness (unadjusted for global measures) | Vertex-wise cortical surface area | Vertex-wise cortical thickness | Vertex-wise sulcal depth | Waist-hip index | Waist-hip ratio | Waist-to-hip ratio adjusted for BMI | White matter integrity (mean diffusivity) | White matter microstructure (axial diusivities) | White matter microstructure (fractional anisotropy) | White matter microstructure (mean diusivities) | White matter microstructure (radial diusivities) | Whole brain free water diffusion (multivariate analysis) | Whole brain restricted directional diffusion (multivariate analysis) | Whole brain restricted isotropic diffusion (multivariate analysis) | Worry | Worry too long after an embarrassing experience	Ning_2021 (rs2696671), Wen_2024 (rs62064415), Leonardsen_2023 (rs2106786), Kim_2023 (rs147431626), Smith_2020 (rs62064364), Jonsson_2019 (rs2435204)
49	grey matter	17q21.31	17	44013966	rs56072903	T	C	0.7983	-0.37387221	0.02692701	-13.8846537361556	7.848e-44	0.00350001573579892	54890	intronic	MAPT	microtubule associated protein tau	protein_coding	0	5	1805	1794		KANSL1 (1.052)	-	KANSL1-AS1 (rs199456;3e-32) | MAPK8IP1P2 (rs199456;4e-32) | MAPK8IP1P1 (rs199451;7e-31) | MAPT (rs2222746;3e-14)	KANSL1 (rs2696532;1e-32) | KANSL1-AS1 (rs199456;5e-29) | MAPT (rs2732599;2e-19) | LRRC37A4P (rs62061817;2e-18) | PLEKHM1 (rs1052594;6e-17) | ARL17A (rs199528;1e-16) | CRHR1-IT1 (rs2668690;3e-14) | MAPT-AS1 (rs62063670;2e-08) | AC005829.1 (rs199441;2e-07)	LINC02210 (49;2e-219) | LRRC37A4P (49;2e-193) | KANSL1-AS1 (49;6e-158) | ENSG00000262539 (49;5e-154) | MAPK8IP1P2 (49;2e-153) | DND1P1 (49;1e-136) | LRRC37A2 (49;2e-118) | ARL17A (46;2e-47) | LRRC37A (45;9e-44) | ENSG00000261575 (44;7e-63) | ENSG00000280022 (39;9e-104) | MAPK8IP1P1 (37;2e-126) | ENSG00000266918 (30;9e-23) | WNT3 (27;2e-41) | PLEKHM1 (27;5e-40) | KANSL1 (24;4e-22) | MAPT (20;4e-117) | NSF (16;1e-09) | ARHGAP27 (15;4e-35) | FAM215B (15;4e-29) | CRHR1 (15;5e-23) | MAPT-AS1 (11;3e-20) | ARL17B (9;5e-34) | DCAKD (7;3e-05) | MAPT-IT1 (6;1e-13) | ENSG00000236234 (6;3e-12) | LRRC37A17P (5;2e-10) | ENSG00000267344 (5;3e-08) | SPPL2C (4;5e-24) | ENSG00000267198 (4;1e-09) | NMT1 (4;3e-06) | RPS26P8 (3;1e-44) | ENSG00000262372 (3;5e-08) | ENSG00000262881 (2;2e-30) | FMNL1 (2;2e-22) | FMNL1-DT (2;5e-10) | FMNL1-AS1 (2;7e-05) | ENSG00000131484 (2;2e-04) | ACBD4 (2;2e-04) | ENSG00000274883 (1;2e-17) | ENSG00000265964 (1;2e-05) | NSFP1 (1;2e-04) | MAP3K14 (1;2e-04) | GOSR2 (1;4e-04)	ENSG00000262539 (49/49;0e+00) | KANSL1-AS1 (49/49;0e+00) | LRRC37A4P (49/49;0e+00) | MAPK8IP1P2 (49/49;0e+00) | MAPK8IP1P1 (37/37;0e+00) | ARL17A (48/49;0e+00) | LRRC37A2 (48/49;0e+00) | DND1P1 (47/49;0e+00) | LINC02210 (46/49;0e+00) | LRRC37A (45/49;0e+00) | ENSG00000261575 (43/48;0e+00) | ENSG00000266918 (43/48;3e-196) | FAM215B (19/22;2e-149) | DCAKD (42/49;1e-35) | KANSL1 (39/49;5e-181) | WNT3 (38/49;2e-270) | ENSG00000280022 (35/49;0e+00) | NMT1 (34/49;4e-37) | ENSG00000262372 (28/49;2e-28) | MAPT-IT1 (11/20;2e-44) | ACBD4 (26/49;2e-17) | PLEKHM1 (25/49;5e-276) | NSFP1 (25/49;4e-11) | ENSG00000267198 (23/46;9e-32)	MAPT (0.75) | KANSL1 (0.19) | CRHR1 (0.09)	KANSL1		Accelerometer-based physical activity measurement (average acceleration) | Age at first birth | Albumin levels | Alcohol consumption | Alcohol consumption (drinks per month) (UKB data field 1578, 4424) | Alcohol consumption (drinks per week) | Alcohol consumption (drinks per week) (MTAG) | Alcohol consumption (heavy vs. light/non-drinkers) | Alcohol frequency weekly (standard GWA) | Alcohol liking | Alcohol use disorder (consumption score) | Alcohol use disorder (total score) | Alzheimer's disease in APOE e4- carriers | Alzheimer’s disease polygenic risk score (upper quantile vs lower quantile) | Anteromedial temporal area (unadjusted for global measures) | aparc-a2009s lh area S-collat-transv-ant | aparc-a2009s lh area S-orbital-H-Shaped | aparc-a2009s lh thickness S-orbital-H-Shaped | aparc-a2009s rh area G-oc-temp-lat-fusifor | aparc-a2009s rh area G+S-occipital-inf | aparc-Desikan lh area fusiform | aparc-Desikan lh area TotalSurface | aparc-Desikan lh thickness inferiortemporal | aparc-Desikan rh area lateraloccipital | aparc-Desikan rh area TotalSurface | aparc-Desikan rh volume fusiform | aparc-DKTatlas lh area fusiform | aparc-DKTatlas rh area lateraloccipital | aparc-DKTatlas rh area lingual | aparc-DKTatlas rh volume fusiform | aparc-pial lh area TotalSurface | aparc-pial rh area TotalSurface | aseg global volume BrainSeg | aseg global volume BrainSegNotVent | aseg global volume BrainSegNotVentSurf | aseg global volume SupraTentorial | aseg global volume SupraTentorialNotVent | aseg lh volume CerebralWhiteMatter | aseg rh volume CerebralWhiteMatter | Attention deficit hyperactivity disorder or autism spectrum disorder or intelligence (pleiotropy) | Automobile speeding propensity | Average diameter for HDL particles | Avocado liking | BA-exvivo rh area V2 | Beans liking | Bioavailable testosterone levels | Brain age (difference between predicted and chronological age) | Brain age gap | Brain morphology (MOSTest) | Brain region volumes | Brain shape (segment 1) | Breast cancer | Breast cancer or critical COVID-19 (pleiotropy) | Breast cancer or hospitalized COVID-19 (pleiotropy) | Breast cancer or ovarian cancer (pleiotropy) | Broad bean liking | Brussel sprout liking | CALCOCO1/IKBKG protein level ratio | CALCOCO1/TJAP1 protein level ratio | Cancer (pleiotropy) | Capers liking | Cardiorespiratory fitness (vo2 max) | CASP2/NUB1 protein level ratio | CDKN2D/CNPY4 protein level ratio | Chronic obstructive pulmonary disease | Circulating docosahexaenoic acid levels | Cognitive ability | Cognitive ability (MTAG) | Cognitive aspects of educational attainment | Common executive function | Corpus callosum fractional anisotropy (body) | Corpus callosum fractional anisotropy (genu) | Corpus callosum fractional anisotropy (MOSTest) | Corpus callosum fractional anisotropy (splenium) | Cortical surface area | Cortical surface area (global PC1) | Cortical surface area (MOSTest) | Cortical thickness | Cortical volume | Corticobasal degeneration | COVID-19 (critical illness vs population or mild symptoms) | COVID-19 (critical illness vs population) | COVID-19 (hospitalized covid vs population) | COVID-19 (hospitalized vs population) | COVID-19 hospitalization or systemic lupus erythematosus (MTAG) | COVID-19 severity | CTF1/ITGB1BP2 protein level ratio | Daytime nap | Depressed affect | Dietary macronutrient intake (multi-trait analysis) | Disruptive behavior (multivariate analysis) | Docosahexaenoic acid levels | Docosahexaenoic acid levels (UKB data field 23450) | Docosahexaenoic acid to total fatty acids percentage (UKB data field 23457) | Dorsolateral prefrontal area (unadjusted for global measures) | Dorsolateral prefrontal thickness (unadjusted for global measures) | Dorsomedial frontal area (unadjusted for global measures) | Drinks per week | Ease of getting up in the morning | ECG cardiac MRI latent space | ECG latent space | Edge-level brain connectivity (multivariate analysis) | Educational attainment | Educational attainment (MTAG) | Educational attainment (years of education) | Eosinophil counts | Eosinophil percentage of white cells | Experiencing mood swings | Eye color | F-acquired taste liking (derived food-liking factor) | F-bitter food liking (derived food-liking factor) | F-cooking vegetables liking (derived food-liking factor) | F-fatty/salty food liking (derived food-liking factor) | F-savoury food liking (derived food-liking factor) | F-sharp flavour liking (derived food-liking factor) | F-small fish liking (derived food-liking factor) | F-strong flavour liking (derived food-liking factor) | F-strong vegetable liking (derived food-liking factor) | Feeling fed-up | Feeling guilty | Feeling hurt | Feeling miserable | Feeling nervous | Feeling worry | FEV1 | Fornix volume | FOXO1/NUB1 protein level ratio | Free testosterone levels | Frontal QRS-T angle | FVC | General cognitive ability | General factor of neuroticism | Generalized anxiety disorder (mental health questionnaire or predicted) | Generalized anxiety disorder (phenotype risk score) | Globe artichoke liking | Goat cheese liking | Granulocyte count | Hand grip strength | Headache | Headache or migraine | Heel bone mineral density | Height | Height (standard GWA) | Hematocrit | Hemoglobin | Hemoglobin concentration | Hemoglobin levels | Herring liking | High light scatter reticulocyte count | High light scatter reticulocyte percentage of red cells | Highest math class taken | Highest math class taken (MTAG) | Hip circumference adjusted for BMI | Horseradish liking | Household income | Household income (MTAG) | Hypertrophic cardiomyopathy | Hypertrophic cardiomyopathy (MTAG) | Hypertrophic cardiomyopathy (sarcomere negative) | Idiopathic pulmonary fibrosis | IDP dMRI ProbtrackX ICVF atr l | IDP dMRI ProbtrackX ICVF atr r | IDP dMRI ProbtrackX ICVF slf l | IDP dMRI ProbtrackX ICVF slf r | IDP dMRI ProbtrackX ICVF str l | IDP dMRI ProbtrackX ICVF str r | IDP dMRI ProbtrackX L1 atr l | IDP dMRI ProbtrackX L1 ptr l | IDP dMRI ProbtrackX L1 slf l | IDP dMRI ProbtrackX L1 slf r | IDP dMRI ProbtrackX L1 str r | IDP dMRI ProbtrackX L2 atr l | IDP dMRI ProbtrackX MD atr l | IDP dMRI ProbtrackX MD str l | IDP dMRI ProbtrackX MD str r | IDP dMRI TBSS ICVF Anterior corona radiata L | IDP dMRI TBSS ICVF Anterior corona radiata R | IDP dMRI TBSS ICVF Anterior limb of internal capsule L | IDP dMRI TBSS ICVF Anterior limb of internal capsule R | IDP dMRI TBSS ICVF Cingulum cingulate gyrus L | IDP dMRI TBSS ICVF Cingulum cingulate gyrus R | IDP dMRI TBSS ICVF External capsule L | IDP dMRI TBSS ICVF External capsule R | IDP dMRI TBSS ICVF Genu of corpus callosum | IDP dMRI TBSS ICVF Posterior limb of internal capsule R | IDP dMRI TBSS ICVF Retrolenticular part of internal capsule L | IDP dMRI TBSS ICVF Superior corona radiata R | IDP dMRI TBSS ICVF Superior fronto-occipital fasciculus L | IDP dMRI TBSS ICVF Superior fronto-occipital fasciculus R | IDP dMRI TBSS L1 Anterior corona radiata L | IDP dMRI TBSS L1 External capsule L | IDP dMRI TBSS L1 External capsule R | IDP dMRI TBSS L1 Superior fronto-occipital fasciculus R | IDP dMRI TBSS L1 Superior longitudinal fasciculus L | IDP dMRI TBSS L1 Superior longitudinal fasciculus R | IDP dMRI TBSS L2 Genu of corpus callosum | IDP dMRI TBSS L2 Superior fronto-occipital fasciculus L | IDP dMRI TBSS L3 Anterior limb of internal capsule L | IDP dMRI TBSS L3 Anterior limb of internal capsule R | IDP dMRI TBSS L3 Genu of corpus callosum | IDP dMRI TBSS L3 Superior fronto-occipital fasciculus L | IDP dMRI TBSS MD Anterior corona radiata L | IDP dMRI TBSS MD Anterior corona radiata R | IDP dMRI TBSS MD Anterior limb of internal capsule L | IDP dMRI TBSS MD Anterior limb of internal capsule R | IDP dMRI TBSS MD Cingulum cingulate gyrus L | IDP dMRI TBSS MD Cingulum cingulate gyrus R | IDP dMRI TBSS MD Genu of corpus callosum | IDP dMRI TBSS MD Posterior limb of internal capsule R | IDP dMRI TBSS MD Superior corona radiata L | IDP dMRI TBSS MD Superior corona radiata R | IDP dMRI TBSS MD Superior fronto-occipital fasciculus L | IDP dMRI TBSS MD Superior fronto-occipital fasciculus R | IDP SWI T2star left putamen | IDP T1 SIENAX brain-normalised volume | IDP T1 SIENAX brain-unnormalised volume | IDP T1 SIENAX white normalised volume | IDP T1 SIENAX white unnormalised volume | Immature fraction of reticulocytes | Inferior parietal area (unadjusted for global measures) | Inferior parietal thickness (unadjusted for global measures) | Intelligence (MTAG) | Interstitial lung disease | Interventricular septum cross-sectional area | Intracranial volume | Irritable mood | ITGB1BP2/MITD1 protein level ratio | Joint mobility (Beighton score) | Lager liking | Left ventricle wall thickness | Left ventricular end diastole anterior wall thickness | Left ventricular end diastole inferolateral wall thickness | Left ventricular end diastole inferoseptal wall thickness | Left ventricular end diastolic mass | Left-handedness | Left-hemisphere limbic network to caudate white-matter structural connectivity | Left–right brain asymmetry | Lifetime smoking (without educational attainment) | Liver enzyme levels (alkaline phosphatase) | Liver liking | Loneliness | Low testosterone levels | Lower thalamus volume | Lumbar spine bone mineral density | Lung function (FEV1) | Lung function (FVC) | Lung function in never smokers (low FEV1 vs high FEV1) | Lymphocyte percentage of white cells | Lymphocyte-to-monocyte ratio | Mackerel liking | Macular thickness | Major depressive disorder or hospitalized COVID-19 (pleiotropy) | Major depressive disorder or severe COVID-19 (pleiotropy) | Male puberty timing (age at voice breaking MTAG) | Male puberty timing (late vs. average onset facial hair) | Male puberty timing (late vs. average onset voice breaking) | Male-pattern baldness | Maximum habitual alcohol consumption | Maximum habitual alcohol consumption (MTAG) | Mean corpuscular volume | Mean reticulocyte volume | Mean spheric corpuscular volume | Medial temporal thickness (unadjusted for global measures) | Medication use (anilides) | Medication use (antithrombotic agents) | Menarche (age at onset) | Middle temporal thickness (unadjusted for global measures) | Moderate to vigorous physical activity duration | Mood instability | Motor premotor area (unadjusted for global measures) | Mouth ulcers | Myeloid white cell count | Neurociticism | Neuroticism | Neutrophil count | Neutrophil percentage of white cells | Neutrophil-to-lymphocyte ratio | Node-level brain connectivity (multivariate analysis) | Number of sexual partners | Number of sexual partners in opposite-sex sexual behavior | Obstructive sleep apnea | Occipital area (unadjusted for global measures) | Occipital thickness (unadjusted for global measures) | Occupational attainment | Omega-3 fatty acid levels | Omega-3 fatty acids levels (UKB data field 23444) | Omega-3 fatty acids to total fatty acids percentage (UKB data field 23451) | Omega-6 fatty acids to omega-3 fatty acids ratio (UKB data field 23459) | Orbitofrontal area (unadjusted for global measures) | Osteoarthritis (hip) | Osteoarthrosis (time to event) | Ovarian cancer or critical COVID-19 (pleiotropy) | Ovarian cancer or hospitalized COVID-19 (pleiotropy) | Pain (pleiotropy) | Parkinson's disease | Parsopercularis area (unadjusted for global measures) | Peak expiratory flow | Personality traits or cognitive traits (multivariate analysis) | Phospholipid levels in large HDL | Phospholipids to total lipids ratio in small HDL | Phospholipids to total lipids ratio in very large HDL | Photoreceptor cell layer thickness phenotypes (MTAG) | Physical activity | Physical activity (overall physical activity time) | Physical activity (Total log acceleration) | Post-traumatic stress disorder (mental health questionnaire or predicted) | Post-traumatic stress disorder (phenotype risk score) | Post-traumatic stress disorder symptom severity (avoidance) | Post-traumatic stress disorder symptom severity (total) | Posterolateral temporal area (unadjusted for global measures) | Precuneus area (unadjusted for global measures) | Primary biliary cirrhosis | Primary open angle glaucoma (MTAG) | Primary open angle glaucoma (multi-trait analysis) | Problematic alcohol use (MTAG) | Progressive supranuclear palsy | Ratio of docosahexaenoic acid to total fatty acid levels | Ratio of omega-3 fatty acids to total fatty acids | Ratio of omega-6 fatty acids to omega-3 fatty acids | Red blood cell count | Red cell distribution width | Refractive error | Regional cortical thickness (inferiorparietal) | Regional cortical thickness (inferiortemporal) | Regional cortical thickness (lateraloccipital) | Regional cortical thickness (middletemporal) | Reticulocyte count | Reticulocyte fraction of red cells | Risk-taking behavior (multivariate analysis) | Risk-taking tendency (4-domain principal component model) | Salad dressing liking | Salami liking | Sardines liking | Schizophrenia | Schizophrenia or breast cancer (pleiotropy) | Schizophrenia or ER positive breast cancer (pleiotropy) | Self-reported math ability | Sensitivity to environmental stress and adversity | Seropositivity for lactobacillus rhamnosus GG peptide (agilent_192425) | Severe COVID-19 or systemic lupus erythematosus (MTAG) | Sleep duration | Sleep duration (long sleep) | Smoking initiation | Snoring | Stool frequency | Subcortical brain region volumes | Sum basophil neutrophil counts | Sum neutrophil eosinophil counts | Superior parietal area (unadjusted for global measures) | Superior temporal area (unadjusted for global measures) | Systemic lupus erythematosus (MTAG) | Systolic blood pressure | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 109) | ThalamNuclei lh volume VAmc | Thalamus volume | Thyroid stimulating hormone levels | Total omega-3 fatty acid levels | Total testosterone levels | Type 1 diabetes | Ventral frontal thickness (unadjusted for global measures) | Ventromedial occipital thickness (unadjusted for global measures) | Vertex-wise cortical surface area | Vertex-wise cortical thickness | Vertex-wise sulcal depth | Waist-hip index | Waist-hip ratio | Waist-to-hip ratio adjusted for BMI | White matter integrity (mean diffusivity) | White matter microstructure (axial diusivities) | White matter microstructure (fractional anisotropy) | White matter microstructure (mean diusivities) | White matter microstructure (radial diusivities) | Whole brain free water diffusion (multivariate analysis) | Whole brain restricted directional diffusion (multivariate analysis) | Whole brain restricted isotropic diffusion (multivariate analysis) | Worry | Worry too long after an embarrassing experience	Ning_2021 (rs2696671), Wen_2024 (rs62064415), Leonardsen_2023 (rs2106786), Kim_2023 (rs147431626), Smith_2020 (rs62064364), Jonsson_2019 (rs2435204)
50	grey matter	17q25.1	17	73873656	rs1105917	T	C	0.1521	0.22596493	0.02909583	7.76623076227762	8.086e-15	0.00109765587856739	54890	intronic	TRIM47	tripartite motif containing 47	protein_coding	0	4	10	14		TRIM47 (1.054)	TRIM47 (1;rs4600514;34.000)	TRIM47 (rs116044941;5e-13)	TRIM47 (rs116044941;1e-09)	TRIM65 (26;1e-24) | FBF1 (24;2e-14) | TEN1 (20;9e-07) | TRIM47 (18;6e-28) | ENSG00000267801 (11;1e-13) | MRPL38 (10;4e-07) | UNC13D (4;2e-11) | WBP2 (4;1e-05) | GALK1 (3;3e-05) | CDK3 (3;3e-05) | ENSG00000267342 (2;2e-05) | UBALD2 (1;1e-05) | ACOX1 (1;9e-05)	TEN1 (48/49;6e-82) | TRIM65 (38/49;1e-184) | FBF1 (36/49;2e-134) | MRPL38 (33/49;4e-52) | ENSG00000267342 (30/49;3e-19) | CDK3 (27/49;3e-17) | TRIM47 (25/49;4e-189) | UNC13D (25/49;5e-36)	TRIM47 (0.68) | TSEN54 (0.39) | GALK1 (0.32)	TRIM47		Mean arterial pressure (BMI adjusted) | Platelet count | Psoriasis | White matter hyperintensities | White matter hyperintensity volume | White matter hyperintensity volume (adjusted for hypertension) | White matter hyperintensity volume x hypertension interaction (2df)	Novel
50	grey and white matter	17q25.1	17	73872969	rs3833085	A	AG	0.8487	-0.19490763	0.02780945	-7.00868337921102	2.406e-12	0.000894142999145408	54890	intronic	TRIM47	tripartite motif containing 47	protein_coding	0	4	24	23		TRIM47 (1.030)	TRIM47 (1;rs4600514;34.000)	TRIM47 (rs116044941;7e-11)	TRIM47 (rs116044941;2e-08)	TRIM65 (26;4e-25) | FBF1 (24;6e-15) | TEN1 (20;4e-06) | TRIM47 (18;2e-27) | ENSG00000267801 (11;9e-13) | MRPL38 (10;4e-07) | UNC13D (4;2e-10) | WBP2 (4;1e-05) | GALK1 (3;8e-06) | CDK3 (3;2e-05) | ENSG00000267342 (2;4e-05) | UBALD2 (1;1e-05) | ACOX1 (1;9e-05)	TEN1 (48/49;1e-77) | TRIM65 (43/49;4e-191) | FBF1 (38/49;4e-133) | ENSG00000267342 (36/49;6e-19) | MRPL38 (30/49;8e-52) | CDK3 (29/49;1e-15) | TRIM47 (25/49;4e-189) | UNC13D (25/49;5e-36)	TRIM47 (0.66) | TSEN54 (0.41) | RECQL5 (0.39)	TRIM47		Mean arterial pressure (BMI adjusted) | Platelet count | Psoriasis | White matter hyperintensities | White matter hyperintensity volume | White matter hyperintensity volume (adjusted for hypertension) | White matter hyperintensity volume x hypertension interaction (2df)	Novel
51	white matter	18q21.2	18	53277143	rs763283047	CCT	C	0.6618	0.12132201	0.0220811	5.49438252623284	3.921e-08	0.000549694742532407	54890	intronic	TCF4	transcription factor 4	protein_coding	0	18	21	20		TCF4 (0.782) | LINC01415 (0.169)	-	-	-	LINC01415 (2;5e-05)	LINC01415 (27/43;2e-24)	TCF4 (0.92)	LINC01415		-	Novel
52	grey and white matter	19q12	19	31036276	19:31036276_AC_A	A	AC	0.1642	0.15076744	0.02712627	5.55798640948424	2.729e-08	0.00056248792074556	54890	intronic	ZNF536	zinc finger protein 536	protein_coding	0	7	71	69 | 263		ZNF536 (1.004)	-	-	-	ENSG00000280061 (4;9e-10)	ENSG00000280061 (28/42;6e-40)	ZNF536 (1.01)	ZNF536		Body mass index | Height	Novel
53	grey and white matter	19q13.32	19	45416178	rs483082	T	G	0.2318	0.15453009	0.02391606	6.46135232977338	1.038e-10	0.000760044868824691	54890	intergenic	APOC1	apolipoprotein C1	protein_coding	1404	4	4	4		APOE (0.618) | APOC1 (0.363)	APOE (1;rs429358;0.007)	-	-	APOC1 (4;2e-06) | APOE (2;1e-10)	-	APOE (2.63) | APOC1 (1.54) | TOMM40 (0.53)	APOE		1-oleoyl-2-linoleoyl-glycerol (18:1/18:2) levels | 1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4) levels | 1-palmitoyl-3-linoleoyl-glycerol (16:0/18:2) levels | 1-palmitoyl-GPE (16:0) levels | 1-stearoyl-2-arachidonoyl-GPE (18:0/20:4) levels | 1-stearoyl-2-linoleoyl-GPE (18:0/18:2) levels | 1-stearoyl-GPE (18:0) levels | 2-palmitoyl-GPE (16:0) levels | ADP-ribosylation factor-like protein 2 levels | Alanine aminotransferase levels | Alzheimer's disease | Apolipoprotein A1 levels | Apolipoprotein B levels | Apolipoprotein C-I levels | Apolipoprotein E levels | Aspartate aminotransferase to alanine aminotransferase ratio | Average diameter for VLDL particles | Average diameter for VLDL particles (UKB data field 23431) | Beta-1,3-N-acetylglucosaminyltransferase radical fringe levels | Beta-1,3-N-acetylglucosaminyltransferase radical fringe levels (RFNG.7203.125.3) | Bioavailable testosterone levels | C-reactive protein levels | Calcium-activated chloride channel regulator 2 levels | Cerebral amyloid angiopathy in Alzheimer’s disease | Cerebral amyloid deposition (PET imaging) | Cerebrospinal fluid amyloid beta 42 levels in abnormal amyloid levels | Cholesterol in large HDL (UKB data field 23561) | Cholesteryl ester_18:2_[M+NH4]1+ levels | Cholesteryl esters in large HDL (UKB data field 23562) | Chronic elevation of alanine aminotransferase (cALT) levels | Cirrhosis | Coactosin-like protein levels | Concentration of large HDL particles | Concentration of very large VLDL particles | Concentration of very large VLDL particles (UKB data field 23488) | CUB and zona pellucida-like domain-containing protein 1 levels (CUZD1.7943.16.3) | Dermokine levels | Diacylglycerol_36:3_[M+H-H2O]1+ levels | Diacylglycerol_36:4_[M+H-H2O]1+ levels | Diacylglycerol_38:5_[M+H-H2O]1+ levels | Diacylglycerol_38:6_[M+H-H2O]1+ levels | Disintegrin and metalloproteinase domain-containing protein 11 levels | Dual specificity protein phosphatase 26 levels | Endothelial monocyte-activating polypeptide 2 levels | Ephrin-B1 levels | Erythrocyte band 7 integral membrane protein levels | Estradiol 17-beta-dehydrogenase 8 levels | Family history of Alzheimer's disease | Fasting apolipoprotein B | Fasting cholesterol esters in large VLDL | Fasting cholesterol esters in very large VLDL | Fasting cholesterol esters in very small VLDL | Fasting free cholesterol in large VLDL | Fasting large VLDL particle concentration | Fasting linoleic acid (18:2) | Fasting phospholipid levels in large VLDL | Fasting phospholipid levels in very large VLDL | Fasting polyunsaturated fatty acids | Fasting remnant cholesterol | Fasting serum total triglycerides | Fasting total cholesterol in large VLDL | Fasting total lipids in large VLDL | Fasting total lipids in very large VLDL | Fasting total lipids in very small VLDL | Fasting triglyceride levels | Fasting triglycerides in VLDL | Fasting triglycerides levels in large VLDL | Fasting triglycerides levels in medium VLDL | Fasting triglycerides levels in small HDL | Fasting triglycerides levels in small VLDL | Fasting triglycerides levels in very large VLDL | Fasting triglycerides levels in very small VLDL | Fasting very large VLDL particle concentration | Free cholesterol in very large VLDL (UKB data field 23493) | Free cholesterol to total lipids ratio in large VLDL | Free cholesterol to total lipids ratio in medium HDL | Glutathione S-transferase Mu 1 levels (GSTM1.7239.9.3) | Glycoprotein acetylation | Glycoprotein acetyls levels | HDL cholesterol levels (UKB data field 23406) | High density lipoprotein cholesterol levels | Hip index | HLA class II histocompatibility antigen, DR beta 3 chain levels | Intelligence | Interferon-induced protein with tetratricopeptide repeats 2 levels | Keratin, type I cytoskeletal 19 levels | Linoleoyl-arachidonoyl-glycerol (18:2/20:4) [1] levels | Linoleoyl-arachidonoyl-glycerol (18:2/20:4) [2] levels | Linoleoyl-linoleoyl-glycerol (18:2/18:2) [1] levels | Lipoprotein (a) levels | Lobar intracerebral hemorrhage | Low density lipoprotein cholesterol levels | Low-density lipoprotein levels (MTAG) | Mental health study participation (completed survey) | Metabolic syndrome | MOB-like protein phocein levels | Multi-trait sex score | Multi-trait sum score | N-acetylated-alpha-linked acidic dipeptidase-like protein levels | Neuralized-like protein 4 levels | Neuronal pentraxin-2 levels | Oleoyl-arachidonoyl-glycerol (18:1/20:4) [2] levels | Oleoyl-linoleoyl-glycerol (18:1/18:2) [1] levels | Oleoyl-linoleoyl-glycerol (18:1/18:2) [2] levels | Oleoyl-oleoyl-glycerol (18:1/18:1) [2] levels | Phosphatidylcholine-O(39:1)_[M+H]1+/Phosphatidylethanolamine-P(39:0)_[M+H]1+ levels | Phosphatidylglycerol-O_42:0_[M-H]1- levels | Phospholipid levels in very large VLDL | Phospholipids in very large HDL | Phospholipids in very large VLDL (UKB data field 23490) | Plasma linoleoyl-arachidonoyl-glycerol (18:2/20:4) [1]* levels in chronic kidney disease | Plasma linoleoyl-arachidonoyl-glycerol (18:2/20:4) [2]* levels in chronic kidney disease | Plasma oleoyl-arachidonoyl-glycerol (18:1/20:4) [1]* levels in chronic kidney disease | Plasma oleoyl-arachidonoyl-glycerol (18:1/20:4) [2]* levels in chronic kidney disease | Platelet distribution width | Postprandial apolipoprotein B | Postprandial cholesterol esters in large VLDL | Postprandial cholesterol esters in very large VLDL | Postprandial free cholesterol in large VLDL | Postprandial free cholesterol in medium VLDL | Postprandial large VLDL particle concentration | Postprandial linoleic acid (18:2) | Postprandial medium VLDL particle concentration | Postprandial omega-6 fatty acids | Postprandial phospholipid levels in large VLDL | Postprandial polyunsaturated fatty acids | Postprandial remnant cholesterol | Postprandial serum total triglycerides | Postprandial total cholesterol in large VLDL | Postprandial total cholesterol in very large VLDL | Postprandial total lipids in large VLDL | Postprandial total lipids in medium VLDL | Postprandial total lipids in very small VLDL | Postprandial triglyceride levels | Postprandial triglycerides in VLDL | Postprandial triglycerides levels in large VLDL | Postprandial triglycerides levels in medium VLDL | Postprandial triglycerides levels in small HDL | Postprandial triglycerides levels in small VLDL | Postprandial triglycerides levels in very small VLDL | Prenylcysteine oxidase 1 levels | Protein FAM69C levels | Protein MENT levels (MENT.5744.12.3) | Protein S100-A13 levels | Protocadherin beta-10 levels | Quinone oxidoreductase-like protein 1 levels | RAC-beta serine/threonine-protein kinase levels | Ras-related protein Rab-14 levels | Ras-related protein Rab-14 levels (RAB14.14283.12.3) | Ratio of triglycerides to phosphoglycerides | Repulsive guidance molecule A levels | Selenoprotein S levels | Serum albumin levels | Serum levels of protein ADAM11 | Serum levels of protein AKT2 | Serum levels of protein ARFGAP1 | Serum levels of protein C1orf56 | Serum levels of protein CRYZL1 | Serum levels of protein CUZD1 | Serum levels of protein FAM159B | Serum levels of protein GAL3ST2 | Serum levels of protein GGT2 | Serum levels of protein GSTM1 | Serum levels of protein HBQ1 | Serum levels of protein HDAC8 | Serum levels of protein HLA-DRB3 | Serum levels of protein IFIT2 | Serum levels of protein NEFL | Serum levels of protein NPTX2 | Serum levels of protein PSG5 | Serum levels of protein RAB14 | Serum levels of protein TMCC3 | Serum levels of protein TOM1L1 | Serum levels of protein TP53I11 | Serum levels of protein YWHAQ | Sex hormone-binding globulin levels | Sex hormone-binding globulin levels adjusted for BMI | SH2 domain-containing protein 3C levels | Sphingomyelin_38:1_[M+H]1+ levels | Sphingomyelin(34:0)_[M+H]1+ levels | Sphingomyelin(42:0)_[M+OAc]1- levels | Synaptotagmin-like protein 4 levels | TOM1-like protein 1 levels | TOM1-like protein 1 levels (TOM1L1.13652.2.3) | Total cholesterol levels | Total lipid levels in large HDL | Total lipid levels in very large VLDL | Total lipids in large HDL (UKB data field 23559) | Total lipids in very large VLDL (UKB data field 23489) | Total triglycerides levels | Total triglycerides levels (UKB data field 23407) | Triacylglycerol_56:5_[M+NH4]1+ levels | Triacylglycerol_56:6_[M+NH4]1+ levels | Triacylglycerol_56:7_[M+NH4]1+ levels | Triglyceride levels | Triglyceride levels (MTAG) | Triglyceride levels in IDL | Triglyceride levels in non-type 2 diabetes | Triglyceride levels in small LDL | Triglyceride levels in small VLDL | Triglyceride levels in very large HDL | Triglyceride levels in very large VLDL | Triglyceride levels in very small VLDL | Triglyceride levels in VLDL | Triglyceride levels x short total sleep time interaction (2df test) | Triglyceride to HDL cholesterol ratio | Triglycerides | Triglycerides in small HDL | Triglycerides in small VLDL (UKB data field 23515) | Triglycerides in very large HDL (UKB data field 23557) | Triglycerides in very large VLDL (UKB data field 23494) | Triglycerides in VLDL (UKB data field 23408) | Triglycerides to total lipids ratio in medium HDL | Triglycerides to total lipids ratio in small HDL | Triglycerides to total lipids ratio in very large HDL | Tubulin-specific chaperone A levels (TBCA.12501.10.3) | Ubiquitin-conjugating enzyme E2 G2 levels | Uncharacterized protein C14orf93 levels | Waist-hip index | Waist-to-hip ratio adjusted for BMI	Smith_2020 (rs429358)
53	white matter	19q13.32	19	45416178	rs483082	T	G	0.2318	0.15447274	0.02497797	6.1843592573776	6.235e-10	0.000696321012286487	54890	intergenic	APOC1	apolipoprotein C1	protein_coding	1404	4	4	6		APOE (0.425) | APOC1 (0.358) | TOMM40 (0.186)	APOE (1;rs429358;0.007)	-	-	APOC1 (4;2e-06) | APOE (2;1e-10)	-	APOE (3.18) | APOC1 (1.68) | CLPTM1 (0.40)	APOE		1-oleoyl-2-linoleoyl-glycerol (18:1/18:2) levels | 1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4) levels | 1-palmitoyl-3-linoleoyl-glycerol (16:0/18:2) levels | 1-palmitoyl-GPE (16:0) levels | 1-stearoyl-2-arachidonoyl-GPE (18:0/20:4) levels | 1-stearoyl-2-linoleoyl-GPE (18:0/18:2) levels | 1-stearoyl-GPE (18:0) levels | 2-palmitoyl-GPE (16:0) levels | ADP-ribosylation factor-like protein 2 levels | Alanine aminotransferase levels | Alzheimer's disease | Apolipoprotein A1 levels | Apolipoprotein B levels | Apolipoprotein C-I levels | Apolipoprotein E levels | Aspartate aminotransferase to alanine aminotransferase ratio | Average diameter for VLDL particles | Average diameter for VLDL particles (UKB data field 23431) | Beta-1,3-N-acetylglucosaminyltransferase radical fringe levels | Beta-1,3-N-acetylglucosaminyltransferase radical fringe levels (RFNG.7203.125.3) | Bioavailable testosterone levels | C-reactive protein levels | Calcium-activated chloride channel regulator 2 levels | Cerebral amyloid angiopathy in Alzheimer’s disease | Cerebral amyloid deposition (PET imaging) | Cerebrospinal fluid amyloid beta 42 levels in abnormal amyloid levels | Cholesterol in large HDL (UKB data field 23561) | Cholesteryl ester_18:2_[M+NH4]1+ levels | Cholesteryl esters in large HDL (UKB data field 23562) | Chronic elevation of alanine aminotransferase (cALT) levels | Cirrhosis | Coactosin-like protein levels | Concentration of large HDL particles | Concentration of very large VLDL particles | Concentration of very large VLDL particles (UKB data field 23488) | CUB and zona pellucida-like domain-containing protein 1 levels (CUZD1.7943.16.3) | Dermokine levels | Diacylglycerol_36:3_[M+H-H2O]1+ levels | Diacylglycerol_36:4_[M+H-H2O]1+ levels | Diacylglycerol_38:5_[M+H-H2O]1+ levels | Diacylglycerol_38:6_[M+H-H2O]1+ levels | Disintegrin and metalloproteinase domain-containing protein 11 levels | Dual specificity protein phosphatase 26 levels | Endothelial monocyte-activating polypeptide 2 levels | Ephrin-B1 levels | Erythrocyte band 7 integral membrane protein levels | Estradiol 17-beta-dehydrogenase 8 levels | Family history of Alzheimer's disease | Fasting apolipoprotein B | Fasting cholesterol esters in large VLDL | Fasting cholesterol esters in very large VLDL | Fasting cholesterol esters in very small VLDL | Fasting free cholesterol in large VLDL | Fasting large VLDL particle concentration | Fasting linoleic acid (18:2) | Fasting phospholipid levels in large VLDL | Fasting phospholipid levels in very large VLDL | Fasting polyunsaturated fatty acids | Fasting remnant cholesterol | Fasting serum total triglycerides | Fasting total cholesterol in large VLDL | Fasting total lipids in large VLDL | Fasting total lipids in very large VLDL | Fasting total lipids in very small VLDL | Fasting triglyceride levels | Fasting triglycerides in VLDL | Fasting triglycerides levels in large VLDL | Fasting triglycerides levels in medium VLDL | Fasting triglycerides levels in small HDL | Fasting triglycerides levels in small VLDL | Fasting triglycerides levels in very large VLDL | Fasting triglycerides levels in very small VLDL | Fasting very large VLDL particle concentration | Free cholesterol in very large VLDL (UKB data field 23493) | Free cholesterol to total lipids ratio in large VLDL | Free cholesterol to total lipids ratio in medium HDL | Glutathione S-transferase Mu 1 levels (GSTM1.7239.9.3) | Glycoprotein acetylation | Glycoprotein acetyls levels | HDL cholesterol levels (UKB data field 23406) | High density lipoprotein cholesterol levels | Hip index | HLA class II histocompatibility antigen, DR beta 3 chain levels | Intelligence | Interferon-induced protein with tetratricopeptide repeats 2 levels | Keratin, type I cytoskeletal 19 levels | Linoleoyl-arachidonoyl-glycerol (18:2/20:4) [1] levels | Linoleoyl-arachidonoyl-glycerol (18:2/20:4) [2] levels | Linoleoyl-linoleoyl-glycerol (18:2/18:2) [1] levels | Lipoprotein (a) levels | Lobar intracerebral hemorrhage | Low density lipoprotein cholesterol levels | Low-density lipoprotein levels (MTAG) | Mental health study participation (completed survey) | Metabolic syndrome | MOB-like protein phocein levels | Multi-trait sex score | Multi-trait sum score | N-acetylated-alpha-linked acidic dipeptidase-like protein levels | Neuralized-like protein 4 levels | Neuronal pentraxin-2 levels | Oleoyl-arachidonoyl-glycerol (18:1/20:4) [2] levels | Oleoyl-linoleoyl-glycerol (18:1/18:2) [1] levels | Oleoyl-linoleoyl-glycerol (18:1/18:2) [2] levels | Oleoyl-oleoyl-glycerol (18:1/18:1) [2] levels | Phosphatidylcholine-O(39:1)_[M+H]1+/Phosphatidylethanolamine-P(39:0)_[M+H]1+ levels | Phosphatidylglycerol-O_42:0_[M-H]1- levels | Phospholipid levels in very large VLDL | Phospholipids in very large HDL | Phospholipids in very large VLDL (UKB data field 23490) | Plasma linoleoyl-arachidonoyl-glycerol (18:2/20:4) [1]* levels in chronic kidney disease | Plasma linoleoyl-arachidonoyl-glycerol (18:2/20:4) [2]* levels in chronic kidney disease | Plasma oleoyl-arachidonoyl-glycerol (18:1/20:4) [1]* levels in chronic kidney disease | Plasma oleoyl-arachidonoyl-glycerol (18:1/20:4) [2]* levels in chronic kidney disease | Platelet distribution width | Postprandial apolipoprotein B | Postprandial cholesterol esters in large VLDL | Postprandial cholesterol esters in very large VLDL | Postprandial free cholesterol in large VLDL | Postprandial free cholesterol in medium VLDL | Postprandial large VLDL particle concentration | Postprandial linoleic acid (18:2) | Postprandial medium VLDL particle concentration | Postprandial omega-6 fatty acids | Postprandial phospholipid levels in large VLDL | Postprandial polyunsaturated fatty acids | Postprandial remnant cholesterol | Postprandial serum total triglycerides | Postprandial total cholesterol in large VLDL | Postprandial total cholesterol in very large VLDL | Postprandial total lipids in large VLDL | Postprandial total lipids in medium VLDL | Postprandial total lipids in very small VLDL | Postprandial triglyceride levels | Postprandial triglycerides in VLDL | Postprandial triglycerides levels in large VLDL | Postprandial triglycerides levels in medium VLDL | Postprandial triglycerides levels in small HDL | Postprandial triglycerides levels in small VLDL | Postprandial triglycerides levels in very small VLDL | Prenylcysteine oxidase 1 levels | Protein FAM69C levels | Protein MENT levels (MENT.5744.12.3) | Protein S100-A13 levels | Protocadherin beta-10 levels | Quinone oxidoreductase-like protein 1 levels | RAC-beta serine/threonine-protein kinase levels | Ras-related protein Rab-14 levels | Ras-related protein Rab-14 levels (RAB14.14283.12.3) | Ratio of triglycerides to phosphoglycerides | Repulsive guidance molecule A levels | Selenoprotein S levels | Serum albumin levels | Serum levels of protein ADAM11 | Serum levels of protein AKT2 | Serum levels of protein ARFGAP1 | Serum levels of protein C1orf56 | Serum levels of protein CRYZL1 | Serum levels of protein CUZD1 | Serum levels of protein FAM159B | Serum levels of protein GAL3ST2 | Serum levels of protein GGT2 | Serum levels of protein GSTM1 | Serum levels of protein HBQ1 | Serum levels of protein HDAC8 | Serum levels of protein HLA-DRB3 | Serum levels of protein IFIT2 | Serum levels of protein NEFL | Serum levels of protein NPTX2 | Serum levels of protein PSG5 | Serum levels of protein RAB14 | Serum levels of protein TMCC3 | Serum levels of protein TOM1L1 | Serum levels of protein TP53I11 | Serum levels of protein YWHAQ | Sex hormone-binding globulin levels | Sex hormone-binding globulin levels adjusted for BMI | SH2 domain-containing protein 3C levels | Sphingomyelin_38:1_[M+H]1+ levels | Sphingomyelin(34:0)_[M+H]1+ levels | Sphingomyelin(42:0)_[M+OAc]1- levels | Synaptotagmin-like protein 4 levels | TOM1-like protein 1 levels | TOM1-like protein 1 levels (TOM1L1.13652.2.3) | Total cholesterol levels | Total lipid levels in large HDL | Total lipid levels in very large VLDL | Total lipids in large HDL (UKB data field 23559) | Total lipids in very large VLDL (UKB data field 23489) | Total triglycerides levels | Total triglycerides levels (UKB data field 23407) | Triacylglycerol_56:5_[M+NH4]1+ levels | Triacylglycerol_56:6_[M+NH4]1+ levels | Triacylglycerol_56:7_[M+NH4]1+ levels | Triglyceride levels | Triglyceride levels (MTAG) | Triglyceride levels in IDL | Triglyceride levels in non-type 2 diabetes | Triglyceride levels in small LDL | Triglyceride levels in small VLDL | Triglyceride levels in very large HDL | Triglyceride levels in very large VLDL | Triglyceride levels in very small VLDL | Triglyceride levels in VLDL | Triglyceride levels x short total sleep time interaction (2df test) | Triglyceride to HDL cholesterol ratio | Triglycerides | Triglycerides in small HDL | Triglycerides in small VLDL (UKB data field 23515) | Triglycerides in very large HDL (UKB data field 23557) | Triglycerides in very large VLDL (UKB data field 23494) | Triglycerides in VLDL (UKB data field 23408) | Triglycerides to total lipids ratio in medium HDL | Triglycerides to total lipids ratio in small HDL | Triglycerides to total lipids ratio in very large HDL | Tubulin-specific chaperone A levels (TBCA.12501.10.3) | Ubiquitin-conjugating enzyme E2 G2 levels | Uncharacterized protein C14orf93 levels | Waist-hip index | Waist-to-hip ratio adjusted for BMI	Smith_2020 (rs429358)
54	grey matter	20q11.21	20	30336992	rs6060924	A	G	0.7093	0.14403343	0.02298341	6.26684334483003	3.684e-10	0.000715005918387753	54890	intronic	TPX2	TPX2 microtubule nucleation factor	protein_coding	0	9	133	86 | 2059		BCL2L1 (0.548) | TPX2 (0.442)	-	-	-	COX4I2 (21;6e-16) | MYLK2 (13;4e-16) | DEFB124 (9;9e-22) | ANKRD20A21P (9;9e-09) | DUSP15 (5;2e-05) | FOXS1 (3;1e-09) | TPX2 (3;2e-08) | TTLL9 (3;2e-08) | ABALON (3;2e-07) | HM13 (2;6e-18) | BCL2L1 (2;2e-13) | REM1 (1;8e-11) | HM13-AS1 (1;2e-08) | ENSG00000226239 (1;6e-05) | POFUT1 (1;1e-04)	ANKRD20A21P (24/25;5e-53) | COX4I2 (45/47;3e-177) | ABALON (25/49;4e-28)	ID1 (0.83) | FOXS1 (0.83) | BCL2L1 (0.69)	BCL2L1		aseg lh volume Putamen | aseg rh volume Pallidum | Brain morphology (min-P) | Brain morphology (MOSTest) | Brain region volumes | Caudate nucleus volume | Height | Lung function (forced vital capacity) | Lung function (FVC) | Pallidum volume | Parkinson's disease | Platelet count | Platelet-to-lymphocyte ratio | Plateletcrit | Prostate cancer | Putamen volume | Subcortical brain region volumes | Subcortical volume (min-P) | Subcortical volume (MOSTest) | Vertex-wise cortical thickness | Vertex-wise sulcal depth	Smith_2020 (rs1888995)
55	white matter	22q13.1	22	38457329	rs738442	T	C	0.3753	-0.21345619	0.02148412	-9.93553331483905	2.916e-23	0.00179524858994362	54890	intronic	PICK1	protein interacting with PRKCA 1	protein_coding	0	23	8	8		PICK1 (0.704) | SLC16A8 (0.120) | POLR2F (0.070) | BAIAP2L2 (0.064)	SLC16A8 (2;rs2076371;1.374) | BAIAP2L2 (1;rs142739979;NA)	PICK1 (rs6000991;2e-16) | POLR2F (rs742396;2e-12) | SLC16A8 (rs6000991;4e-11) | SOX10 (rs2076370;2e-10) | AL031587.1 (rs6000991;2e-09) | AL031587.4 (rs2076370;4e-07)	PICK1 (rs5756894;4e-10)	PICK1 (21;4e-26) | SLC16A8 (13;1e-31) | TRIOBP (13;2e-09) | ENSG00000272720 (9;5e-19) | BAIAP2L2 (5;9e-48) | MICALL1 (4;1e-06) | TMEM184B (3;7e-07) | GCAT (3;9e-07) | GALR3 (1;5e-12) | ENSG00000279010 (1;2e-07) | NOL12 (1;3e-06) | CSNK1E (1;1e-05) | PDXP-DT (1;2e-05) | C22orf23 (1;3e-05) | ENSG00000273866 (1;3e-05) | ENSG00000279738 (1;4e-05) | TPTEP2 (1;4e-05) | H1-0 (1;6e-05) | POLR2F (1;6e-05)	TRIOBP (43/49;1e-78) | PICK1 (26/49;4e-223)	LGALS1 (1.24) | SOX10 (1.09) | PICK1 (0.84)	PICK1		aseg lh volume CerebralWhiteMatter | aseg rh volume CerebralWhiteMatter | Brain morphology (MOSTest) | Corpus callosum fractional anisotropy (body) | Corpus callosum fractional anisotropy (MOSTest) | Corpus callosum fractional anisotropy (splenium) | IDP dMRI ProbtrackX FA fmi | IDP dMRI ProbtrackX FA ifo r | IDP dMRI ProbtrackX ICVF cgc r | IDP dMRI ProbtrackX ICVF fmi | IDP dMRI ProbtrackX ICVF ilf r | IDP dMRI ProbtrackX L3 cgc l | IDP dMRI ProbtrackX L3 fmi | IDP dMRI ProbtrackX MD cgc l | IDP dMRI TBSS FA Genu of corpus callosum | IDP dMRI TBSS ICVF Genu of corpus callosum | IDP dMRI TBSS ICVF Sagittal stratum R | IDP dMRI TBSS L3 Sagittal stratum L | IDP dMRI TBSS L3 Sagittal stratum R | IDP dMRI TBSS MD Sagittal stratum R | IDP T1 SIENAX white normalised volume | IDP T1 SIENAX white unnormalised volume | Regional cortical thickness (cuneus) | Ventral frontal thickness (unadjusted for global measures) | White matter microstructure (fractional anisotropy)	Smith_2020 (rs742396), Wen_2024 (rs1894525)
55	grey and white matter	22q13.1	22	38450620	rs2018980	A	G	0.3717	-0.15923167	0.02064007	-7.7146865296484	1.213e-14	0.00108314974293296	54890	intergenic	PICK1	protein interacting with PRKCA 1	protein_coding	2642	7	11	11		PICK1 (0.929) | SLC16A8 (0.059)	SLC16A8 (1;rs4289289;24.100)	PICK1 (rs6000991;1e-11) | POLR2F (rs742396;1e-09) | AL022322.1 (rs5756894;2e-09) | SLC16A8 (rs6000991;7e-09) | SOX10 (rs2076370;2e-08) | AL031587.1 (rs6000991;7e-08) | AL031587.4 (rs2076370;3e-06)	PICK1 (rs5756894;2e-08)	PICK1 (21;1e-25) | SLC16A8 (13;9e-31) | TRIOBP (13;5e-09) | ENSG00000272720 (9;6e-19) | BAIAP2L2 (5;7e-48) | MICALL1 (4;1e-06) | GCAT (3;2e-07) | TMEM184B (3;2e-07) | GALR3 (1;8e-13) | ENSG00000279010 (1;2e-07) | NOL12 (1;1e-06) | CSNK1E (1;1e-05) | PDXP-DT (1;2e-05) | C22orf23 (1;3e-05) | ENSG00000273866 (1;3e-05) | ENSG00000279738 (1;4e-05) | TPTEP2 (1;4e-05) | H1-0 (1;5e-05) | POLR2F (1;6e-05)	TRIOBP (41/49;1e-73) | PICK1 (26/49;4e-223)	PICK1 (1.05) | LGALS1 (0.86) | SOX10 (0.65)	PICK1		aseg lh volume CerebralWhiteMatter | aseg rh volume CerebralWhiteMatter | Brain morphology (MOSTest) | Corpus callosum fractional anisotropy (body) | Corpus callosum fractional anisotropy (MOSTest) | Corpus callosum fractional anisotropy (splenium) | IDP dMRI ProbtrackX FA fmi | IDP dMRI ProbtrackX FA ifo r | IDP dMRI ProbtrackX ICVF cgc r | IDP dMRI ProbtrackX ICVF fmi | IDP dMRI ProbtrackX ICVF ilf r | IDP dMRI ProbtrackX L3 cgc l | IDP dMRI ProbtrackX L3 fmi | IDP dMRI ProbtrackX MD cgc l | IDP dMRI TBSS FA Genu of corpus callosum | IDP dMRI TBSS ICVF Genu of corpus callosum | IDP dMRI TBSS ICVF Sagittal stratum R | IDP dMRI TBSS L3 Sagittal stratum L | IDP dMRI TBSS L3 Sagittal stratum R | IDP dMRI TBSS MD Sagittal stratum R | IDP T1 SIENAX white normalised volume | IDP T1 SIENAX white unnormalised volume | Regional cortical thickness (cuneus) | Ventral frontal thickness (unadjusted for global measures) | White matter microstructure (fractional anisotropy)	Smith_2020 (rs742396), Wen_2024 (rs1894525)
56	grey matter	Xp22.2	X	13891499	rs2188767	A	G	0.4154	0.10708689	0.01745761	6.13410942276749	8.564e-10	0.0006850590564229	54890	intronic	GPM6B	glycoprotein M6B	protein_coding	0	-	1 | 10	1 | 1 | 7		-	-	-	-	GEMIN8 (3;2e-05) | GPM6B (1;6e-21) | OFD1 (1;9e-15) | RAB9A (1;3e-10)	GEMIN8 (45/49;5e-34)	-	GEMIN8		Left-hemisphere default mode network to right-hemisphere control network white-matter structural connectivity | Left-hemisphere default mode network to right-hemisphere default mode network white-matter structural connectivity | Left-hemisphere salience/ventral attention network to right-hemisphere salience/ventral attention network white-matter structural connectivity	Novel
56	grey and white matter	Xp22.2	X	13891499	rs2188767	A	G	0.4154	0.09657698	0.01666613	5.79480539273365	6.84e-09	0.000611413030735121	54890	intronic	GPM6B	glycoprotein M6B	protein_coding	0	-	8	10		-	-	-	-	GEMIN8 (3;2e-05) | GPM6B (1;6e-21) | OFD1 (1;9e-15) | RAB9A (1;3e-10)	GEMIN8 (45/49;5e-34)	-	GEMIN8		Left-hemisphere default mode network to right-hemisphere control network white-matter structural connectivity | Left-hemisphere default mode network to right-hemisphere default mode network white-matter structural connectivity | Left-hemisphere salience/ventral attention network to right-hemisphere salience/ventral attention network white-matter structural connectivity	Novel
57	grey matter	Xq22.3	X	107888149	X:107888149_CAA_C	CAA	C	0.7409	-0.11428578	0.02045899	-5.5860910044924	2.322e-08	0.000568187632070813	54890	intronic	COL4A5	collagen type IV alpha 5 chain	protein_coding	0	-	-	176		-	-	-	-	-	-	-	-		-	Novel
58	grey matter	Xq26.3	X	133781440	X:133781440_CTG_C	CTG	C	0.2876	-0.1127918	0.02001977	-5.63402077046839	1.761e-08	0.000577974126903762	54890	intronic	PLAC1	placenta enriched 1	protein_coding	0	-	41 | 60	41 | 60		-	-	-	-	-	-	-	-		-	Novel
59	white matter	Xp22.33	XY	2149565	rs34250447	T	C	0.7428	-0.25149953	0.02494865	-10.0806869309562	6.725e-24	0.00191243343147823	53037	intronic	DHRSX	dehydrogenase/reductase X-linked	protein_coding	0	-	54	54		-	-	-	-	DHRSX (11;7e-12) | DHRSX-IT1 (1;4e-05)	DHRSX (47/49;2e-109) | DHRSX-IT1 (25/34;6e-18)	-	DHRSX		-	Novel
59	grey and white matter	Xp22.33	XY	2137156	rs35679611	A	G	0.758	-0.22475779	0.02376448	-9.45771967238501	3.147e-21	0.00168375322458941	53037	downstream	DHRSX	dehydrogenase/reductase X-linked	protein_coding	0	-	38	38		-	-	-	-	DHRSX (11;7e-12) | CD99 (1;7e-06) | DHRSX-IT1 (1;4e-05)	DHRSX (47/49;2e-109) | DHRSX-IT1 (25/34;6e-18)	-	DHRSX		-	Novel
59	grey matter	Xp22.33	XY	2124487	rs189737749	T	C	0.2435	0.16869295	0.02539927	6.6416456063501	3.102e-11	0.000831051145168781	53037	intergenic	DHRSX	dehydrogenase/reductase X-linked	protein_coding	13068	-	48	47		-	-	-	-	DHRSX (11;2e-10) | CD99 (1;7e-06) | DHRSX-IT1 (1;4e-05)	DHRSX (47/49;4e-105) | DHRSX-IT1 (25/34;6e-18)	-	DHRSX		-	Novel
